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The international system of units and units derived thereof have been used. 
[M+H]+ molecular ion plus hydrogen 
[M-H]- molecular ion minus hydrogen 
× g gravitational acceleration 
5-FOA 5-fluoroorotic acid 
6-MSA 6-methylsalicyclic acid 
A domain adenylation domain 
A. cristatus Aspergillus cristatus 
A. fumigatus Aspergillus fumigatus 
A. glaucus Aspergillus glaucus 
A. nidulans Aspergillus nidulans 
A. niger Aspergillus niger 
A. oryzae Aspergillus oryzae 
A. ruber Aspergillus ruber 
aa amino acid 
ACP domain acylcarrier protein domain 
AT domain acyl transferase domain 
ATP adenosine triphosphate 
BGC biosynthetic gene cluster 
br broad (NMR signal) 
C domain condensation domain 
C. purpurea Claviceps purpurea 
CD3OD deuterated methanol 
CDB czapek dox broth 
CDCl3 deuterated chloroform 
cDNA copy deoxyribonucleic acid 
CLF  chain length factor 
CoA coenzyme A 





dd double doublet 
ddd double double doublet 
DEBS 6-deoxyerythronolide B synthase 




DMAPP dimethylallyl diphosphate 
DMATS dimethylallyltryptophan synthase 
DMOA 3,5-dimehtylorsellinic acid 
DMSO dimethyl sulfide  
DMSO-d6 deuterated dimethyl sulfoxid 
DNA deoxyribonucleic acid 
dq double quartet 
dt double triplet 
E. coli. Escherichia coli 




ECFP extended connectivity fingerprint 
EIC extracted ion chromatogram 
ER domain enoylreductase domain 
ESI electrospray ionization 
EtOAc ethyl acetate 
FPP farnesyl diphosphate 
GA general prenyl moiety acceptor 
GB general base 
GD general prenyl moiety donor 
GGPP geranylgeranyl diphosphate 
GMM glucose minimal medium 
GP general prenylation product 
GPP geranyl diphosphate 
GTP guanosine triphosphate 
His6 hexahistidine 
HMBC heteronuclear multiple bond correlation 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrometry 
HR-PKS highly reducing-polyketide synthase 
HSQC heteronuclear single quantum coherence 
Hz hertz 
i.e. id est 
IPP isopentenyl pyrophosphate 
J coupling constant 
JGI Joint Genome Institute 
kBp kilo base pairs 
kcat turnover number 
kDa kilodaltons 
KM Michaelis-Menten constant 
KR domain ketoreductase domain 
KS domain ketoacyltransferase domain 
LB lysogeny broth 
LC-MS liquid chromatography–mass spectrometry 
m multiplet 
m/z mass-to-charge ratio 
mAU milliabsorbance unit 
Mb mega base pairs 
MCAT malonyl-CoA:ACP transferase 
MEP methylerythritol phosphate 
MHz mega hertz 
mRNA messenger ribonucleic acid 
MT domain methyl transferase domain 
multi multiplicity 
MVA mevalonate 
n × C5 number of C5 units, minimum 1 
NADH nicotinamide adenine dinucleotide 
NADPH nicotinamide adenine dinucleotide phosphate 
NMR nuclear magnetic resonance 
NP natural product 
NR-PKS non-reducing-polyketide synthase 
NRPS nonribosomal peptide synthetase 
OSMAC one strain many compounds 




P. crustosum Penicillium crustosum 
P. rubens Penicillium rubens 
PCP   peptidyl carrier protein domain 
PCR polymerase chain reaction 
PD potato dextrose 
PDB potato dextrose broth 
PEG polyethylene glycol 
PFAM protein family (database) 
PGB protonated general base 
PKS polyketide synthase 
PKS-NRPS polyketide synthase-nonribosomal peptide synthetase 
PPi inorganic pyrophosphate 
ppm parts per million 
PR-PKS partially reducing-polyketide synthase 
PT prenyltransferase 
PT domain product template domain 
q quartet 
R domain release domain 
RBS ribosome binding site 
RNA ribonucleic acid 
rpm revolutions per minute 
s singlet 
S. cerevisiae Saccharomyces cerevisiae 
SAT domain starter unit acyl transferase domain 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SM secondary metabolite 
SMARTS SMILES arbitrary target specification 
SMILES simplified molecular input line entry system 
SMIRKS a hybrid language of SMILES and SMARTS 
t triplet 
T domain thiolation domain 
TB terrific broth 
td triple doublet 
TE domain thioesterase domain 
Tris 2-amino-2-(hydroxymethyl)-propan-1,3-diol 
tsept triple septet 
UTR untranslated region 
UV ultraviolet 
v/v volume per volume 
w/v weight per volume 
WT wild type  







At least 3.5 billion years ago, the first life on earth arose. This was the starting point of the evolutionary 
development of numerous living beings. According to current estimations, there are 1012 different 
species on our planet. Most of this enormous biodiversity originates from the kingdom of bacteria and 
archaea. Based on these estimations, only 0.001 % of all species are known to this day. The 
omnipresent competition between living beings led to the development of secondary metabolism. The 
metabolites derived from this metabolism are not essential for survival, yet their production offers the 
organism various selection advantages. Plants, bacteria, and fungi are the main producers of secondary 
metabolites. The more than 2,140,000 million known secondary metabolites can be divided into five 
large groups: (1) non-ribosomal polypeptides, (2) polyketides, (3) alkaloids, (4) terpenoids and steroids 
and (5) enzyme cofactors. Many of these natural compounds show a biological or pharmaceutical 
activity and were used for the development of drugs. The large number of not yet identified 
microorganisms harbors an enormous, mostly unused genetic potential to produce further new natural 
compounds. Such compounds may be suitable for the development of urgently needed new drugs. 
Various approaches, such as heterologous expression in suitable host organisms, are being 
investigated to make this potential accessible. Additionally, through synthetic biology approaches, the 
diversity of natural substances can be further extended, and new natural substances can be discovered 
or produced. 
In the context of research on secondary metabolites, this work focuses on three main topics: 1. The 
extension of the spectrum of possible substrates for prenyltransferases, by using a database to predict 
new substrates. 2. The identification and characterization of previously unknown biosynthetic gene 
clusters, as well as the investigation of a possible application of the enzymes involved to produce new 
natural substances. 3. The generation of a host for the heterologous expression of secondary 
metabolite genes and investigation of their unknown products. 
Prenyltransferases catalyze the transfer of prenyl units (n × C5) to their target substrates. This is of 
importance, as an increase in the biological activity of prenylated compounds compared to their 
unprenylated counterparts has been observed for many compounds. A special property of 
prenyltransferases is their promiscuity with respect to the substrates. This makes them suitable 
candidates to produce pharmaceutically active substances. However, in practice, it is difficult to 
identify new substrates for prenyltransferases. In order to address this problem, a database, PrenDB, 
was developed for the prediction of such substrates. The predictive power of this database was 
experimentally tested with 38 predicted substrates by their acceptance with the prenyltransferases 
FtmPT1, FgapT2, and CdpNPT. For 27 of the 38 substrates, prenylation by at least one of the three 
tested enzymes was observed, 17 with conversion yields of more than 50 %. This proved the predictive 
power of the developed database and enabled the targeted selection of new potential substrates and 




The identification of biosynthetic gene clusters and the subsequent biochemical characterization of 
the enzymes involved in the biosynthetic pathways form the basis for synthetic biology approaches to 
produce natural products. Based on the cyclic dipeptide echinulin, a possible procedure for the 
identification of the responsible gene cluster and the use of the involved enzymes for the biosynthesis 
of new substances was described. The enzymatic prerequisites for the biosynthesis of echinulin were 
determined based on the structural peculiarities of echinulin. Potential candidate gene clusters must 
encode one non-ribosomal peptide synthetase and several prenyltransferases. In the genome of the 
echinulin producer Aspergillus ruber, a gene cluster with these prerequisites was identified. Enzyme 
assays with the echinulin precursor cyclo-L-tryptophanyl-L-alaninyl and the heterologously produced 
prenyltransferases EchPT1 and EchPT2 led to a well-founded biosynthetic hypothesis and confirmed 
the involvement of this cluster in the biosynthesis of echinulin. The combination of EchPT1 and EchPT2 
with cyclo-L-tryptophanyl-L-alaninyl as a substrate led to the formation of 7 products with different 
degrees of prenylation. This special property was subsequently used to prenylate further cyclic 
dipeptides. The stereoisomers of cyclo-tryptophanyl-alaninyl and cyclo-tryptophanyl-prolinyl were 
used for this purpose. Analogous to the biosynthesis of echinulin, this led to the formation of tri-
prenylated main products prenylated at position C2, C5 and C7, as well as further di-, tri- and tetra-
prenylated side products. 
Another possibility to investigate and produce secondary metabolites is the heterologous expression 
in a suitable host. A potential new host for heterologous expression, Penicillium crustosum, was 
examined in this thesis. The genome of the fungus was sequenced and the involvement of the 
polyketide synthase Pcr4401 in the biosynthesis of the melanin precursor YWA1 was confirmed by 
deletion and expression experiments. Successful integration of foreign genes in the pcr4401 gene locus 
can easily be recognized by the occurrence of an albino phenotype. For better use as an expression 
host, a pyrG deficient strain and two plasmids were generated to integrate foreign genes into the 
pcr4401 gene locus. The applicability as an expression host was subsequently verified by the successful 





Vor mindestens 3,5 Milliarden Jahren entstand das erste Leben auf der Erde. Dies war der Startpunkt 
der evolutionären Entwicklung zahlreicher Lebewesen. Nach aktuellen Schätzungen existieren 1012 
verschiedene Arten auf unserem Planeten. Der überwiegende Anteil dieser enormen Artenvielfalt 
stammt aus dem Reich der Bakterien und Archaeen. Basierend auf dieser Schätzung sind bis zum 
heutigen Tag gerade einmal 0,001 % aller Arten bekannt. Die allgegenwärtige Konkurrenz zwischen 
den Lebewesen führte unter anderem zu der Entwicklung des Sekundärstoffwechsels. Die aus diesem 
Stoffwechsel stammenden Sekundärmetabolite sind nicht essenziell für das Überleben, dennoch bietet 
deren Produktion dem Organismus zahlreiche Selektionsvorteile. Pflanzen, Bakterien und Pilze 
gehören zu den Hauptproduzenten von Sekundärmetaboliten. Die über 2.140.000 Millionen 
bekannten Sekundärmetabolite lassen sich in fünf große Gruppen einteilen: (1) nicht-ribosomale 
Polypeptide, (2) Polyketide, (3) Alkaloide, (4) Terpenoide und Steroide und (5) Enzymkofaktoren. Viele 
dieser Naturstoffe weißen eine biologische bzw. pharmazeutische Aktivität auf und dienten zur 
Entwicklung von Arzneimitteln. Die große Anzahl bisher nicht identifizierter Mikroorganismen 
beherbergt ein gewaltiges ungenutztes genetisches Potential zur Produktion weiterer neuer 
Naturstoffe. Solche Stoffe können sich zur Entwicklung dringend gebrauchter neuer Arzneimittel 
eignen. Verschiedene Ansätze, wie z.B. die heterologe Expression in geeigneten Wirtsorganismen 
werden verfolgt, um dieses Potential zugänglich zu machen. Des Weiteren können durch Ansätze der 
synthetischen Biologie die Diversität der Naturstoffe erweitert werden und so neue Naturstoffe 
entdeckt bzw. produziert werden. 
Im Rahmen der Forschung an Sekundärmetaboliten beschäftigt sich diese Arbeit mit drei thematischen 
Schwerpunkten: 1. Die Erweiterung des Spektrums möglicher Substrate für Prenyltransferasen mittels 
einer Datenbank zur Vorhersage neuer Substrate. 2. Die Identifizierung und Charakterisierung bisher 
unbekannter Biosynthesegencluster, sowie die Untersuchung einer möglichen Anwendung der 
beteiligten Enzyme für die Produktion neuer Naturstoffe. 3. Die Generierung eines Stamms für die 
heterologe Expression von Sekundärmetabolitgenen und die Untersuchung ihrer unbekannten 
Produkte. 
Prenyltransferasen katalysieren den Transfer von Prenyleinheiten (n × C5) auf ihre Zielsubstrate. Dies 
ist von besonderer Bedeutung, da bei zahlreichen Verbindungen eine Zunahme der biologischen 
Aktivität von prenylierten Verbindungen im Vergleich zu ihren nicht prenylierten Vorstufen beobachtet 
wurde. Eine besondere Eigenschaft von Prenyltransferasen ist ihre Promiskuität bezüglich der von 
ihnen akzeptierten Substrate. Dies macht sie zu geeigneten Kandidaten für die Produktion 
pharmazeutisch wirksamer Substanzen. Jedoch gestaltet es sich in der Praxis schwierig neue passende 
Substrate für Prenyltransferasen zu identifizieren. Um dieses Problem anzugehen, wurde im Rahmen 
dieser Studie eine Datenbank, PrenDB, für die Vorhersage solcher Substrate entwickelt. Die 
Vorhersagekraft dieser Datenbank wurde anschließend mit 38 vorhergesagten Substraten und deren 




der 38 Substrate konnte eine Prenylierung von mindestens einem der drei getesteten Enzymen 
beobachtet werden. Des Weiteren zeigten 17 Substrate mit mindestens einer Prenyltransferase 
Umsatzrate von mehr als 50 %. Dies belegt die Vorhersagekraft der entwickelten Datenbank und 
ermöglicht so die zielgerichtete Auswahl neuer potenzieller Substrate und Identifizierung neuer 
Substratklassen. 
Die Identifizierung von Biosynthesegenclustern und die anschließende biochemische 
Charakterisierung der an der Biosynthese beteiligten Enzyme bildet die Grundlage für die Ansätze der 
synthetischen Biologie zur Produktion von Naturstoffen. Anhand von dem cyclischen Dipeptid 
Echinulin wurde in dieser Arbeit ein mögliches Vorgehen zur Identifizierung des verantwortlichen 
Genclusters und die Verwendung der beteiligten Enzyme zur Biosynthese neuer Substanzen 
beschrieben. Basierend auf den strukturellen Eigenschaften von Echinulin wurde die enzymatischen 
Voraussetzungen für dessen Biosynthese ermittelt. Ein Gencluster dafür muss demnach Gene für eine 
nichtribosomalen Peptidsynthetase und mehrere Prenyltransferasen enthalten. Im Genom des 
Echinulin-Produzenten Aspergillus ruber konnte ein Gencluster mit diesen Vorrausetzungen 
identifiziert werden. Enzymtests mit der Echinulin-Vorstufe cyclo-L-Tryptophanyl-L-Alaninyl und den 
heterolog produzierten Prenyltransferasen EchPT1 und EchPT2 führten zu einer fundierte 
Biosynthesehypothese und bestätigten die Beteiligung des Genclusters an der Biosynthese von 
Echinulin. Das Zusammenwirken von EchPT1 und EchPT2 mit cyclo-L-Tryptophanyl-L-Alaninyl als 
Substrat führte zu Bildung von insgesamt 7 Produkten mit unterschiedlicher Anzahl an Prenylierungen. 
Diese besondere Eigenschaft wurde anschließend genutzt um weitere zyklische Dipeptide mehrfach zu 
prenylieren. Hierfür wurden die Stereoisomere von cyclo-Tryptophanyl-Alaninyl und cyclo-
Tryptophanyl-Prolinyl verwendet. Analog zur Biosynthese von Echinulin führte dies zur Bildung von an 
Position C2, C5 und C7 dreifach-prenylierten Hauptprodukten, sowie weiteren zweifach-, dreifach- und 
vierfach-prenylierten Nebenprodukten.  
Eine weitere Möglichkeit Sekundärmetabolite zu produzieren und zu untersuchen ist die heterologe 
Expression in einem geeigneten Stamm. Ein potenzieller neuer Stamm für die heterologe Expression, 
Penicillium crustosum, wurde in dieser Arbeit untersucht. Dafür wurde das Genom des Pilzes 
sequenziert und durch Deletions- und Expressionsexperimente die Beteiligung der Polyketidsynthase 
Pcr4401 an der Biosynthese der Melaninvorstufe YWA1 bestätigt. Die erfolgreiche Integration von 
fremden Genen in den pcr4401 Genlokus lässt sich durch das Auftreten eines Albinophänotyps leicht 
erkennen. Zur besseren Verwendung als Expressionsstamm wurde ein pyrG defizienter Mutant und 
zwei Plasmide zur Integration fremder Gene in den pcr4401 Genelokus generiert. Die Eignung als 
Expressionswirt wurde anschließend durch die erfolgreiche Expression von drei PKS Genen und die 
Strukturaufklärung der gebildeten Produkte verifiziert. 
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The phylum of Ascomycota is the most abundant phylum in the fungal kingdom with more than 64.000 
known species.1 From all yet described fungal species, 65 % belong to the phylum of Ascomycota.2 This 
phylum can be subdivided into three major subphyla, the Taphrinomycotina, the Saccharomycotina, 
and the Pezizomycotina.3 Ascomycota can occur as unicellular organisms and reproduce themselves 
by budding e.g. Saccharomyces cerevisiae (Saccharomycotina) or by fission e.g. Schizosaccharomyces 
pombe (Taphrinomycotina). In contrast, most members of the subphylum Pezizomycotina e.g. 
Aspergillus or Penicillium species grow as filamentous fungi, forming a dense network of hyphae, the 
so-called mycelium. The filamentous fungi reproduce themselves either asexually by the formation of 
conidia or sexually by the formation of ascospores. In their asexual reproduction form, called 
anamorph, the conidia are formed at specially developed hyphae known as conidiophores. The sexual 
reproduction form, called teleomorph, produce fruiting bodies for ascospores production. At this fruit 
bodies, also known as ascocarp, the ascospores are produced in specialized tube- or sac-like cells 
termed asci.4  
The evolutionary divergence of the Pezizomycotina started over 450 million years ago.5 Within million 
years of diversification and adaption, Ascomycota conquered almost all possible terrestrial and aquatic 
habitats. Furthermore, they developed a wide variety of lifestyles, ranging from saprotrophic or 
necrotrophic to biotrophic, parasitic or symbiotic behavior.4 Fungi can be a curse but also a blessing 
for humankind. Fungal pathogens affect humans directly ranging from simple dermatophytosis caused 
by dermatophytes to life-threatening aspergillosis caused by Aspergillus fumigatus.6 Every year more 
than one billion people suffer from a fungus-related disease, with more than 1.5 million deaths.7 
Besides these direct effects on humankind, molds and fungal plant-pathogens affect human health and 
wealth indirectly. Since mankind became agriculturally active, it encountered fungal plant-pathogens 
e.g. Blumeria graminis responsible for the powdery mildew disease in various types of grains. It is 
estimated that fungi are responsible for the destruction of approximately one-third of all food crops 
each year.8 Moreover, the production of mycotoxins can lead to food spoilage and human poisoning. 
Mycotoxins are compounds with low molecular weight, typically less than 1,000 Da, which are 
particular products of the secondary metabolism from filamentous fungi. So far, more than 400 
mycotoxins are known, whose main producers belong to the genus of Aspergillus, Penicillium and 
Fusarium.9 Despite their great structural diversity, the most important food-related mycotoxins belong 
to one of the following six subgroups: Aflatoxins, ochratoxins, fumonisins, zearalenone, 
trichothecenes, and ergot alkaloids.10 All these mycotoxins can be found in daily consumed foodstuff, 
including grains, maize, nuts and fruits. Aflatoxins, especially aflatoxin B1 (1) mainly produced by 
Aspergillus flavus and Aspergillus parasiticus, are highly hepatotoxic and cancerogenic. Aspergillus 
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ochraceus, Aspergillus carbonarius, and Penicillium verrucosum are the main producers of the 
nephrotoxic and potential cancerogenic ochratoxins, e.g. ochratoxin A (2). Fumonisins, e.g. fumonisin 
B1 (3) are produced by members of the genus Fusarium e.g. Fusarium verticillioides and are cancer 
promoting mycotoxins. Also, the mycotoxin zearalenone (4) is produced by Fusarium species, in 
particular by Fusarium graminearum. The acute toxicity is considered low, but it shows potent 
estrogenic effects on mammalian livestock and humans. The subgroup of trichothecenes are 
sesquiterpenes, including more than 100 compounds sharing a common 12,13-epoxytrichothec-9-ene 
structure, e.g. deoxynivalenol (5). Due to the huge variety of the members, the effects on human 
health are diverse as well, ranging from immunosuppressive effects to gastrointestinal discomfort. 
Main producers are Fusarium species e.g. F. graminearum. Claviceps purpurea is the main producer of 
the ergot alkaloids, e.g. ergotamine (6). Intoxication with ergot alkaloids can result in ergotism, which 
is characterized by symptoms like diarrhea, muscle spasms, psychosis, vomiting and 
vasoconstriction.11,12 In contrast to these harmful mycotoxins, there are also secondary fungal 
metabolites with potential benefits for human health. For example, ergometrine (7) an ergot alkaloid 
produced by Claviceps purpurea is used as a medication for the treatment of bleeding after childbirth 
because of its uterine contracting effects.13 Chemical or chemoenzymatic modification of natural 
secondary metabolites is used to convert these metabolites to suitable drugs or to alter the molecular 
parameters e.g. target specificity, bioavailability, or stability for more convincing pharmaceutical use.14 
Besides Streptomyces species, fungi from the Ascomycota are a valuable source for identification 
and/or production of antibiotics. The best-known representative is penicillin G (8) discovered by 
Alexander Fleming in 1928, which is produced by Penicillium rubens (formerly known as Penicillium 
chrysogenum).15 
 
Figure 1: Secondary metabolites produced by fungi of Ascomycota. 
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Another important utilization for ascomycetous fungi is the biotechnological application within the 
food and additive (e.g. enzymes) production. Penicillium roqueforti and Penicillium camemberti are 
used for a long time in the cheese production and Saccharomyces cerevisiae in beer, wine, and bread 
production.16 An established fungal strain for the production of soy sauce and sake is Aspergillus 
oryzae. Additional to the use in food technology, Aspergillus oryzae is also established in 
biotechnological applications e.g. the production of enzymes like α-amylases.17,18 Microbial enzymes 
are commonly used in textile, starch processing, food, detergent, pulp, and paper industries. Roughly 
half of these commercially used enzymes originate from fungi. Industrially interesting enzymes often 
belong to amylases, amyloglucosidases, cellulases, glucose oxidases, lipases, proteases and 
xylanases.19 Additional to the wide biotechnological applications, the scientific interest in Ascomycota 
is steadily increasing. Saccharomyces cerevisiae, Aspergillus nidulans and Penicillium chrysogenum are 
well-known model organisms concerning cellular, genetic, and regulatory studies. Ongoing research 
aims to further increase their biotechnological applicability as cell factories for the production of 
enzymes or natural products.20-22 
1.2. Secondary metabolism and biosynthetic gene cluster 
Metabolism can be subdivided into primary and secondary metabolism. The primary metabolism is 
defined as the whole set of biochemical reactions necessary for growth, development, reproduction, 
energy transformation, and to maintain the vitality of living organisms or cells. Catabolism and 
anabolism are the two major aspects of primary metabolism. Catabolism includes all reactions to break 
down molecules for energy generation or to biosynthesize precursors for anabolic reactions. In 
contrast, anabolic processes are responsible for building up macromolecules like proteins, nucleic 
acids, carbohydrates, and lipids.23 Besides these essential life-sustaining processes, especially 
microorganisms like bacteria and fungi developed an enormous repertoire of biosynthetic pathways 
for the production of a diverse set of nonessential molecules in the so-called secondary metabolism. 
The building blocks used to produce secondary metabolites originate mainly from the central carbon 
metabolism with acetyl-CoA and amino acids as the most relevant precursors (Figure 2).24 During the 
evolutionary adaptation to different ecological niches, microorganisms developed the ability to 
produce a variety of secondary metabolites. The biosynthesis of these substances led to diverse 
selection advantages based on properties such as hindering of competitor´s growth, protection against 
other microorganisms, acquisition of nutrition factors e.g. siderophores and for intra and inter-species 
communication purposes.25 Most fungal secondary metabolites belong to one of the four main groups 
i.e. polyketides,  non-ribosomal polypeptides, alkaloids and terpenoids and steroids (Figure 2).26 Up to 
the year 2010 over 500,000 natural products were discovered in total and approximately 30,000 
originated from fungi. Between the years 2001 to 2010, around 61 % of the identified bioactive 
13
 1. Introduction 
 
secondary metabolites were from fungal origin, underlining their potential for finding and 
development of new drugs.27 
 
Figure 2: Schematic presentation of the connection between primary and secondary metabolism.  
MVA: mevalonate pathway; MEP: methylerythritol phosphate pathway; DMAPP: dimethylallyl pyrophosphate; IPP: 
isopentenyl pyrophosphate 
In the year 1976, the first complete genome sequence with a total length of 3,569 nucleotides from 
the bacteriophage MS2 was elucidated and published.28 This can be considered as the early starting 
point of the genomic era. The first genome of the prokaryotic organism Haemophilus influenzae was 
published 19 years later, followed by the first eukaryotic genome from Saccharomyces cerevisiae one 
year later.29,30 Analysis of the genomic sequence revealed that genes are not randomly distributed in 
microorganisms. Genes can be organized in close proximity to form a gene cluster. In prokaryotes, 
gene clusters are coregulated and cotranscribed forming functional metabolic groups, known as 
operons (Figure 3A).31,32 Around 1990 and in the following years it was proven that also in fungi genes 
encoding for enzymes of a given biosynthetic pathway are also often organized in close proximity.26 
These biosynthetic gene clusters (BGCs) share a common set-up, usually consisting of genes for a 
backbone enzyme, such as a non-ribosomal peptide synthetase (NRPS), a polyketide synthase (PKS) or 
a terpene synthase, and different kinds of tailoring enzymes for modification of the formed metabolic 
scaffold (Figure 3B). Optionally, further genes for regulation of the whole gene cluster or transporters 
for secretion of the products or uptake of special substrates are included in the BGCs.24 
The size of a fungal genome is in the range from 9 to 178 Mb with an average size for ascomycetous 
genomes of 37 Mb.33 The search and identification of biosynthetic gene clusters in this plethora of 
genomic data has led to the term genome mining. In particular, the rapid development in the area of 
next-generation sequencing and the associated increasing amount of available data required 
computationally high-throughput methods for genome analysis. Nowadays, various user-friendly 
computational tools for genome analysis and BGC identification exist, e.g. antiSMASH 5.034, SMURF35, 
PRISM3,36 and others37. The fundamental concept of these genome mining tools for gene cluster 
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detection is based on the common set-up of BGCs (see above), a database with already characterized 
BGCs and protein families (PFAM) and the presence of conserved domain sequences within the 
backbone and tailoring genes. In short, for BGCs detection, a comparative BLAST analysis, PFAM 
analysis, and backbone genes domain analysis is performed. Additionally, the simultaneous 
comparison with characterized BGCs assists in the detection of putatively unknown BGCs.38 The above 
mentioned ongoing development in next-generation sequencing techniques resulted in a tremendous 
cost and time reduction for sequencing of a genome.39 As a result, the scientific community today has 
access to numerous genomic sequences. For example, the database of the “1,000 fungal genomes” 
project from the Joint Genome Institute’s (JGI) consists of 1,322 sequenced genomes (as of July 2019). 
 
Figure 3: Schematic presentation of typical prokaryotic operon gene cluster (A) and eukaryotic biosynthetic gene cluster (B). 
UTR: Untranslated region; RBS: Ribosome binding site. 
Microbial genome mining revealed the presence of a plethora of BGCs in these organisms. On average, 
Actinomycetes and Ascomycetes harbor around 20-50 and 40-80 BGCs per species, respectively. A 
comparison of the number of BGCs with known secondary metabolites isolated from these species 
demonstrated that the capability for secondary metabolite production is far from being exhausted. 
The reason for this is the silence of most of the gene clusters, i.e. they are transcriptionally inactive 
under standard laboratory or naturally observed cultivation conditions.40-42 To exploit this hidden 
potential for secondary metabolite production and identification of new natural products, several 
strategies for activation of these silent gene clusters were developed. The early observation that 
microorganisms produce various secondary metabolites depending on the cultivation conditions led 
to the OSMAC (one strain many compounds) strategy. This easy and fast to realize approach is based 
on the adjustment of media composition, cultivation temperature, pH value, aeration etc. without the 
requirement of the genetic accessibility of the producer.43,44 Another strategy is to mimic a 
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competitional microbial environment through co-cultivation of different microorganisms. It is 
suggested that this strategy is based on signaling molecules and metabolic precursors produced by 
either one or both co-cultivated species.45 Both strategies result in a change of the environmental 
factors that the microorganism experiences. In order to adapt to or react to this changes a complex 
framework consisting of sensory systems and genetic regulatory circuits and pathways has been 
developed by the organisms. The model organism Aspergillus nidulans is frequently used to study these 
genetic regulation systems. For this, the heterotrimeric velvet complex consisting of the three proteins 
VelB, VeA, and LaeA was identified, and its crucial role in secondary metabolite regulation and 
reproduction was investigated. In the end, the velvet complex acts as a transcriptional activator 
mediated by the secondary metabolism main regulator LaeA.46,47 Beside these global transcriptional 
regulators, approximately 50 % of the BGCs harbor a biosynthetic pathway specific transcription factor, 
responsible for BGC transcriptionally regulation.24,48 Epigenetic modification is another important 
transcriptional regulation mechanism, which is based on the condensation state of the genomic DNA. 
Chromatin can be divided into heterochromatin consisting of condensed DNA and proteins and 
euchromatin being much less condensed. Genes and BGCs in less condensed genomic regions are more 
accessible for transcription factors and the RNA-polymerase and are therefore more often 
transcriptionally active. The DNA condensation state is regulated inter alia by the methylation and 
acetylation status of the histones. This is adjusted by the action of histone acetyl- and 
methyltransferases as well as by histone deacetylases and demethylases.49,50 For example, an acetyl 
group from acetyl-CoA can be transferred to a lysine residue of the N terminal histone tail. This leads 
to a reduced positive charge of the histone accompanied by a reduction of the DNA-histone 
interaction, resulting in a less tight chromatin condensation state and activation of otherwise inactive 
genes.51 Therefore, inactivation of histone deacetylases by gene deletion or via the use of chemical 
inhibitors resulted in the increased expression of formerly inactive BGCs and thus to the identification 
of newly produced secondary metabolites.52,53 
A prerequisite for the strategies described above is the cultivability of the targeted microorganisms 
under laboratory conditions. Even so, the often low yields of the newly produced substances, hamper 
the identification and characterization of these compounds. With progress in DNA manipulation and 
cloning methods, heterologous expression in appropriate hosts became a promising method to 
overcome these limitations.54 The first requirement for an effective heterologous expression of BGCs 
or synthetic biology approaches is a fast and reliable cloning and manipulating method of large DNA 
fragments. Therefore, methods for capturing and cloning of whole BGCs were developed.55 
Sometimes, even further modifications steps e.g. promoter exchanges are necessary for BGCs 
activation. This is realized for example, via ligation-independent DNA manipulating methods like 
homologous recombination cloning in E. coli.56 The second requirement is the availability of 
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appropriate heterologous expression host. The ideal host must meet the following criteria: good 
genetic tractability, easy and inexpensive cultivability combined with rapid growth and sufficient 
supply with metabolic precursors with a clear native secondary metabolite background profile. In 
addition, the host should have a similar DNA splicing and glycosylation pattern compared to the BGC 
donor organism.57 Fungal systems for heterologous expression were proven to be a promising choice 
for secondary metabolite production, isolation and characterization with yields up to 950 mg per liter 
medium for certain compounds.54 
1.2.1. Polyketide synthases 
The members of the large and structurally diverse polyketide family are mainly produced in bacteria, 
fungi, and plants by enzymes called polyketide synthases (PKS). Based on their structural composition, 
they can be divided into three types. Type I PKSs are large multidomain megaenzymes organized in 
distinct modules. Type II PKSs consist of monofunctional proteins forming multienzyme complexes. 
Type III PKSs are small homodimeric enzyme complexes without a so-called acylcarrier protein domain. 
The fundamental chemical aspect in the biosynthesis of polyketides is the Claisen condensation 
reaction, where the polyketide backbone is formed by the condensation of starter units e.g. acetyl-
CoA with extender units e.g. malonyl-CoA. On the one hand, structural variety is achieved by PKS 
inherent factors e.g. the use of various starter and extender units (Figure 5B), the difference in 
polyketide length, degree of reduction and methylation, as well as by different release and cyclization 
mechanisms. On the other hand, further diversification can be achieved by polyketide modifying 
tailoring enzymes for oxidation, reduction, rearrangement, and transfer reactions.58 Prominent 
representatives of the clinically used polyketides and their derivatives are lovastatin (9), a cholesterol-
lowering agent,59 griseofulvin (10) used due to its antimycotic effect,60 doxorubicin (11) as a 
chemotherapeutic agent in the treatment of cancer,61 and the macrolide antibiotic erythromycin A 
(12).62 In addition to the potential within the development of new drugs, PKSs can also be used for 
production of bulky compounds and biofuel in the chemical industry, as well as pigments in the textile 
industry.63,64 
The domain-based architecture is typical for type I PKS. Enzymes of this family consist of multiple 
domains with distinct functions and can be divided into modular and iterative type I PKS. The 
biosynthesis of polyketides proceeds in three phases, (1) starter unit loading, (2) chain elongation and 
reduction, (3) polyketide cyclization and release (Figure 5A). All these steps are catalyzed by the 
concerted action of the different domains. Except for the modular type I PKS, the chain elongation is 
carried out by iterative cycles. In contrast, each module of a type I modular PKS, consisting of different 
domains, is used only once during polyketide biosynthesis. Depending on the domain architecture, the 
type I iterative PKS can be further subdivided into non-reducing- (NR-), partially reducing- (PR-) and 
highly reducing- (HR-) PKS (Figure 6).  
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Figure 4: Polyketides and derivatives thereof produced by various microorganisms and plants. 
The minimal domain architecture of a NR-PKS consists of the starter unit acyl transferase (SAT), 
ketoacyltransferase (KS), acyltransferase (AT), product template (PT), acyl carrier protein (ACP), and 
the thioesterase (TE) or the release (R) domains (Figure 6).65 Biosynthesis of the polyketide begins with 
the selection and loading of the starter unit to the SAT domain. Beside acetyl-CoA, SAT domains are 
known to use other compounds as starter units, e.g. a C6 fatty acid in the case of norsolorinic acid (13) 
biosynthesis. Moreover, in the biosynthesis of chaetoviridin A (14) a highly reduced triketide, produced 
by another PKS, is used as starter unit.66-68 The AT domain selects the extender unit and catalyzes its 
transfer to the ACP domain. In the next step, the KS domain catalyzes the decarboxylative Claisen-like 
condensation of the starter and extender unit, resulting in an elongated polyketide chain bounded to 
the ACP domain. The elongation steps are repeated iteratively until the polyketide chain reaches a 
certain length. Afterward, cyclization occurs at the PT domain eventually followed by the release of 
the polyketide at the TE or R domain. In addition to the already mentioned domains, some PKS harbor 
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a methyltransferase (MT) domain, catalyzing the methylation of the elongated polyketide chain as in 
the case of 5-methylorsellinic acid (15) biosynthesis.69 
 
Figure 5: Reaction mechanism of polyketide chain elongation (A) and commonly used starter and extender units (B). 
PR- and HR-PKSs harbor additional domains to reduce the growing polyketide chain. The ketoreductase 
(KR) domain is NADPH-dependent and catalyzes the reduction of the keto group to a hydroxyl group. 
Further reduction is achieved by water elimination catalyzed by the dehydratase (DH) domain. Action 
of the NADPH-dependent enoyl reductase (ER) domain finally leads to a fully saturated extender unit 
covalently bound to the growing polyketide chain (Figure 6).70 It is worth noting that not necessarily 
every extender unit becomes fully or partially reduced. A well-studied PR-PKS is the 6-methylsalicylic 
acid synthase, which is involved in the biosynthesis of the 6-methylsalicylic acid (16) related 
meroterpenoids e.g. yanuthone D (17).71,72 Most prominent representative of the HR-PKS is LovB, 
participating in the biosynthesis of lovastatin (9).73 
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Figure 6: Representatives of the NR-, PR-, and HR-PKS, their domain architecture and their reaction products. 
As mentioned above, modular type I PKSs don’t work iteratively. Instead, the growing polyketide is 
handed to each module once where the extender unit is added and modified according to the domain 
set-up. Since each module is used only once, it is easier to predict the formed polyketide compared to 
iterative type I PKS. The modular structural architecture results in a much larger enzyme (Figure 7). 
 
Figure 7: Representative of the modular type I PKS, its domain architecture and the reaction product. 
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The 6-deoxyerythronolide B synthase (DEBS) responsible for building the macrolide scaffold 6-
deoxyerythronolide B (18) in the biosynthesis of the antibiotic erythromycin (12), is one of the best-
studied PKS.74 As with DEBS, modular type I PKSs do not necessarily consist of multiple polypeptides. 
Contrarily, DEBS comprises loading domain, six extending modules and one TE domain organized in 
three polypeptides.75 
Unlike type I PKS, type II PKSs are not large megaenzymes, but consist of monofunctional proteins that 
form a functional unit (Figure 8A). Fungal type II PKSs are not known up to date, therefore type II PKSs 
are currently limited to the bacterial kingdom, especially to Streptomyces species.76,77 Nevertheless, 
type II PKSs contribute significantly to polyketide diversity. For example, members of, bacterial 
anthracyclines, aureolic acid (19), tetracycline (20) and tetracenomycin C (21) are type II PKS based.76 
The minimal set-up of a type II PKS displays the KS domain, catalyzing the Claisen-like condensation of 
acetyl- and malonyl-CoA units in an iterative fashion, the ACP domain which anchors the polyketide to 
the enzyme complex and the chain length factor (CLF), which shows very high similarity to the KS and 
determines the length of the growing polyketide (Figure 8A). Additionally, in some cases, the CLF 
domain can catalyze the decarboxylation of malonyl-CoA to acetyl-CoA to generate the starter unit.78 
Not part of the enzyme complex is the malonyl-CoA:ACP transferase (MCAT) responsible for loading 
malonyl-CoA to the ACP domain. A well-studied example for type II PKS is TcmKLM involved in 
catalyzing the formation of the antibiotic tetracenomycin C (21).79 
Type III PKS are small homodimeric complexes with a common size of 80 – 90 kDa. Therefore, they are 
the smallest types of PKS known up to this point (Figure 8B). These homodimers are able to catalyze 
all necessary reactions for polyketide biosynthesis.80 Type III PKS were not only firstly identified in 
plants but are also widely distributed over the plant kingdom and were initially thought to be exclusive 
to plants.81 However, type III PKSs were later also identified in bacteria.82 Fungal type III PKSs are rare, 
but they are more frequently identified. Currently, five examples are characterized.83 Type III PKSs 
catalyze the biosynthesis of small aromatic polyketides. Typically, ring-form and chain-form acyl-CoAs 
are used as starter units and are extended by the condensation of malonyl‐CoA. For cyclization and 
product release, various types of cyclization reactions are used like Claisen condensation, aldol or 
lactone formation.80 The best-studied type III PKS belongs to the family of chalcone synthases 
catalyzing the formation of naringenin (22).84 
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Figure 8: Representatives of type II and III PKS and their reaction products 
As described in this chapter, PKS of all types contribute significantly to natural product diversity. Based 
on the growing knowledge about structural functionality in the fields of starter/extender unit selection, 
cyclization and release reactions, approaches for PKS engineering emerged to increase polyketide 
product diversification further. In the context of PKS engineering, modular type I PKS are of particular 
interest because of their linear order of catalytic domains and the associated predictability of the 
formed product. Truncation of several modules from the DEBS combined with the fusion to the native 
TE domain leads to the production of new polyketides. Generation of hybrid-PKS by adding domains 
from other PKS e.g. DH or KR domains or replacement of the AT domain responsible for starter unit 
selection furthermore increased product diversity.85-87 Interfering with the cyclization pattern during 
polyketide biosynthesis is another approach to produce new products. This is exemplified by the 
combination of the DEBS with the aromatases and cyclases from the bacterial actinorhodin (23) gene 
cluster.88 Studies on the structural functionality of the AT domain of the modular avermectin B1a (24) 
PKS, which shows high promiscuity towards starter units, revealed deeper insights into starter unit 
selection. In these studies, the authors were able to modify and alter the accepted substrate space.89 
Although there are already successful PKS engineering approaches, due to the complex interactions 
between the growing polyketide chain and the domains, module-module interactions, and domain 
structure-function relationships, many questions and uncertainties remain in order to fully exploit the 
PKS engineering potential.90 
1.2.2. Nonribosomal peptide synthetases 
Nonribosomal peptides, biosynthesized by nonribosomal peptide synthetase (NRPS), are another rich 
and diverse family of secondary metabolites. Structural diversity is achieved by using the 20 
proteinogenic amino acids or many other nonproteinogenic amino acids as condensation substrate for 
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building a linear, cyclic or branched-cyclic product.91 Complexity of cyclic nonribosomal peptides can 
range from simple cyclic dipeptides with a 2,5-diketopiperazine backbone e.g. brevianamide F (25) to 
large cyclic peptides e.g. the immunosuppressive drug cyclosporin A (26) or to branched-cyclic 
peptides e.g. the antibiotic bacitracin (27).92-94 Linear peptides can vary in length ranging from 3 to 20 
amino acids e.g. the virostatic and antibiotic agent feglymycin (28).95 As with the PKS, various tailoring 
enzymes carry out numerous modifications on the nonribosomal peptide scaffold.96 Main producers 
of nonribosomal peptides are bacteria, especially species belonging to the phylum Firmicutes, 
Proteobacteria and Actinobacteria, and filamentous fungi of the phylum Ascomycota.97 
 
Figure 9: Nonribosomal peptides and derivatives thereof produced by various microorganisms. 
Like PKS, NRPS are large modular mega proteins. Depending on the sequential assembly of the 
condensation substrates or whether individual modules are used several times, three different NRPS 
types are defined. Linear type NRPSs use every module only once and the sequence of the modules 
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determines the order of the condensed substrates. In iterative NRPSs, modules are used several times 
until the product is released. For non-linear type NRPSs, the order of the condensation product does 
not match the order of the modules (Figure 10).98 The minimal domain set up of a module consists of 
an adenylation (A), a thiolation (T), also known as peptidyl carrier protein (PCP), and a condensation 
(C) domain (Figure 10A). To incorporate an amino acid into a growing peptide chain, the amino acid is 
first selected and activated via adenylation by the A domain. Consequently, the A domain catalyzes 
the transfer of the aminoacyl residue to the thiol group of the T domain. In the second step, the C 
domain catalyzes the assembly of a downstream amino acid bound to a T domain with an upstream 
amino acid via peptide bond formation. The elongated peptide chain is finally bound to the 
downstream T domain and ready for further elongation at the next module. Elongation goes on in a 
linear fashion depending on the module order until the thioester domain (TE) is reached. This domain 
catalyzes the release of the formed peptide either by hydrolysis resulting in a linear peptide or by an 
intramolecular cyclization reaction resulting in a cyclic peptide.99 In addition to the minimal domains, 
a module can harbor additional domains that catalyze different modifications at the activated amino 
acid. Such modifications include epimerization, heterocyclization, formylation, halogenation, and 
oxidation or reduction reactions.98 
As with PKSs, NRPSs are interesting candidates for protein engineering due to their modular nature 
and their diversity in accepted substrates. Various approaches were developed to redesign an NRPS so 
that completely new substances were generated, or the products were modified so that they meet the 
desired pharmaceutical properties.100 Domain or module exchange approaches were successfully used 
to alter the polypeptide sequence. For example, the antibiotic daptomycin (29) is a NRPS product from 
Streptomyces roseosporus. The exchange of one or multiple modules leads to the predicted change of 
the amino acid sequence.101 Instead of whole module exchanges, also single domain swapping is 
possible as well to generate new products. This was done in a combinatorial study to get new 
pyoverdine derivatives by swapping A or C domains.102 Additionally, deletion or insertion of modules 
is another way to alter the produced products. This is exemplified by the reduction of the ring size of 
surfactin (30) through NRPS module deletion or by elongation of balhimycin (31) with additional amino 
acids via NPRS module insertion.103,104 
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Figure 10: Schematic presentation of the linear (A), iterative (B) and non-linear (C) NRPS types. 
1.2.3. Prenyltransferases 
Prenyltransferases fulfill an important function in biosynthesis within primary and secondary 
metabolism. By catalyzing the attachment of a prenyl moiety from a donor to a wide range of prenyl 
acceptors, they contribute substantially to natural product diversity. The prenyl donors consisting of n 
× C5 units e.g. dimethylallyl (DMAPP; n = 1), geranyl (GPP; n = 2), farnesyl (FPP; n = 3) or geranylgeranyl 
(GGPP; n = 4) diphosphates (Figure 11A). These prenyl donors are derived from the terpenoid 
biosynthetic pathway.105,106 In the primary metabolism they are involved, for example in the mena- 
and ubiquinone or heme biosynthesis.107,108 Furthermore, prenyltransferases are also able to catalyze 
the farnesylation and geranylgeranylation of proteins e.g. members of the Ras superfamily GTPases. 
The correct and stable localization in membranes of these members is crucial for their proper function, 
for example in growth or intracellular protein transport regulation.109 Most of the known and 
characterized prenyltransferases participate in the biosynthesis of various secondary metabolites. For 
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this, they transfer the prenyl moiety in a regular or reverse fashion onto a plethora of substance classes 
such as flavonoids, coumarins, xanthones, quinones, and especially indoles (Figure 11B). Furthermore, 
they are the key enzymes involved in the biosynthesis of isoprenoid natural products.106  
 
Figure 11: Schematic presentation of IPP, DMAPP, GPP and FPP structures (A) and the regular or reverse prenylation (B). 
Terpenes, terpenoids and steroids are belonging to the large family of the isoprenoids with more than 
80,000 known members.110 The biosynthetic precursors, DMAPP and isopentenyl diphosphate (IPP) 
are either derived from the mevalonate (MVA) or methylerythritol phosphate (MEP) pathway and 
provide the basis for the isoprenoid biosynthesis.111 With the utilization of these precursors, cis- and 
trans-prenyltransferases are the key enzymes in the biosynthetic pathway of isoprenoid production. 
They catalyze the head-to-tail consecutive condensation of DMAPP and IPP to form a carbon backbone 
with different sizes in length. The configuration of the formed double bond can be either cis (Z) or trans 
(E). Therefore, the prenyltransferases can be divided into cis- and trans-prenyltransferases.111,112 Trans-
prenyltransferases catalyze the formation of linear allylic diphosphates with a size between C10 to 
C50.113 In contrast, cis-prenyltransferases catalyze the formation of polyprenyl diphosphates ranging 
from C10  to C10.000.112 Although both groups of prenyltransferases catalyze similar reactions and are 
depending on Mg2+ ions for their reaction, they differ clearly in their three-dimensional structure.106 
Due to their ability to catalyze the prenylation of aromatic substrates, a further group of 
prenyltransferases is classified as aromatic prenyltransferases. As tailoring enzymes, they contribute 
significantly to structural diversification in various biosynthetic pathways. In general, they catalyze the 
transfer of a prenyl moiety from a prenyl donor to an acceptor in regular or reverse fashion. Prenylation 
typically occurs at C, N or O atoms of a broad spectrum of substrate groups e.g. phenols, flavonoids, 
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coumarins, naphthalenes, indoles and derivatives thereof.105,106,114 Depending on enzyme inherent 
factors such as soluble or membrane-bound state, metal ion dependency, structural organization, and 
motifs further classification into subgroups is possible. The assignment to the subgroups comes from 
the archetypical representative of the family. These are the UbiA family, the CloQ / NphB group, the 
LtxC group and the superfamily of dimethylallyltryptophan synthase (DMATS).105,106 
Members of the UbiA family are membrane-bound proteins and show one or more NDxxDxxxD 
aspartate-rich motifs being responsible for coordination of the prenyl donor during the prenylation 
reaction.115 In the majority of this family, the coordination step is assisted by divalent ions. They have 
an essential role in primary metabolism.116 The bacterial UbiA, as well as the eukaryotic homolog 
COQ2, is involved in the biosynthesis of ubiquinones and menaquinones. Thereby, they catalyze the 
transfer of a polyprenyl chain to 4-hydroxybenzoate.117,118 Another representative is the COX10 
enzyme, responsible for the farnesylation of protoheme during heme A biosynthesis.119 In addition to 
participation in primary metabolism, members of the UbiA family also play an important role in the 
biosynthesis of secondary metabolites. For example, a prenyltransferase from a Streptomyces species 
transfers a farnesyl chain to a quinoline chromophore during the biosynthesis of aurachin SS (32).120 
More recently, the UbiA prenyltransferase AscA from Acremonium egyptiacum was reported to 
catalyze the farnesylation of orsellinic acid in the biosynthesis of ascofuranone (33) and ascochlorin 
(34).121 
The reactions catalyzed by soluble members of the CloQ / NphB group are mostly independent of the 
presence of divalent ions. Representatives of this group are found in bacteria and fungi. They share 
the same structural feature of an aßßa-fold, also known as PT barrel, with prenyltransferases of the 
DMATS superfamily. This fold contains ten anti-parallel β-strands surrounded by a-helixes.106,122 The 
eponymous enzymes CloQ und NphB of this group were identified in Streptomyces roseochromogenes 
and Steptomyces sp. CL190, respectively. NovQ is responsible for the prenylation of 4-
Hydroxyphenylpyruvate in the biosynthesis of the antibiotic novobiocin (35), whereas, CloQ catalyzes 
the same reaction in the biosynthesis of clorobiocin (36). NphB catalyzes the prenylation of the 
naphthalene flaviolin in the biosynthetic pathway of naphterpin (37).105,122  
The LtxC group consists of soluble, mostly bacterial prenyltransferases, which show no aspartate-rich 
motifs and are independent of divalent ions. The natural substrates of these prenyltransferases are 
usually indole-containing substances.123 They share a relatively high sequence similarity with the 
members of fungal DMATS (see below), so that these two groups can theoretically be merged. LtxC 
was identified in the cyanobacterium Lyngbya majuscula. It is involved in the biosynthesis of 
lyngbyatoxin A (38), where it catalyzes the reverse prenylation of (-)-indolactam V.123 Resolving the 
crystal structure of the LtxC homolog TleC showed that this group of prenyltransferases also share the 
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structural aßßa-fold motif.124 The bacterial prenyltransferase PriB from Streptomyces sp. RM-5-8 also 
owns this motif and catalyzes the prenylation of L-tryptophan. Furthermore, it shows a wide 
promiscuity towards the accepted prenyl donors and acceptors.125  
 
Figure 12: Prenylated compounds produced by various microorganisms  
The fourth group of aromatic prenyltransferases belongs to the DMATS superfamily. To date, more 
than 60 representatives of this family have been identified and characterized. For this reason, they are 
the best-studied group of prenyltransferases.106 In addition to biochemical characterization, the crystal 
structure of some prenyltransferases such as FtmPT1, AtaPT, FgaPT2, and CdpNPT has also been 
elucidated.126-129 This information allowed the identification of characteristic structural features of the 
DMATS superfamily. Members of this family are soluble enzymes with no aspartate-rich motifs. 
Consequently, their reactions are independent of divalent metal ions. However, numerous examples 
have shown that the presence of such ions, e.g. Mg2+ and Ca2+ have a positive influence on their 
activities.106,130 The members of the DMATS superfamily share low or no sequence similarity with the 
CloQ / NphB group on the amino acid level. Nevertheless, both groups show the characteristic tertiary 
structure of the PT barrel.126 The elucidation of the crystal structure also enabled the clarification of 
the reaction mechanism. Formation of a dimethylallylic cation by cleavage of the diphosphate group 
from the prenyl donor initiates the Friedel-Crafts alkylation. The dimethylallylic cation is then 
nucleophilically attacked by the substrate to be prenylated, for example by the indole nucleus. 
Rearomatization finally leads to the release of the prenylated product.126 One important feature of the 
DMATS prenyltransferases is their high flexibility toward aromatic substrates. Common substrates are 
indole-containing substances such as tryptophan and tryptophan-containing cyclic dipeptides. In 
contrast, most DMATS are specific for their prenyl donors and use DMAPP as a prenyl donor. However, 
there are also examples using FPP and GPP for their reactions.106 
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Figure 13: Prenylation reactions catalyzed by the prenyltransferases FtmPT1 (A), FgaPT2 (B) and CdpNPT (C). 
In 1992, the first representative of the DMATS superfamily, DmaW, was identified in Claviceps 
fusiformis (reported as C. purpurea). DmaW catalyzes the attachment of the prenyl moiety at position 
C4 of tryptophan. Therefore, it is also known as 4-DMATS.131,132 In the following two decades, the 
research on DMATS was intensified. As a result, a wide variety of members are now identified, so that 
for every possible prenylation position of tryptophan or tryptophan-containing cyclic dipeptides at 
least one DMATS is described.106,133 FtmPT1 from Aspergillus fumigatus is a cyclic dipeptide 
prenyltransferase involved in the biosynthesis of fumitremorgin-type alkaloids. In this pathway, it 
catalyzes the regular prenylation of brevianamide F (24) at position C2 of the indole nucleus (Figure 
13A). Later it was shown that it could prenylate further cyclic dipeptides. In addition to the C2-
prenylation, prenylation at position C3 may also occur, accompanying the formation of a fused ring 
system between the indole nucleus and the diketopiperazine backbone.134,135 FgaPT2 from Aspergillus 
fumigatus is an orthologue of DmaW (4-DMATS) (Figure 13B), catalyzing the initial step in the 
biosynthesis of ergot alkaloids.131,136 A recent study showed that FgaPT2 could also transfer other 
unnatural prenyl donors to tryptophan. It was shown that the prenyl donor could have an influence on 
the prenylation position. In addition to position C4, the unnatural prenyl donors were also transferred 
to positions N1, C3 and C5.137 Furthermore, the cyclic dipeptide prenyltransferase CdpNPT identified 
in Aspergillus fumigatus catalyzes the reverse prenylation of tryptophan-containing cyclic peptides at 
position C3 (Figure 13C).128,138,139 
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2. Aim of this thesis 
The following issues have been addressed in this thesis: 
Expanding the prenyltransferase substrate diversity by in silico methods and experimental proof of the 
prediction strength: 
Members of the DMATS superfamily contribute immensely to the structural diversity of natural 
products. They are also known for their promiscuity toward accepted substrates. Previous strategies 
to identify further substrates were based on comparisons to known substrates by trial and error 
approach. Prof. Peter Kolb and Dr. Jakub Gunera developed a database based on reactions of known 
DMATS enzymes and structural information to predict new possible substrates. The predictive strength 
was then tested experimentally. Therefore, the following experiments were carried out by the author 
of this thesis:  
➢ Overproduction and purification of the DMATS enzymes, FtmPT1, FgaPT2, and CdpNPT. 
➢ Assessing the acceptance of the 38 selected substrates by in vitro enzyme assays and LC-MS 
analysis. 
➢ Determination of the conversion rates of the accepted substrates with the tested enzymes. 
➢ Isolation and structure elucidation of the enzyme products of two substrates 
 
Application of EchPT1 and EchPT2 as biocatalysts for production of tri- and tetraprenylated 
cyclodipeptides: 
The two DMATS prenyltransferases EchPT1 and EchPT2 govern the consecutive prenylation of the 
NRPS product cyclo-L-tryptophanyl-L-alaninyl during the biosynthesis of echinulin and derivatives 
thereof in Aspergillus ruber. In this biosynthetic pathway, up to four prenylation reactions are involved. 
Because of the known promiscuity of the DMATS enzymes, the potential use of EchPT1 and EchPT2 in 
the production of tri- and tetraprenylated cyclodipeptides was investigated. For this, the following 
experiments were carried out: 
➢ Overproduction and purification of the DMATS enzymes EchPT1 and EchPT2 
➢ Consecutive enzymatic assays with EchPT1 and EchPT2 with stereoisomers of cyclo-
tryptophanyl-alaninyl and cyclo-tryptophanyl-prolinyl. 
➢ Isolation and structure elucidation of the obtained products 
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Manipulation of Penicillium crustosum for use as a potential heterologous expression host: 
Heterologous expression of silent biosynthetic gene clusters is an excellent method for the discovery 
of new secondary metabolites. A suitable host for heterologous expression must fulfill various 
requirements. Firstly, it should grow rapidly, provide enough precursors for the biosynthesis of natural 
products and show good genetic tractability. Furthermore, the successful integration of foreign genes 
should be easy to verify, and the own metabolic background should be clear for easy identification of 
newly produced products. In this study, the Ascomycota Penicillium crustosum was investigated as a 
new putative host for heterologous expression. The following experiments were carried out: 
➢ Sequencing and analysis of the Penicillium crustosum genome. 
➢ Identification of the putative conidial pigment synthase PKS Pcr4401 by sequence comparison. 
➢ Establishment of the deletion protocol for Penicillium crustosum 
➢ Verification of the involvement of PKS Pcr4401 in melanin biosynthesis by gene deletion and 
heterologous expression experiments.  
➢ Isolation and structure elucidation of the heterologously produced PKS Pcr4401 products.  
➢ Creation of a pyrG deficient Penicillium crustosum strain  
➢ Creation of two plasmids for the heterologous expression of foreign genes at the pcr4401 locus 
in Penicillium crustosum. 
➢ Testing the potential of Penicillium crustosum for heterologous expression by the integration 
of three different PKS genes. 
➢ Extraction, isolation and structure elucidation of the heterologously produced PKS products 
from the generated Penicillium crustosum strains.  
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3. Results and discussion 
3.1. The substrate prediction database PrenBD for further expanding the 
prenyltransferase substrate diversity by in silico methods – experimental proof of 
the prediction strength 
Enzymes belonging to the diverse family of prenyltransferases participating in primary and especially 
in secondary metabolism. As tailoring enzymes, they contribute to structural diversification in various 
biosynthetic pathways.106 At the beginning of this study, more than 40 fungal and bacterial 
prenyltransferases belonging to the dimethylallyltryptophan synthase superfamily have been 
identified and biochemically characterized.106 They show a broad spectrum of aromatic substrates 
belonging to different substance classes e.g. xanthones, naphthalenes or indole derivatives including 
tryptophan-containing dipeptides. Whereas prenyl acceptor promiscuity for a given prenyltransferase 
is commonly observed, they are mostly strict with prenyl donors.140 However, there are also 
prenyltransferases, e.g. AtaPT, with both prenyl acceptor and donor promiscuity.129 Resolving the 
structures of prenyltransferases and multiple sequence analyses opened new opportunities to expand 
their catalytic applications. By identifying and changing amino acid residues involved in substrate 
binding, the prenylation position could be altered141 and/or the number of accepted substrates could 
be expanded.142-144 Additionally, by identifying and changing amino acids involved in prenyl donor 
binding, the promiscuity prenyl donors could be increased or altered.129,145,146  
Beside protein-engineering, the acceptor promiscuity itself offers unused potential to further increase 
product diversity by using prenyltransferases as biocatalysts. Up to this study, the selection of 
substrates of interest was done by similarity comparison with known substrates/products and by trial 
and error. To address and use the promiscuity of prenyltransferases in a more logical and determined 
way the PrenDB database was created. This database is based on the data of 32 characterized 
prenyltransferases, 167 substrates and their reaction information. Referring to this information, an 
algorithm was created to automatically identify and extract the reactive atom, where the prenylation 
occurs and its surrounding, the so-called repitope. The next step was the multistep virtual screening 
of putative substrates (Figure 14). The collected repitope information was used to search the ZINC 
database, with over five million commercially available compounds, for substances that share at least 
one of the identified repitopes. The identified substrates were further screened by their physico-
chemical properties and their one- and three-dimensional shape congruency to known accepted 
substrates. In the last step, the remaining putative substrates were docked into the resolved crystal 
structure of FtmPT1, FgaPT2, and CdpNPT to ensure the best possible fitting into the enzyme. The best 
fitting results were analyzed manually, and 38 predicted substrates were selected for experimental 
validation. 
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Figure 14: Schematic presentation of the four-step screening process and information about substrate acceptance and 
prediction hit rate. 
To test the predictive strength of PrenDB, the 38 predicted substrates were assayed with the two cyclic 
dipeptide prenyltransferases FtmPT1 and CdpNPT as well as the tryptophan prenyltransferase FgaPT2 
for acceptance and conversion yield (Figure 14). To analyze the acceptance, the reaction mixtures of 
the predicted substrates, the corresponding purified enzymes, and DMAPP as prenyl donor were 
incubated and afterward analyzed via LC-MS. Acceptance was evaluated by detection of product peaks 
with a longer retention time compared to the substrate and 68 Da larger [M+H]+ ions for each prenyl 
moiety than that of the substrate. Multiple prenylation attachments have not been observed in this 
study. The acceptance of 23 substrates by FtmPT1, 22 by FgaPT2, and 25 by CdpNPT corresponded to 
prediction hit rates of 60.5 %, 57.9 %, and 65.8 %, respectively. Remarkably, product yields greater 
than 50 % were detected in FtmPT1, FgaPT2, and CdpNPT assays with 12, 7, and 10 substrates, 
respectively (Figure 14). The fact that the native substrates for 78 % of the prenyltransferases present 
in PrenDB are tryptophan or indole derivatives leads to a clearly indole-biased database regarding the 
identified epitopes. This is also manifested in the predicted substrates. Nevertheless, substrates with 
a good conversion could be identified, even though no comparable natural substrate counterparts are 
known for these enzymes. This is exemplified by substances with an indole-4-imidazolin-2-one motif 
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or with a benzylated hydroxyl-indole structure, respectively. After conversion with FtmPT1, the 
products of indole 3-ethyl ethylsulfonamide and 6-benzyloxyindole were investigated and their 
structure elucidated. 3-ethyl ethylsulfonamide shows a conversion rate of 98.6% with FtmPT1. Two 
products in a ratio of 1 to 1 could be identified. In one product, the prenyl group was attached to 
position N1. Whereas, the other product was prenylated reversely at position C3, which 
simultaneously led to the formation of a 6/5/5 fused ring system. 6-benzyloxyindole shows a 
conversion rate of 60.1% with FtmPT1. Two products with regular prenylation at position C2 and C5 
respectively and a ratio of 1 to 0.85 were identified. This study shows the strength of systematic 
analysis of known reactions of an enzyme class to predict new possible substrates. Experimental 
verification of the prediction showed that 71 % of the predicted substrates were accepted by at least 
one of the three tested prenyltransferases. This provides an excellent opportunity to identify new 
possible substrate classes and thus significantly expand the repertoire of prenylated substances. 
This project was a cooperation with Dr. Jakub Gunera and Prof. Peter Kolb. Dr. Jakub Gunera was 
responsible for PrenDB design and implementation of the cataloged prenyltransferase reaction, 
substrate space analysis, the automatic repitope extraction and virtual substrate screening, docking, 
and selection. Subsequently, I was responsible for the design of the enzyme assays, their execution 
using heterologously produced enzymes and the analysis using LC-MS. Furthermore, I isolated the 
enzymatic products and elucidated their structure. 
 
For further details about this publication see section 4.1: 
Jakub Gunera*, Florian Kindinger*, Shu-Ming Li and Peter Kolb (2017) PrenDB: A substrate prediction 
database to enable biocatalytic use of prenyltransferases. Journal of Biological Chemistry 292: 4003-
4021 
*The authors contributed equally to this work.
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3.2. Biochemical investigations on the both prenyltransferases EchPT1 and 
EchPT2 from the echinulin biosynthetic cluster and their application as 
biocatalysts for production of tri- and tetraprenylated cyclodipeptides 
 
Nonribosomal peptides, especially those with an indole nucleus, are interesting starting candidates for 
the development of new drugs. This indole nucleus is also found in the essential amino acid 
tryptophan, which is used for the biosynthesis of serotonin and almost all proteins. Numerous 
receptors such as G protein-coupled receptors, possess a binding domain for the recognition of the 
indole motif. This explains why many indole motif-containing substances have a pharmaceutical effect 
e.g. anti-inflammatory effects or why they act as 5-hydroxytryptamine receptor agonists or 
antagonists.147 An interesting group of nonribosomal peptides are cyclic dipeptides with a 2,5-
diketopiperazine nucleus consisting of tryptophan and another amino acid which are mainly produced 
by microorganisms.148,149  
Echinulin (39) and its congeners also belong to this group. In two studies, we examined the biosynthesis 
of these substances and the enzymes involved. Echinulin consists of L-tryptophan and L-alanine with a 
reverse attached prenyl moiety at position C2 and two regular prenyl residues, one at positions C5 and 
another at position C7 of the indole nucleus. Well-known producers of echinulin and its congeners e.g. 
preechinulin (40), variecolorin L (41), neoechinulin A (42), dehydroechinulin (43), and 
neoechinulin B (44) are Aspergillus species such as Aspergillus amstelodami and Aspergillus ruber 
(Figure 15A).150 In the genome sequence of Aspergillus ruber, genes coding for three 
prenyltransferases of the DMATS superfamily were identified. Two of them, echPT1 and echPT2, are 
closely located to the NRPS gene echPS. In addition, genes for a putative transporter and a cytochrome 
P450 enzyme, echP450, are also found in close proximity (Figure 15B). This putative gene cluster 
encodes the enzymatic requirements for the biosynthetic steps of echinulin, postulated from its 
structure. Since deletion experiments were not successful, due to the insufficient genetic tractability 
of Aspergillus ruber, we decided to characterize the biosynthetic pathway of echinulin by biochemical 
characterization of the involved enzymes. Therefore, the prenyltransferases EchPT1 and EchPT2 were 
heterologously produced in E. coli and subsequently isolated and purified. Afterward, the acceptance 
of the putative EchPS product cyclo-L-Trp-L-Ala (45) with EchPT1 and EchPT2 was investigated by in 
vitro enzymatic assays. Through extensive investigations using in vitro enzyme assays, isolation, and 
structure elucidation of intermediates and end products, we were able to provide a well-founded 
hypothesis for the biosynthesis of echinulin (Figure 15C). According to this hypothesis, EchPS catalyzes 
the formation of cyclo-L-Trp-L-Ala, which is subsequently prenylated reversely at position C2 by EchPT1 
leading to the formation of preechinulin (40). Only this product is accepted by EchPT2. As a result, 
regular prenylation occurs at position C5 leading to the formation of tardioxopiperazine A (46). This 
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product is then further prenylated at position C7 resulting in the formation of echinulin (39). Both 
prenylations are catalyzed by EchPT2. The fact that the prenyltransferase EchPT2 catalyzes two 
prenylation reactions during the biosynthesis of echinulin is already remarkable. There are only a few 
other known prenyltransferases that also catalyze several prenylation reactions within one 
biosynthetic pathway. For example, the prenyltransferase HsPTpat from Hypericum calycinum 
catalyzes the gem-diprenylation during the biosynthesis of patulone.151 However, EchPT2 has another 
unique feature and is able to transfer up to three additional prenyl moieties to preechinulin (40). 
Meaning, the resulted di- and triprenylated products simultaneously serve as substrates for EchPT2. 
The enzyme EchP450 is expected to catalyze the single or double dehydrogenation reaction at the 
diketopiperazine core from preechinulin (40). Thereby, neoechinulin A (42) and neoechinulin B (44), 
the precursors of the neoechinulin A and B series, are created, which can also be prenylated several 
times by EchPT2 to form isoechinulin A (47), dehydroechinulin (43), isoechinulin B (48) and 
tetrahydroechinulin (49).  
 
Figure 15: Schematic presentation of some echinulin derivatives isolated from A. ruber (A), the putative echinulin gene 
cluster (B) and the echinulin biosynthetic pathway hypothesis (C).  
In a further study, the possible application of the prenyltransferases EchPT1 and EchPT2 for the 
biosynthetic production of tri- and tetraprenylated cyclic dipeptides and the influence of the substrate 
stereochemistry was investigated. Prenyltransferases show high promiscuity toward the accepted 
substrates and in some cases also toward the prenyl donor.106,129 This provides an excellent basis for 
the chemoenzymatic synthesis of new prenylated compounds. Previous studies have already shown 
that stereochemistry can have a significant influence on the acceptance of the substrate.139 Therefore, 
we decided to study a total of eight substrates consisting of all the four stereoisomers of cyclo-Trp-Ala 
and cyclo-Trp-Pro, respectively. With the help of EchPT1, we successfully prenylated all eight 
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substrates reversely at position C2. A total of six of the eight substrates examined showed good 
conversion yields from 52.6 ± 2.4 to 87.3 ± 1.8 % (Table 1). Only the two exclusively D-configured 
cyclodipeptides cyclo-D-Trp-D-Ala and cyclo-D-Trp-D-Pro were poorly accepted, with conversion rates 
of 16.3 ± 3.9 and 42.5 ± 1.9 %, respectively (Table 1). A similar effect has already been observed for 
the prenyltransferases AnaPT and CdpC3PT.139 The C2 reversely prenylated substrates were isolated 
and used as substrates for further investigations with EchPT2, which also accepted all eight reversely 
monoprenylated cyclo-Trp-Ala and cyclo-Trp-Pro stereoisomers. The conversion yields were calculated 
between 21.2 ± 2.4 and 98.3 ± 1.2 % (Table 1). Again, we were able to observe that the exclusive D-
configured isomers with conversions rate of 21.2 ± 2.4 % for cyclo‐D‐2-tert‐DMA‐Trp‐D‐Pro and 47.0 ± 
0.9 % for cyclo‐D‐2‐tert‐DMA‐Trp‐D‐Ala were clearly less converted compared to the other isomers. 
Similar to the biosynthesis of echinulin, EchPT2 also catalyzes the formation of di-, tri- and partly tetra-
prenylated products with the substrates mentioned above. Thereby, the main products are the C2, C5, 
and C7 triprenylated derivatives. Except for cyclo-L-2-tert-DMA-Trp-L-Pro and cyclo-D-2-tert-DMA-Trp-
D-Pro, the formation of one or two tetra-prenylated products was observed after the conversion of the 
substrates with EchPT2. In the formation of tetra-prenylated products, a clear influence of the 
substrate configuration on the formation of these products was observed. The ratio of tetra-prenylated 
products in (S, S) and (R, R) configured substrates was only 4% of total yields. In comparison, the ratio 
of C2, C4, C5, and C7-tetraprenylated products of the (S, R) and (R, S) configured substrates was 
determined at about 30 % (Table 1). 
Table 1: Conversion rate resp. proportion of total turnover in the biosynthetic production of mono- to tetraprenylated 
cyclic dipeptides catalyzed by EchPT1 and EchPT2.  
 
With their prenyl acceptor promiscuity, the prenyltransferases EchPT1 and EchPT2 join a steadily 
growing group of prenyltransferases.106,140 In this study, we were able to show that EchPT1 and EchPT2 
are well suited for use in the chemoenzymatic production of multiple prenylated cyclic dipeptides. This 
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is of particular importance since an increase in the biological activity of prenylated compounds 
compared to their unprenylated counterparts was observed for numerous compounds.152,153 For 
example, it could be shown that the presence of a prenyl group in various polyphenols is crucial for 
the inhibitory effect on melanin biosynthesis in B16 melanoma cells.154 The increase of the biological 
activity is presumably based on a higher lipophilicity of the prenylated substances, which can lead to a 
better interaction with biological membranes.155 In another study, it was demonstrated by in silico 
modeling that the prenyl group of a flavonoid fits very well into the hydrophobic binding pocket of the 
human estrogen receptor resulting in a higher agonistic activity.156 The structural elucidation and 
analysis of some enzymes such as EchPT1 and EchPT2 is of fundamental importance for the targeted 
structure-based enzyme design. By using structure-based engineering of some prenyltransferases, the 
spectrum of prenyl acceptors and donors has already been increased considerably. In a recent study, 
the accepted prenyl donor could be changed from DMAPP to FPP or GPP by identification of the amino 
acid Met328 in FgaPT2 and its mutation to glycine or alanine.146 Similar prenyl donor gatekeeper amino 
acids have also been identified in other prenyltransferases such as CdpNPT, CdpC2PT, CdpC3PT, 
FtmPT1, and BrePT. Their mutation also led to a clear increase in the acceptance of GPP.145 Such 
structure-based changes would further increase the applicability of EchPT1 and EchPT2 as biocatalysts 
for the synthesis of new natural products. 
The studies were realized in cooperation with Viola Wohlgemuth. The identification of the putative 
echinulin gene cluster by bioinformatic methods, as well as the culturing of Aspergillus ruber and the 
isolation of a few natural substances were carried out by me. Furthermore, I was involved in the 
purification of the prenyltransferases EchPT1 and EchPT2, as well as in the enzyme assays and isolation 
of some of the formed products.  
For further details about these publications see section 4.2 and 4.3: 
Viola Wohlgemuth, Florian Kindinger, Xiulan Xie, Bin-Gui Wang, and Shu-Ming Li (2017) Two 
Prenyltransferases govern a consecutive prenylation cascade in the biosynthesis of echinulin and 
neoechinulin. Organic Letters. 19: 5928-5931 
 
Viola Wohlgemuth*, Florian Kindinger* and Shu-Ming Li (2018) Convenient synthetic approach for tri- 
and tetraprenylated cyclodipeptides by consecutive enzymatic prenylations. Applied Microbiology and 
Biotechnology 102: 2671-2681 
 
*The authors contributed equally to this work.
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3.3. Expanding the available filamentous fungal expression hosts: Manipulation 
on Penicillium crustosum for use as a potential heterologous expression host 
The ongoing progress in the development of sequencing technologies and the associated reduction in 
costs for the sequencing of a genome is leading to a flood of genomic information from various 
organisms.157 At the same time, analysis of this information led to the conclusion that the genetic 
potential for the production of secondary metabolites is much greater than that of the natural products 
actually produced. The explanation for this is that most of the biosynthetic gene clusters are silent, i.e. 
not active, under the standard laboratory cultivation conditions.40 Therefore, different methods have 
been developed to exploit the unused potential of these silent gene clusters. A particularly suitable 
approach to realize this is the heterologous expression of the gene clusters in a suitable expression 
host.158 Hence, the potential of Penicillium crustosum for heterologous gene expression was 
investigated in order to expand the availability of appropriate expression hosts. 
First, the genome of Penicillium crustosum was sequenced and analyzed, leading to the identification 
of 56 putative BGCs. We were able to show that this fungus produces almost no native secondary 
metabolites when cultivated in minimal medium. This is an ideal prerequisite to identify and isolate 
heterologously produced new substances easily. The disruption of the PKS pcr4401 gene by deletions 
experiments was accompanied by the occurrence of albino phenotype. Subsequently, heterologous 
expression of the PKS pcr4401 gene in Aspergillus nidulans confirmed the involvement of this PKS in 
the biosynthesis of the melanin precursor YWA1 (50) which is responsible for the green pigmentation 
of the conidia. Furthermore, the dehydrated YWA1 derivative nor-rubrofusarin (51) was observed as a 
non-enzymatic side product (Figure 16). 53,159  
 
Figure 16: Formation of YWA1 and nor-rubrofusarin by Penicillium crustosum PKS Pcr4401. 
Therefore, the deletion of the PKS Pcr4401 leads to the observed albino phenotype. The successful 
introduction of a foreign gene into this locus can therefore be easily determined by the phenotype. 
This, together with the clean metabolic profile, rapid growth, good genetic manipulability as well as 
simple and inexpensive cultivation conditions, makes Penicillium crustosum a potentially usable 
expression host. To verify this, two unknown PKS genes from Penicillium camemberti and Penicillium 
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brevicompactum were successfully introduced into Penicillium crustosum based on the hygromycin B 
resistance selection marker. For this purpose, the plasmid pFK20 was created, allowing the simple 
cloning of a foreign gene and targeting the pcr4401 gene locus. Subsequently, the heterologously 
produced products were isolated and their structure elucidated as 3,5-dimethylorsellinic acid (52) and 
nor-toralactone (53) (Figure 17) by NMR and MS analyses. In order to ensure a better applicability of 
Penicillium crustosum as a heterologous expression host, pyrG was deleted afterward. The resulting 
uracil and uridine auxotrophic phenotype allows the use of pyrG as a further selection marker. Similar 
to pFK20, an additional plasmid pFK23 was constructed for foreign gene integration at the pcr4401 
locus. Instead of hygromycin B resistance as in the case of pFK20, the pyrG gene from Aspergillus 
fumigatus was used for selection. With this plasmid, we were also able to successfully introduce an 
additional PKS gene from Aspergillus ruber into the Penicillium crustosum pcr4401 gene locus. From 
the strain generated in this way, 6-methylsalicylic acid (54) was isolated as the accumulated product 
and its structure was elucidated by NMR and MS analyses (Figure 17). 
 
Figure 17: Heterologous production and product yield of the compounds 52, 53 and 54 in Penicillium crustosum. 
Although various fungi are already established and used as heterologous expression hosts, there is still 
a demand for alternative expression systems. The most frequently used fungi for heterologous 
expression are strains of the genus Aspergillus, e.g. Aspergillus nidulans, Aspergillus niger or Aspergillus 
oryzae.160-162 However, since the splicing pattern can already differ between species and especially 
between different genera, this can lead to problems during heterologous gene expression. This was 
the case in the heterologous expression of a PKS-NRPS hybrid gene of Magnaporthe oryzae in the 
heterologous host Aspergillus oryzae.163 Another potential problem is the possibility of host-
dependent cross-chemistry events. Depending on the chosen expression host, different products may 
be formed. This was observed in the heterologous expression of a NRPS-like enzyme. Although the 
same gene was expressed heterologously in the hosts Aspergillus niger and Aspergillus oryzae, 
different products were formed.164 An important step in the transformation of filamentous fungi by 
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polyethylene glycol-mediated protoplasts is the formation of the protoplasts. By using lysing enzymes 
from Trichoderma harzianum and yatalase from Corynebacterium sp. OZ-21, a protoplast 
concentration between 1.2 x 107 and 2.1 x 108 protoplasts per milliliter could be reached. These 
concentrations are comparable to the reported values for other fungi.165 The gene targeting rate is 
between 5 - 10 %. In combination with the simple visual identifiability upon successful integration into 
the pcr4401 locus Penicillium crustosum is well genetically tractable. Therefore, Penicillium crustosum 
can be a useful alternative for heterologous expression. Already with cultivation in minimal medium, 
heterologous production of PKS products with yields of 2.1 to 11.2 mg per liter medium was possible 
(Figure 17). When cultivated in complex media such as potato dextrose broth or rice, Penicillium 
crustosum produces large amounts of its own native secondary metabolites. This hinders the 
identification and isolation of new products under the given cultivation conditions. However, recently, 
we identified the natively produced secondary metabolites and the gene clusters responsible for the 
biosynthesis of these products.166 A double deletion of the PKS backbone genes claF and traA would 
block the formation of all Penicillium crustosum's own secondary metabolites. Thus, the clean 
metabolic profile favored for heterologous expression would also be available under these conditions. 
At the same time, a better supply of nutrients due to this medium would probably lead to higher 
yields.167 In conclusion, we proved Penicillium crustosum as a suitable host for the expression of fungal 
secondary metabolite genes and have thus expanded the spectrum of applicable expression systems. 
 
For further details about these publications see section 4.4: 
Florian Kindinger, Jonas Nies, Anke Becker, Tianjiao Zhu and Shu-Ming Li (2019) Genomic locus of a 
Penicillium crustosum pigment as integration site for secondary metabolite gene expression. ACS 
Chemical Biology 14: 1227-1234
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prenyltransferases. 
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Prenyltransferases of the dimethylallyltryptophan synthase
(DMATS) superfamily catalyze the attachment of prenyl or pre-
nyl-like moieties to diverse acceptor compounds. These accep-
tor molecules are generally aromatic in nature and mostly
indole or indole-like. Their catalytic transformation represents
a major skeletal diversification step in the biosynthesis of sec-
ondary metabolites, including the indole alkaloids. DMATS
enzymes thus contribute significantly to the biological and
pharmacological diversity of small molecule metabolites.
Understanding the substrate specificity of these enzymes could
create opportunities for their biocatalytic use in preparing com-
plex synthetic scaffolds. However, there has been no framework
to achieve this in a rational way. Here, we report a chemoinfor-
matic pipeline to enable prenyltransferase substrate prediction.
We systematically catalogued 32 unique prenyltransferases and
167 unique substrates to create possible reaction matrices and
compiled these data into a browsable database named PrenDB.
We then used a newly developed algorithm based on molecular
fragmentation to automatically extract reactive chemical
epitopes. The analysis of the collected data sheds light on the
thus far explored substrate space of DMATS enzymes. To assess
the predictive performance of our virtual reaction extraction
tool, 38 potential substrates were tested as prenyl acceptors
in assays with three prenyltransferases, and we were able to
detect turnover in >55% of the cases. The database, PrenDB
(www.kolblab.org/prendb.php), enables the prediction of poten-
tial substrates for chemoenzymatic synthesis through substructure
similarity and virtual chemical transformation techniques. It aims
at making prenyltransferases and their highly regio- and stereose-
lective reactions accessible to the research community for integra-
tion in synthetic work flows.
Prenylated primary and secondary metabolites, including
indole alkaloids, flavonoids, coumarins, xanthones, quinones,
and naphthalenes, are widely distributed in terrestrial and
marine organisms. They exhibit awide range of biological activ-
ities, including cytotoxic, antioxidant, and antimicrobial activ-
ities (1–3). Compared with their non-prenylated precursors,
these compounds usually demonstrate distinct and often
improved biological and pharmacological activities, which
makes them promising candidates for drug discovery and
development (1, 2, 4–6). These compounds could be consid-
ered hybrid molecules of prenyl moieties of different chain
lengths (nC5, where n is an integer number) and aromatic skel-
etons originating from various biosynthetic pathways (7, 8).
Prenyl transfer reactions (i.e. the connections of prenyl moi-
eties to the aromatic nucleus) are catalyzed by a diverse family
of prenyltransferases. Interestingly, this step usually represents
the key transformation in the biosynthesis of such compounds.
A prenylmoiety can be attached by prenyltransferases via its C1
(regular prenylation) or C3 (reverse prenylation) to carbon,
oxygen, or nitrogen atoms of an acceptor (Fig. 1,A and B) (7, 8).
Together with the observed regiospecific prenylations at differ-
ent positions of an acceptor molecule, prenyltransferases con-
tribute significantly to the structural and biological diversity of
natural products (7).
Based on their amino acid sequences and biochemical and
structural characteristics, prenyltransferases are categorized
into different subgroups (7). In the last decade, significant
progress has been achieved with the members of the dimethyl-
allyltryptophan synthase (DMATS)5 superfamily, and 40
enzymes of this group were identified and characterized by
mining of fungal and bacterial genomes (7). These enzymes
catalyze transfer reactions of a prenyl moiety from prenyl
diphosphate (e.g. dimethylallyl diphosphate (DMAPP)) to
diverse acceptors, such as tryptophan, tyrosine, tryptophan-
containing cyclic dipeptides, xanthones, tricyclic or tetracyclic
aromatic moieties, or even non-aromatic compounds. Among
the acceptors, indole derivatives, including tryptophan and
tryptophan-containing cyclic dipeptides, are substrates ofmost
of the DMATS enzymes investigated so far (7, 9).
The DMATS enzymes have already been demonstrated to dis-
play high substrate and catalytic promiscuity. They not only cata-
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FIGURE 1. A, exemplary transformation of brevianamide F (E1) to tryprostatin B (E3). B, regiochemistry of the nucleophilic attack on the prenyl moiety. For
regular prenylation, bond formation occurs between C2 and the carbon adjacent to the pyrophosphate group. An attack of C2 on the tertiary carbon of
DMAPP leads to the reversely prenylated product. C, illustration of the SMIRKS-like notation derived from A (generated by SMARTSviewer) (22). GA,
general prenyl moiety acceptor; GD, general prenyl moiety donor; GB, general base; GP, general prenylation product; PP, pyrophosphate; PGB, proto-
nated general base. D (left), a reactive epitope indicated around the reactive atom ([cH1:1]) with the atomic properties given in SMARTS nomenclature
(brackets). D (right), reactive epitope as generated by SMARTSviewer.
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lyzeprenylationof their substrates andclosely relatedcompounds,
but they also use structurally quite different compounds as prenyl
acceptors (10). Therefore, these enzymes were successfully used
for production of a large number of prenylated derivatives,
including prenylated tryptophan and tyrosine analogs, trypto-
phan-containing peptides and derivatives thereof, hydroxyxan-
thones, hydroxynaphthalenes, flavonoids, indolocarbazoles,
and acylphloroglucinols (10). For example, N1-, C4-, C5-, C6-
and C7-prenylated tryptophan and N1-, C2-, C3-, C4- and
C7-prenylated tryptophan-containing peptides and derivatives
were obtained by usingDMATS enzymes as biocatalysts (9, 10).
One of the challenges in discovery and use of DMATS
enzymes as biocatalysts in a rational and targetedmanner is the
prediction of the acceptance of a putative substrate. On the one
hand, the enzymes share similar structures, albeit often at low
sequence identities, and catalyze, in many cases, similar reac-
tions.On the other hand, different enzymeswith similar natural
substrates accept further non-native aromatic substances with
clearly different activities (7). Therefore, bioinformatic and
chemoinformatic approaches for the prediction of the catalytic
activity of these enzymes are welcome and necessary to harness
the full biosynthetic potential of this enzyme class.
We describe in this work the creation and evaluation of a
database that catalogs and stores prenyltransferase reaction
information. Because storage of the reactions is automated, the
database is not static but will grow with each new reaction
described in the literature. Furthermore, we present an appli-
cation of PrenDB, where we predict and validate putative sub-
strates for prenyltransferases (Fig. 2).
Results
PrenDB Statistics—Digitalization and chemoinformatic
encoding of enzymatic reactions of the DMATS superfamily
allow for a deep analysis of their substrate space and reactivity
toward distinct chemical epitopes (Fig. 3). In total, 32 unique
enzymes were found throughout the literature examined. The
three most prominent prenyltransferases in terms of the num-
ber of annotated transformations are 7-DMATS, FgaPT2, and
SirD, accounting for 15, 14, and 13% of the reactions in the
database, respectively. At the other end of the spectrum, there
are seven enzymes for which only a single reaction has been
published. With respect to promiscuity, the number of unique
reactive epitopes–molecular substructures centered around
the reactive atom and henceforth called repitopes in this work–
was used as a descriptor (cf. Fig. 1D for an exemplary repitope).
The enzymes 7-DMATS, FgaPT2, and AnaPT transfer prenyl
moieties onto the broadest range of chemical epitopes.



























































FIGURE 2. Schematic of the underlying work flow. A, reactions of prenyltransferases were digitalized and stored in PrenDB. The reactive atoms were detected
algorithmically and reconstituted to reactive epitopes (repitopes). Prenylation candidates were selected by a multistep virtual screening approach, and their
transformation potentials were evaluated experimentally on selected prenyltransferases. B, multistep virtual screening of database compounds (colored
triangles): (i) repitope-based substructure search based on the substrate space covered in PrenDB; (ii) one-dimensional property and three-dimensional shape
comparison with known substrates; and (iii) docking screen on three promiscuous prenyltransferases with available crystal structure.
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FIGURE 3. Illustrative interpretation of the analysis of PrenDB. Thirty-two enzymes contribute to the entirety of digitalized reactions (top histogram). The
reactions can be further subdivided into categories based on the chemistry of the transformation (middle). Each subgroup corresponds to one or more
enzymes (bottom histogram). *, the contribution of the enzyme with the highest contribution to a particular group was set to 100.
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space. Knowledge of the reactive atom and its surroundings
makes a further distinction of enzymatic transformations pos-
sible; the Sankey diagram in Fig. 3 shows how the cataloged
reactions not only can be linked to their prenyltransferases, but
also can be subdivided into types per the reactive atom. The
clear majority of reactions (87%) corresponds to the regular
type of prenyl moiety transfer (Fig. 1B, right), where the ther-
modynamicallymore stable regioisomer is formed. In 73% of all
reactions and in all reverse attachments, the reactive atom is a
member of a ring system (endo). Only a small part of regular
prenylations occur at exocyclic atoms (exo, 26%). There, prenyl
moieties are transferred onto oxygen and nitrogen atoms
of tyrosine and aniline-like moieties by SirD, FtmPT2, or
4-DMATS. Reverse prenylation can be observed at carbon and
nitrogen atoms only. They are incorporated in aromatic ring
systems and less frequently also in alicyclic moieties, such as
benzoquinones. More than 60% of all reactions occur at aro-
matic carbon atoms; derivatives of indole, including trypto-
phan, are the most frequent repitopes in this largest reaction
subclass. Much rarer are prenylations at nitrogen (8%) or at
exocyclic oxygen atoms (23%). By comparison, 5% (33 entries)
of reactions of tryptophan-like moieties (e.g. at atom position
C2 in brevianamide F (E1) (Fig. 1A) lead to formation of com-
pounds with a fused ring system, where the atomic environ-
ment of the reactive atom becomes dearomatized during the
reaction (FtmPT1, Fur7, and 4-DMATS).
Substrate Space—Throughout the analyzed literature (44
articles from17 journals), 167 unique substrateswere found.To
analyze the substrate space diversity of prenyltransferases, a
similarity matrix based on the pairwise ECFP4 (11) finger-
print molecular similarity was calculated (Fig. 4, Table 1, and
supplemental Table S1), followed by a hierarchical clustering.
This allows the grouping of substrates based on their chemical
structure. From the corresponding dendrograms and sup-
ported by the reorganized distancematrix, five substrate classes
distributed over 14 clusters can be deduced: (i) unsubstituted
indoles, derivatives of tryptophan and proline-tryptophan














































FIGURE 4. Hierarchical clustering of the substrates extracted from PrenDB. Individual clusters derived from the dendrograms are annotated with an image
of the corresponding cluster representative. Magenta and brown bars indicate 14 detected clusters. Black horizontal lines on the leaves of the dendrogram
indicate the number of molecules grouped together.
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tions on benzene and aliphatic atoms; (iii) naphthalene, qui-
none, and flavonoid derivatives; (iv) side chain-modified
tyrosines; (v) side chain-modified and multiply prenylated
tryptophans. More than 50% of the substrate space is cov-
ered by indole-containing compounds. Molecules with tyro-
sine and flavonoid or xanthone motifs contribute 18 and 26%
to the substrate space, respectively. Furthermore, the space
spanned by the fragments obtained via bond cleavage during
the fragment-based subgraph isomorphism perception pro-
cess (cf. “Materials and Methods”) is covered to an extent of
64% by tryptophan and diketopiperazine epitopes. This pre-
dominance of indoles can be explained by tryptophan and
indole derivatives being the native substrates for 78% of the
enzymes in PrenDB. This, combined with the DMATS bias
in the literature, eventually leads to strongly indole-biased
data.
Fig. 5 shows the knowledge about prenyltransferase reac-
tions, as digitalized and stored within PrenDB, in terms of cat-
alyzed transformations (combinations of a particular substrate
and an enzyme) and the corresponding yield achieved. In the
top right corner of the matrix, transformations of the most
abundant substrates (tryptophan, tyrosine, diketopiperazines,
and their derivatives, respectively) together with the most pro-
miscuous enzymes (7-DMATS, FtmPT1, CdpNPT, SirD, and
FgaPT2) can be found. At the same time, the matrix is sparse
(i.e. contains a lot of blanks). This sparsity is the result of the
availability of data and thus represents the research focus of the
prenyltransferase field in the past. It presents a challenging
starting situation for model building.
Repitopes—For each of the 665 cataloged reactions (each
defined as a unique triplet of a substrate, product, and enzyme),
a repitope (i.e. reactive epitope; see “Materials and Methods”
for a complete definition) was extracted using the reactive atom
detection and repitope reconstitution routines of the algorithm
developed in this work (see “Materials and Methods”). Each
repitope comprises four reconstitution depths (from 2 to 5
bond distances). Over all repitope depths, 276 unique
repitopes, defined by their unique SMARTS string, were
extracted. A SMARTS string is a one-dimensional encoding of
chemical substructures and an efficient way to store a complete
definition of each repitope (see “Materials and Methods”). A
reconstitution depth of 5 delivered the largest contribution to
the repitope space with 135 (49%) members. This is consistent
with expectations, because larger depths will lead to more
diverse descriptions. Depths 2, 3, and 4 account for 25 (9%), 69
(25%), and 94 (34%) repitopes, respectively. Interestingly, the
sum over all amounts of each reconstitution level is greater
than the total number of unique repitopes. This means that
distinct combinations of the substrate molecule, its reactive
atom, and the depth level are not mutually exclusive, thus
resulting in duplicate entries. Fig. 6 shows the distribution of
repitopes for the various depth levels of reconstitution, under-
lining the relationship between repitope size and diversity.
Although the largest class of repitopes contributes the most to
repitope space, also smaller, more general and ambiguous
repitopes are among the top 10 most frequent repitopes; sub-
structures of tyrosine, benzene, and indole are at ranks 3, 5, 6, 7,
and 9, respectively, whereas complete and extended indole and
tyrosine structures are at ranks 1, 2, and 4 and, at 8, 10, and 11.
Prediction of Novel Substrates via a Multistep Screening
Procedure—In a sequential application of virtual screening
tools (Fig. 2), beginning with prenylation prediction through
repitopes stored in PrenDB and concluding with docking into
three prenyltransferases with a known crystal structure
(FgaPT2, FtmPT1, and CdpNPT), 38 virtual hits were selected
through the following procedure. (i) A compound was consid-
ered as a virtual hit if any PrenDB repitope could be found
within its molecular framework at least once. Supplemental
Table S2 shows the number of repitopes matching a particular
hit, with a high repitope hit rate indicating promiscuous com-
pounds (i.e.molecules that are classified as substrates of multi-
ple enzymes). Using repitopes based on a reconstitution depth
of 3, 168,906 compounds were selected in this first step. (ii)
Comparison of molecular properties with those of known sub-
strates and removal of molecules outside the respective ranges
(Table 2) reduced the number of virtual hits to 90,559. Going
beyond one- and two-dimensional molecular descriptors and
ensuring that the (iii) three-dimensional shape (judged by a
high score in the OEChem shape congruency tool; see “Mate-
rials andMethods”)matched between putative and known sub-
strates led to a selection of 451 compounds. This repitope-,
property-, and shape-based determination of prenylation
potential of the selected compounds was further refined by the
(iv) docking results; for each compound, an optimal enzyme
structure for docking was selected based on a compound’s
structural overlap with the co-crystallized substrate. The
amount of this overlap was quantified by the same shape con-
gruency methodology mentioned above but was automati-
cally invoked from within the docking application HYBRID
(see “Materials and Methods”). The generated poses, from
which 38 molecules were selected for experimental valida-
tion, show a distinct geometrical consensus of the key inter-
actions with the enzymes (Fig. 7): first, polar interactions
TABLE 1
Cluster size and substrate space coverage derived from hierarchical
clustering
PrenDB, a Substrate Prediction Database
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FIGURE 5. Coverage of enzyme-substrate space. Orange squares indicate transformation yields 10%, and cornflower squares show a yield 10% for the
corresponding enzyme-substrate combination, respectively. White squares, absence of data.
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with the general base Glu-89/102/116; second, occupation of
the apolar indole-subpocket and hydrogen bond interactions
in the vicinity of the opening of the active site, residues His-
279 and Arg-244.
Novel Substrates for Prenyltransferases FgaPT2, FtmPT1, and
CdpNPT—To assess the predictive performance of our virtual
screening, the 38 potential substrates were tested as prenyl
acceptors in enzyme assays with the tryptophan prenyltrans-
ferase FgaPT2 and the two tryptophan-containing cyclic dipep-
tide prenyltransferases FtmPT1 and CdpNPT. The selected
substances clearly differ structurally from the substrates for the
DMATS prenyltransferases reported previously (7, 10). The



























































FIGURE 6. Distribution of repitopes of different depth in repitope space. Dashed lines, conjugated bonds.
TABLE 2
Range limits of physico-chemical properties derived from the sub-
strate space stored in PrenDB
Physico-chemical
property Minimum Maximum
Molecular mass (Da) 140 515
No. of heavy atoms 11 37
No. of carbon atoms 8 27
No. of heteroatoms 1 10
No. of chiral centers 0 5
Hydrogen bond acceptors 0 6
Hydrogen bond donors 1 6
No. of atoms in a ring system 6 25
No. of rotatable bonds 0 6
No. of rigid bonds 9 40
XLogP 3.94 3.76
Minimal solubility attribute Poorlya
2D polar surface area (Å2) 20.0 1125
Removal of known aggregators Trueb
a Solubility categories (insoluble, poorly, moderately, soluble, very, highly) are de-
rived from reparametrized atom types from the XLogP algorithm within the
OEChem toolkit.
b An aggregator is considered an exact match with one of approximately 400 pub-
lished aggregators compiled in the OEChem toolkit.
FIGURE 7. Molecular features extracted from poses of the selected virtual
hits. Left, red spheres, hydrogen bond acceptors; yellow discs, aromatic moi-
eties. The majority of acceptor functionalities can be found around the basic
residues Arg-255 and His-279. Right, blue spheres indicate hydrogen bond
donors. They are located around the highly conserved glutamate (Glu-89/
102/116) and in the vicinity of backbone carbonyls (omitted for clarity).
PrenDB, a Substrate Prediction Database
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reaction mixtures were analyzed with LC-MS to detect the for-
mation of prenylated products. As shown in supplemental
Table S2 and Fig. 8, 23 of these substances were accepted by
FtmPT1, 22 by FgaPT2, and 25 by CdpNPT. In relation to the
number of hits selected from our virtual screen, this corre-
sponds to a hit rate of 60.5% for FtmPT1, 57.9% for FgaPT2, and
65.8% for CdpNPT. Product yields of 50% were observed for
12 substrates with FtmPT1, 7 with FgaPT2, and 10 with
CdpNPT, respectively. The prenylated products can be
detected in a straightforward manner as signals in their corre-
sponding mass spectra; their [M  H] ions are shifted by 68
Da relative to their educts. Overall, we thus obtained high hit
rates and yields 50% in the case of 29 reactions (25% of all
attempted reactions).
Similarity Analysis of Known Substrates and Selected
Compounds—To assess the novelty of the 38 selected com-
pounds, the similarity with the substrate space catalogedwithin
PrenDB (167 substrates) was calculated and visualized by gen-
erating a similarity matrix based on the ECFP4 fingerprint-
based Tanimoto similarity (Fig. 9, left). The matrix shows an
overall low similarity score between our selection and the
known substrate space. This points toward the potential to
access truly novel substrate space by employing repitopes. Of
note, the similarity is higher in columns corresponding to com-
pounds that were successfully prenylated in our assays by at
least two of our test enzymes. The right panel of Fig. 9 shows
similarity scores as calculated by our in-house fragment-based
method RedFrag (12); in contrast to ECFP4, RedFrag compares
the fragmental composition of molecules and the two-dimen-
sional arrangement of fragments. RedFrag accentuates the
commonalities and differences between known substrates and
our selections. Compound 1, a tryptophan-homoproline-dike-
topiperazine (94.1% yield on FtmPT1), shows high similarity
scores with tryptophan, its indole core derivatives, and, expect-
edly, tryptophan-tryptophan-, tryptophan-alanine-, trypto-
phan-glycine-, and tryptophan-proline-diketopiperazines from
clusters 1, 2, and 3, respectively. Of note, RedFrag emphasizes
the similarity of compound 1 and cluster 3 based on the pres-
ence of the indole scaffold. In contrast, ECFP4 emphasizes the
dissimilarity of this compound originating from the absence of
the diketopiperazinemotif in the same cluster. Compounds 12,
26, and 32 show high similarity with substrates from cluster 3
(also 9, 10, and 11). Compounds 12 and 32 are regioisomers of
a brominated tryptophan derivative. They show distinctly dif-
ferent yields: 14.4 and 8.5% for12 inCdpNPTandFtmPT1; 47.5
and 44.7% for 32 in FtmPT1 and FgaPT2, respectively. It is
evident that the position of the bromine atom has a major
impact on the role of such compounds as substrates. The influ-
ence of regiochemistry of indole core substitutions or single-
atom replacements at this core is further exemplified by com-
pound 26. Its benzothiophene moiety (replacing the nitrogen
atom in an indole by a sulfur atom) is not accepted as a substrate
by any of the three test enzymes.
Selected compounds with low similarity but remarkable
yields indicate novel substrate classes or motifs; compound 16
shows a good yield in FtmPT1 and moderate yields in FgaPT2
and CdpNPT (68.8, 34.8, and 29.7%, respectively). Its conju-
gated indole-4-imidazolin-2-one motif has no similar counter-
parts within the known substrate space. This is also true for
compound 30 (yields of 60.1, 59.4, and 96.1%, respectively) and
its benzylated hydroxyl-indole structure. Compound 27, a
pyrimidine-indole, shows excellent yield in FgaPT2 (82.9%).
Further exampleswith high yields but RedFrag similarity scores
0.6 are compounds 11, 13, 20, 23, and 33.
Structure Elucidation of the Products of Compounds 21 and
30—To investigate at which position within a given substrate
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FIGURE 8. Transformation rates of virtual hits relative to L-tryptophan
obtained for the three examined enzymes FtmPT1, CdpNPT, and
FgaPT2. Horizontal bars, mean; vertical bars, S.D.; orange interval, S.E.; colored
circles, data points.
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incubationswith two indole derivatives, indole 3-ethyl ethylsul-
fonamide (21) and 6-benzyloxyindole (30), which were very
well (98.6% yield) and moderately (60.1% yield) accepted by
this enzyme, respectively (Fig. 10 and supplemental Table S2).
As shown in Fig. 11A, a single dominant peak was observed in
the LC-MS chromatograms of the incubation mixtures, which
were isolated on aMultospher 120 RP-18 column for structure
elucidation. 1H NMR data revealed, surprisingly, the presence
of two compounds in each reaction mixture. 21a and 21b orig-
inated from 21 in a ratio of 1:1 from the reaction mixture, and
30a and 30b originated in a ratio of 1:0.85 from 30. Further
purification resulted in four pure products. Through NMR and
MS analyses, the structure of 21a was subsequently elucidated
as a regularly N1-prenylated derivative. The second product,
21b,was identified as a reversely C3-prenylated derivative with
a simultaneous cyclization of C2 of the indole with the nitrogen
atom of the side chain located at C3, resulting in the formation
of a 6/5/5 fused ring system. Compounds 30a and 30b were
proven to be regularly C2- and C5-prenylated derivatives,
respectively. These results unequivocally proved specific pre-
nylations at the indole ring without or with additional modifi-
cations, such as cyclization. Detailed studies of the relation-
ships of enzymes, substrates listed in supplemental Table S2,
and their products are under further investigation.
A comparison of the elucidated structures of the products
21a, 21b, 30a, and 30bwith the PrenDB-predicted prenylation
sites of their corresponding educts reveals that the prenylation
site was correctly predicted in two of four cases. However, the
responsible enzyme, FtmPT1, was only proposed for the preny-
lation of 21 to yield 21a. In the case of 30, the product 30bwas
predicted to originate from the enzyme CdpNPT or FgaPT2.
Discussion
This study demonstrates the power of systematically orga-
nizing and analyzing diverse and disparate experimental enzy-
matic data by means of chemoinformatic methods. Besides a
comprehensive repository of the existing knowledge about pre-
nyltransferase reactions, the determination of repitopes
allowed us to predict novel substrates that are distinctly differ-
ent from the ones that have been identified previously, both
natural and synthetic. Moreover, we achieved an overall high
hit rate of 71% in terms of molecules that were accepted by at
least one prenyltransferase. However, it has to be noted that the
repitopes stored in PrenDB are not yet accurate enough in all
cases to precisely predict the correct enzyme and/or the correct
reactive atom. This shortcoming is presumably correlated with
the comparatively small number of instances in the database.
Although the existing body of literature clearly represents a
considerable experimental effort, chemistry and the biochemi-
cal reactivity of enzymes are so diverse that even higher num-
bers of substrate-enzyme-product triplets would be necessary
to obtain more complete repitopes that also account for the
different reactivity of certain substructures. The chemoinfor-
matic strategy thatwe employed in thiswork is certainly flexible
enough to accurately model more fine-grained patterns.
At the same time, a database such as PrenDB can provide
excellent help in determining which reactions and substrates
would be worthwhile to test next. On a basic level, one could
simply be guided by the number of reactions already described
for each enzyme and focus on the underrepresented ones. But
also more sophisticated approaches can be envisioned; enzyme
phylogenetic trees could be based not on amino acid sequence,
but on substrate similarity. Further exploration would thus focus
on filling in the missing links. Ultimately, such strategies might
merge with machine learning approaches, where the algorithm
itself would suggest which enzyme-substrate pairs to test next
based on themaximum information gain of each investigation.
Nevertheless, despite some shortcomings, our database and
resulting prediction algorithm are already useful for correctly
predicting a large number of substrates and thereby aiding in
the creation of novel chemical matter. The imprecisions could
also be taken as a strength in this context, in that they allow for
serendipitous discoveries (e.g. the reverse prenylation of 21 to
21b by FtmPT1).
Last, it has to be emphasized that the concept of repitopes
and their fragment-based determination can easily be extended
to other enzymatic reactions. The automatic processing of
potentially large numbers of reactions and the concomitant
conversion into the reaction principles (i.e. repitopes) will lead
FIGURE 9. Similarity matrix between the selected compounds and known substrates for prenyltransferases extracted from PrenDB. Left, ECFP4
fingerprint similarity. Middle, RedFrag scores calculated with ECFP4 fingerprints. Color coding (top), green, yield 50%; yellow, yield between 1 and 50%; gray,






















































FIGURE 10. Transformations of virtual hits 21 and 30 by FtmPT1. A, indole
3-ethyl ethylsulfonamide (21) was regularly prenylated at position N1, lead-
ing to 21a, and reversely prenylated at position C3 with a simultaneous for-
mation of a 6/5/5 fused ring system (21b). Typically for C3-prenylation at
indole substructures, a dearomatization and intramolecular cyclization
accompany the prenylation reaction. B, 6-benzyloxyindole (30) was regularly
prenylated at positions C2 and C5.
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to facile systematizations and gain of knowledge from the anal-
yses of the emerging data.
The high hit rates (58–66%) for each enzyme and the fact
that one-fourth of the reactions had a yield of 50% demon-
strate the excellent performance of our knowledge-based
repitope approach. The combination of PrenDB and its ligand-
based approach with protein structure-based tools, such as
docking, therefore seems to constitute a powerful combination
of strategies. Furthermore, these results prove the potential
usefulness of the tested enzymes for the production of preny-
lated derivatives.
Materials and Methods
The prenylation reaction as conducted by the enzymes of the
DMATS superfamily formally corresponds to a substitution
reaction occurring on carbon, oxygen, and nitrogen atoms of
small metabolites through the transfer of small apolar moieties
(denoted as dma (short for dimethylallyl) in the following
example). The leaving group is always a pyrophosphate (PPi)
and a formal proton accepted by a general base. The reaction
can be written in a symbolic way (SMIRKS notation, Daylight
Chemical Information System, Inc. website, accessed March
16, 2016; see below); the atoms taking part in the chemical
transformation are arranged in a one-line notation showing the
bond cleavages and formations.
[C,O,N:1][H:2]  dma[C:3][O:4]PP i  [gB:5]
3
[C,O,N:1][C:3]dma  [O:4]PP i  [gB:5][H:2]
REACTION 1
Square brackets enclose individual atoms, and adjacent
atoms are taken to be linked by covalent bonds. Letters denote
elements, gB is the general base, and PPi is pyrophosphate;
commas represent a logical OR; and numbers are arbitrary
labels to allow for unambiguous tracking of each atom. In the
above example, it can be seen that the hydrogen atomwith label
2 ([H:2]) is substituted by the dma group and moves from its
adjacent carbon, oxygen, or nitrogen atom (labeled 1) to the





































































EIC: 224.1070; 292.1696 ± 0.005
A
B
FIGURE 11. LC-MS analysis of the reaction mixtures and prenyl transfer reactions of FtmPT1 with 21 (A) and 30 (B). EIC, extracted ion chromatogram;
mAU, milliabsorbance unit.
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mation in a two-dimensional way exemplarily for the reaction
between brevianamide F (E1) and DMAPP (E2) catalyzed by
FtmPT1. With this symbolic notation and common chemoin-
formatic tools in hand, it is possible to virtually transform, for
example, any carbon atom [C:1] bearing a hydrogen atom [H:2]
(GA in Fig. 1C) into the prenylated product (GP), at the same
time generating a protonated general base (PGB) and pyro-
phosphate (PP) as by-products. Although feasible in silico, a
chemical transformation based solely on the reactive atom is
unreasonable and ambiguous; in reality, only carbon, nitrogen,
and oxygen atoms located within the correct atomic surround-
ings can undergo prenylation. Thus, the entire molecule, or at
least a crucial motif within it, is necessary to completely char-
acterize a reactive environment. We call such a set of atoms
consisting of the reactive atom, to which the transferredmoiety
will be attached, and its neighboring atoms a “reactive epitope”
(repitope for short). In the case of the transformation of E1, the
corresponding repitope is shown in Fig. 1D. The specification




where lowercase letters denote membership of an atom in an
aromatic system, HX indicates the presence of X adjacent
hydrogen atoms, and parentheses indicate branching of the
molecular framework. From this notation, it can be concluded
that the reactive atom is aromatic and is bound to one hydrogen
atom; its direct neighbors are an aromatic nitrogen and another
aromatic carbon without any attached hydrogen atoms. The
second neighbor shell consists of two aromatic carbon atoms
and one aliphatic carbon atom. This convenient one-line nota-
tion of chemical environments is called SMARTS (one-line
molecular patterns; Daylight Chemical Information System,
Inc. website; accessedMarch 16, 2016) and is widely used in the
field of chemoinformatics, especially for substructure searches.
Atoms, their properties, and binding characteristics are
encoded with alphanumeric characters. Multiple molecule
SMARTS together with the information about bond breakage
and formation yield the SMIRKS of a reaction.With a repitope,
such as the one described above, and the enzymatic transfor-
mation encoded in SMIRKS notation, it is possible to virtually
transform any substratemolecule into its corresponding preny-
lation product or to easily search for putative substrates by
invoking substructure-based virtual screens in publicly avail-
able vendor databases.
The corresponding SMARTS notation for each repitope
could in principle be deduced by hand, given the chemical
structures of the substrate and product molecules. To achieve
an efficient handling of several hundred enzymatic transforma-
tions, with only the two-dimensional structures of substrate,
product, and the transferred moiety as input, an automated
procedure for the extraction of transformation SMARTS, and
thus repitopes, appears to be as indispensable as it is difficult to
accomplish. A fully specified repitope requires knowledge of
the reactive atom as well as its surroundings. Repitope deduc-
tion can be accomplished by applying subgraph isomorphism-
based algorithms followed by the reconstitution of the chemical
environment. Both steps (reactive atom perception and repitope
reconstitution) will be described in detail below. All coding was
done in python. For chemoinformatic calculations, the python
wrappers of theRDKit (open source toolkit for chemoinformatics;
accessedMarch 16, 2016) library were utilized. Fingerprint-based
similarity calculation was carried out with the OEChem toolkit
(OpenEye Scientific Software, Inc., Santa Fe, NM).
Perception of the Reactive Atom
In the case of a simple linear substitution reaction, as
depicted in Fig. 1A, the reactive atom can be found by mapping
the molecular structure of the substrate molecule onto the
molecular structure of the product. For non-symmetric mole-
cules, this leads to a unique match with an atom-to-atom cor-
respondence between substrate and product. Because the num-
ber of atoms in the product is always greater than the number in
the substrate, the substrate is a substructure of the product (i.e.
its complete molecular skeleton can be found within that of the
product). With the same approach, the atom-to-atom corre-
spondence between the transferred moiety (i.e. the prenyl
group) and the product molecule can be obtained. The inter-
section of the atom-to-atom matched sets of the substrate and
the transferred moiety consists of only one atom, the reactive
atom (Fig. 12A). If, however, the enzymatic transfer of a moiety
is accompanied by a subsequent (or concerted) rearrangement
of the molecular skeleton of the product (e.g. a cyclization), the
substrate cannot be considered to be a direct substructure of
the product anymore. Thus, the reactive atom can no longer be
determined through the atom-wise substrate-to-product map-
ping as described above. In such a case, a possible strategy for
establishing a substructure correspondence (i.e. a subgraph iso-
morphism) would be to weaken atom or bond type matching
criteria. The resulting atom-to-atom correspondences are
allowed to bemore general in that way but are often ambiguous
at best. To circumvent this problem, we assumed that, although
the entire substrate may undergo dramatic changes in its
molecular skeleton, smaller structural motifs (molecular frag-
ments) remain unaffected by such transformations and can
therefore still be unambiguously mapped onto the substrate
structure before and after the reaction. Fig. 12B illustrates the
consecutive steps in this fragment-based substructure isomor-
phism approach. In contrast to the aforementioned subgraph
isomorphism based on the entire substrate structure, an addi-
tional fragmentation step has to be performed. Breakable bonds
(bonds connecting ring systemswith other ring systems or with
acyclic motifs (see Fig. 13 (A and B) for exemplary fragmenta-
tions and the breakable bond definition)) are cleaved, leading to
a set of fragments. An intermediate filter step ensures that very
small fragments (single atoms, linker moieties, terminal
groups) are not considered further. The remaining fragments
are mapped onto the product structure, and their atom-to-
atom correspondence is investigated for an intersection with
the atom mappings of the transferred moiety and the product
molecule. By preserving the atom-to-atom correspondences
between the substrate molecule and its fragments, the reactive
atomcanbe identified by finding the intersecting atomof one of
the matching fragments in the substrate.
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Reconstitution of the Reactive Epitope
As already mentioned, knowledge of the reactive atom alone
is only of limited use for substructure searches or virtual trans-
formations, because both methods yield ambiguous results
when only a single atom is given as input. It is therefore neces-
sary to rebuild the chemical environment of the reactive atom
to obtain a description of a particular transformation that has
discriminative power. To obtain such a description, the reactive
atom is augmented with additional atoms from its first, second,
third, (etc.) neighbor shells (Fig. 14) (i.e. by traversing the
atomic neighborhood of the reactive atomup to a fixed distance
(i.e. number of bonds)). The traversed atoms are then extracted
as a molecular subset and converted into a regular molecular
object and, eventually, a SMARTS string. Different depths of
reconstitution lead to either small and nonspecific repitopes (d 
1) or larger and more stringent ones for large depths (d  3). In
extremis, at the largest possible depth, the repitope becomes iden-
tical to themolecule itself. Thus, a balancehas to be found, and the
most useful repitopes are able to represent reasonable chemical
environments for a particular reaction but still allow for certain
flexibility and diversity in retrieving putative substrates.
Database of Prenylation Reactions
With the algorithmic tools to deconstruct a given trans-
formation catalyzed by a prenyltransferase into a reaction
SMARTS and the corresponding repitopes in hand, investiga-
tion of as many transformations as possible can readily be con-
ducted. Hence, we decided to create a database (PrenDB) stor-
ing the known transformations in an efficiently browsable and
queryable manner. For this purpose, a literature search was
performed to extract substrates, products, enzymes, and avail-
ablemetadata (such as kinetics and yields) from 44 publications
(full articles, reviews, and communications) across 17 journals.
Each enzymatic reaction is represented by the SMILES strings
(13) of the product and substratemolecules, combinedwith the
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FIGURE 12. A, substrate-based subgraph isomorphism. The substrate structure matches the product as a whole. The intersection of atom overlaps between
substrate and prenyl moiety delivers the reactive atom (orange arrows, index 9). B, fragment-based subgraph isomorphism. Substrate structure is fragmented
into smaller epitopes preserving the substrate-fragment atom matchings. By matching fragments onto the product and analyzing the intersection with the
prenyl moiety, the reactive atom can be found within the structure of the substrate (orange arrows, index 1).
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SMARTS is that each reaction can be visualized and processed
with common chemoinformatic software. Furthermore, each
reaction entry contains multiple repitopes, generated with the
aforementioned algorithm and different environmental depths
(2–5 bonds around the detected reactive atom). This reaction
table (a table is a collection of database entries that are seman-
tically equal) is supported by and connected with further tables
holding metadata extracted from the literature and/or calcu-
lated with chemoinformatic tools (Fig. 15). The molecule dic-
tionary table comprises all small molecules involved in the
reaction: substrates, products, transferred moieties (such as
DMAPP or benzylpyrophosphate), and fragments. Addition-
ally, each entry comes with a molecular properties table, where
basic physico-chemical properties can be looked up. The refer-
ence table contains the literature used for data extraction
together with hyperlinks to articles and entries on PubMed and
UniProtKB. PrenDB can be browsed and extended with python
scripts bundled with the algorithms for repitope generation
described in this work (or more conveniently via a web inter-
face) in a straightforward manner. Because of access speed and
portability considerations, we decided to use the sqlite3 back-
end as the underlying database architecture and the Django
python package for middleware and frontend.
Virtual Screen for Putative Substrates of Prenyltransferases
To predict novel substrates for transformation by a prenyl-
transferase, a multistep screening process was carried out with
a subset of the ZINC database (14), which stores commercially
available small molecules in ready-to-be-processed formats.
First, the ZINC clean leads database, with a total of 5.1 million
compounds, was filtered for the presence of any of the extracted
repitopes from PrenDB. The repitope depth was 3. The screen-
ing was carried out as substructure searches using the python
wrappers of the OEChem toolkit. Second, compounds were
filtered utilizing the MolProp toolkit (OpenEye Scientific Soft-
ware). Only compounds with physico-chemical properties























not a ring bond
any atom except terminal
[R] !@ [!D1]
FIGURE 13. A, fragmentation rule expressed as SMARTS string. The rule con-
sists of two atom definitions and a bond definition. Enclosed in square brack-
ets (blue) are atoms connected by any bond type except for a ring bond
(orange). The atom on the left can be of any type but must be a member of a
ring system (hydrogen atoms are excluded indirectly because they are not
allowed to form ring systems). On the right, the atom must not be a terminal
atom (hydrogen atoms are excluded indirectly because they are always termi-
nal). B, breakable bonds (orange) as defined by the fragmentation rule and the
resulting fragments (blue) based on the substrates 21 and 30 and their corre-










































































aliphatic / aromatic Caromatic N
H
x
number of hydrogens carbon in ring of size xRx
A B
FIGURE 14. A, a repitope is generated by sequentially rebuilding the substrate molecule shell by shell with the reactive atom (index 1) as anchor point. Each
iteration adds another neighbor shell to the repitope, resulting in a fully defined depth-3 repitope as depicted by SMARTSviewer (B).
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PrenDB were allowed (Table 2). The remaining compounds
were subsequently submitted to the shape congruency analysis
based on the OEChemAPI. In short, for each compound, a low
energy conformer was generated, and its 3-dimensional overlay
with each known substrate was optimized. Compounds with an
overlay score 0.9, reflecting excellent three-dimensional
shape matching, were allowed for the next step. Fourth, the
remaining compounds were docked into the three most pro-
miscuous prenyltransferases for which a crystal structure had
been determined (FgaPT2, FtmPT1, and CdpNPT; Protein
Data Bank codes 3I4X, 3O2K, and 4E0U, respectively), employ-
ing the multi-target HYBRID (15) engine; for each compound,
up to 200 conformers were generated with OMEGA (16). The
ensemble of conformations of each molecule was then overlaid
with the co-crystallized ligand in each of the three selected
crystal structures to determine the best suited enzyme for
the following exhaustive docking. Themethod for overlaying
conformers is built directly into the HYBRID engine and is
based on the same methodology as implemented in the
OEChem API and the ROCS application (17). For the actual
docking step (translational and rotational optimization of a
compound conformer within the binding site of the protein),
HYBRID scores for a given protein-ligand complex were cal-
culated based on the shape and electrostatic complementa-
rity of the ligand and protein’s binding site (Fig. 16). Shape
and electrostatic features are represented by Gaussian
potentials. During optimization, the overlap between ligand
and protein features is maximized. After docking, calculated
poses were visually inspected to remove those that form
improbable interactions that are not sufficiently penalized
by present-day scoring functions, and the selected com-
pounds were acquired from their respective vendors and
experimentally tested.
Experimental Validation
Chemicals, Bacterial Strains, andCultureConditions—DMAPP
was synthesized according to the method described for geranyl
diphosphate reported previously (18). The 38 tested substrates
were purchased from Enamine Ltd. (Kiev, Ukraine), Chem-
Bridge Corp. (San Diego, CA), MolPort (Riga, Latvia), Vitas-M
Ltd. (Apeldoorn, Netherlands), and Mcule, Inc. (Budapest,
Hungary).
Escherichia coli strains XL1 Blue MRF (Stratagene, Heidel-
berg, Germany) and E. coli BL21 (DE3) (Invitrogen, Karlsruhe,
Germany) were used for protein overproduction. The strains
with expression plasmids were cultivated in lysogeny broth or
Terrific brothmediumat 37 °Cwith 50gml1 carbenicillin or



























































FIGURE 15. Design of PrenDB. The database tables are related to each other in a one-to-one (reactions and repitopes), one-to-many (substrates and reactions),
or many-to-many (substrates and fragments) relationship, reflecting their real world correspondence. The central reaction dictionary holds the necessary data to
encode a reaction based on substrate, product, and cofactor molecules, the enzyme, and the resulting repitope. A reference table is added to supplement the database
with metadata and enhance its usability. Dashed lines, abstract inheritance; solid wedged lines, one-to-many relationships (e.g. a molecule can act as substrate in as
many reactions as an enzyme). A repitope belonging solely to one particular reaction is indicated by a straight solid line (one-to-one relationship).
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FIGURE 16. Distribution of docking scores for each of the 42 initially selected poses. Each distribution (represented as a box plot) shows 10 scores
(circles)/compound. Boxes embrace 50% of the scores, and horizontal lines (whiskers) cover 99.3% of the scores. Circles with black diamonds, outliers.
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FtmPT1 with pAG012, FgaPT2 with pIU18, and CdpNPT with
pHL5 were carried out as reported previously (19–21).
Enzyme Assays with Recombinant Proteins—In the assays to
determine the acceptance of the different substrates, the
enzyme reaction mixtures contained 50 mM Tris-HCl, pH 7.5,
10 mM CaCl2, 2 mMDMAPP, 2–7.5% (v/v) glycerol, 1–2% (v/v)
DMSO, 1 mM aromatic substrate, and 0.4 mgml1 purified
recombinant protein in a volume of 100 l. The reaction mix-
tures were incubated at 37 °C for 16 h and terminated by the
addition of an equal volume of methanol. The reaction mix-
tures were brought to dryness by vacuum evaporation and sub-
sequently resuspended in 100l ofmethanol and centrifuged at
13,000 rpm for 15 min. Five l of the supernatants were ana-
lyzed on LC-MS.
For isolation of the enzyme products, the reaction mixtures
were scaled up to 10ml, containing 50mMTris-HCl, pH 7.5, 10
mM CaCl2, 2 mM DMAPP, 2–7.5% (v/v) glycerol, 1–2% (v/v)
DMSO, 1 mM aromatic substrate, and 0.4 mgml1 purified
recombinant protein, and incubated at 37 °C for 16 h. The
reactions were terminated by the addition of 10 ml of meth-
anol and brought to dryness by using a rotary evaporator at
37 °C. The residues were resuspended in 1 ml of methanol,
centrifuged at 13,000 rpm for 15 min, and purified on an
HPLC device.
LC-ESI-HRMS Analysis of the Reaction Mixtures—The
treated enzyme reactionmixtures (5 l) mentioned above were
analyzed on an Agilent 1260 Infinity HPLC system (Böblingen,
Germany) in combinationwith a photodiode array detector and
aBrukermicrOTOF-Q IIImass spectrometer. For separation, a
Multospher 120 RP-18 column (250  2 mm, 5 m, CS-Chro-
matographie Service, Langerwehe,Germany)with a flow rate of
0.25mlmin1was used.Water (solvent A) andMeCN (solvent
B), both containing 0.1% (v/v) formic acid, were used for a linear
gradient of 5–100% (v/v) solvent B in A in 40 min. Subse-
quently, the column was washed with 100% solvent B for 5 min
and equilibrated with 5% (v/v) solvent B for 10 min. The sepa-
rations weremonitored with the BrukermicrOTOF-Q III mass
spectrometer using the positive ion ESI. HPLC and MS data
were processed by using Bruker Compass DataAnalysis version
4.2 (build 383.1) software.
Isolation of Enzymatic Products—Isolation of the enzyme
products was performed on an Agilent HPLC series 1200. The
separationwas carriedoutonaMultoHighChiralAM-RPcolumn
(250  10 mm, 5 m, CS-Chromatographie Service) with a flow
rate of 1 mlmin1 and different linear gradients of methanol in
water.
NMRAnalysis—The isolated enzyme products were brought
to dryness by using a rotary evaporator at 37 °C and dissolved in
0.7 ml of CD3OD. NMR spectra were recorded on a JEOL ECA
500-MHz spectrometer (JEOL Germany GmbH, Munich, Ger-
many). The signal of CD3OD at 3.31 ppm was used as an inter-
nal reference for chemical shifts. Data processing was done by
using MestReNova version 6.0.2-5475 software.
Compound 21a—1HNMR (methanol-d4, 500MHz)   7.55
(dt, J  8.0, 0.9 Hz), 7.30 (dt, J  8.2, 0.9 Hz), 7.12 (ddd, J  8.2,
7.0, 0.9 Hz), 7.06 (s), 7.02 (ddd, J  8.0, 7.0, 0.9 Hz), 5.35 (m),
4.70 (d, J  6.8 Hz) Approx. 3.33 (t, J  7.3 Hz, signal overlap-
ping with those of solvent), 2.9 (t, J  7.3 Hz), 2.89 (q, J  7.4
Hz), 1.85 (s), 1.76 (s), 1.19 (t, J  7.4 Hz); HR-ESI-MS: m/z 
321.1647, Calcd. for C17H25N2O2S, [M  H]
: 321.1631.
Compound 21b—1HNMR (methanol-d4, 500MHz)   7.14
(d, J 7.6Hz), 7.05 (td, J 7.6, 1.1Hz), 6.70 (td, J 7.6, 0.9Hz),
6.60 (d, J 7.6Hz), 6.07 (dd, J 17.4, 10.9Hz), 5.38 (s), 5.12 (dd,
J  10.9, 1.3 Hz), 5.08 (dd, J  17.4, 1.3 Hz), 3.54 (dd, J  10.0,
8.4Hz), 3.10 (q, J 7.4Hz), 2.94 (ddd, J 11.5, 9.7, 5.3Hz), 2.40
(ddd, J  12.1, 11.9, 7.9 Hz), 2.07 (dd, J  12.3, 5.3 Hz), 1.29 (t,
J  7.4 Hz), 1.10 (s), 0.98 (s); HR-ESI-MS: m/z  321.1642,
Calcd. for C17H25N2O2S, [M  H]
: 321.1631.
Compound 30a—1HNMR (methanol-d4, 500MHz)   7.46
(br d, J 7.5Hz), 7.37 (d, J 8.6Hz), 7.35 (br t, J 7.5Hz), 7.30
(br t, J  7.5 Hz), 6.92 (d, J  2.2 Hz), 6.81 (s), 6.73 (dd, J  8.6,
2.2 Hz), 5.40 (m), 5.08 (s), 3.38 (d, J  7.0 Hz), 1.76 (s), 1.74 (s);
HR-ESI-MS:m/z 292.1703, Calcd. for C20H22NO, [MH]
:
292.1696.
Compound 30b—1HNMR (methanol-d4, 500MHz)   7.48
(br d, J  7.5 Hz), 7.37 (br t, J  7.5 Hz), 7.29 (br t, J  7.5 Hz),
7.24 (s), 7.04 (d, J  3.2 Hz), 6.96 (s), 6.28 (dd, J  3.2 Hz, 0.9),
5.35 (m), 5.09 (s), 3.39 (d, J  7.5 Hz), 1.72 (s), 1.67 (s); HR-ESI-
MS: m/z  292.1704, Calcd. for C20H21NO, [M  H]
:
292.1696.
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ID PrenDB ID SMILES C 
S1 PTDBSUB00695 O=C1NC(Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@@H]12 1 
S2 PTDBSUB00027 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@H]12 1 
S3 PTDBSUB00022 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@@H]12 1 
S4 PTDBSUB00001 O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@@H]12 1 
S5 PTDBSUB00017 O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@H]12 1 
S6 PTDBSUB00286 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)Nc2ccccc21 2 
S7 PTDBSUB00392 O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)Nc2ccccc21 2 
S8 PTDBSUB00049 C[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O 2 
S9 PTDBSUB00044 C[C@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O 2 
S10 PTDBSUB00032 C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O 2 
S11 PTDBSUB00039 C[C@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O 2 
S12 PTDBSUB00012 O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1Cc1ccccc1 2 
S13 PTDBSUB00005 O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1Cc1ccc(O)cc1 2 
S14 PTDBSUB00412 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1Cc1ccc(O)cc1 2 
S15 PTDBSUB00059 O=C1CNC(=O)[C@H](Cc2c[nH]c3ccccc23)N1 2 
S16 PTDBSUB00072 O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1Cc1c[nH]c2ccccc12 2 
S17 PTDBSUB00054 O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H]1Cc1cnc[nH]1 2 
S18 PTDBSUB00064 CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O 2 
S19 PTDBSUB00103 [NH3+][C@@H](Cc1c[nH]c2ccccc12)C(=O)[O-] 3 
S20 PTDBSUB00173 [NH3+][C@H](Cc1c[nH]c2ccccc12)C(=O)[O-] 3 
S21 PTDBSUB00186 C[C@@]([NH3+])(Cc1c[nH]c2ccccc12)C(=O)[O-] 3 
S22 PTDBSUB00189 C[C@]([NH3+])(Cc1c[nH]c2ccccc12)C(=O)[O-] 3 
S23 PTDBSUB00179 [NH3+]CCc1c[nH]c2ccccc12 3 
S24 PTDBSUB00415 O=C([O-])Cc1c[nH]c2ccccc12 3 
S25 PTDBSUB00491 O=C([O-])C(=O)Cc1c[nH]c2ccccc12 3 
S26 PTDBSUB00297 O=C([O-])CCc1c[nH]c2ccccc12 3 
S27 PTDBSUB00496 O=C([O-])CCCc1c[nH]c2ccccc12 3 
S28 PTDBSUB00676 CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(C)=O 3 
S29 PTDBSUB00317 CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)[O-] 3 
S30 PTDBSUB00423 CC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)[O-] 3 
S31 PTDBSUB00183 C[NH2+][C@@H](Cc1c[nH]c2ccccc12)C(=O)[O-] 3 
S32 PTDBSUB00192 O=C([O-])[C@@H](O)Cc1c[nH]c2ccccc12 3 
S33 PTDBSUB00195 O=C([O-])[C@H](O)Cc1c[nH]c2ccccc12 3 
S34 PTDBSUB00176 [NH3+][C@H](CC(=O)[O-])Cc1c[nH]c2ccccc12 3 
S35 PTDBSUB00418 [NH3+][C@@H](CC(=O)[O-])Cc1c[nH]c2ccccc12 3 
S36 PTDBSUB00139 [NH3+][C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)[O-] 3 
S37 PTDBSUB00488 [NH3+][C@H](Cc1c[nH]c2ccccc12)C(=O)NO 3 
S38 PTDBSUB00499 COC(=O)[C@H]([NH3+])Cc1c[nH]c2ccccc12 3 
S39 PTDBSUB00593 [NH3+][C@@H](C(=O)[O-])[C@@H](O)c1ccc(O)c(O)c1 4 
S40 PTDBSUB00722 [NH3+][C@@H](C(=O)[O-])C(O)c1ccc(O)c(O)c1 4 





S41 PTDBSUB00689 Cc1ccc(C[C@@H]2NC(=O)[C@H](Cc3ccc(O)cc3)NC2=O)cc1 5 
S42 PTDBSUB00571 O=C([O-])[C@@H](O)Cc1ccc(O)cc1 5 
S43 PTDBSUB00574 O=C([O-])[C@H](O)Cc1ccc(O)cc1 5 
S44 PTDBSUB00554 [NH3+][C@@H](C(=O)[O-])c1ccc(O)cc1 5 
S45 PTDBSUB00551 [NH3+][C@@H](CC(=O)[O-])c1ccc(O)cc1 5 
S46 PTDBSUB00718 [NH3+]C(CC(=O)[O-])c1ccc(O)cc1 5 
S47 PTDBSUB00376 CC([NH3+])(Cc1ccc(O)cc1)C(=O)[O-] 5 
S48 PTDBSUB00578 C[C@@]([NH3+])(Cc1ccc(O)cc1)C(=O)[O-] 5 
S49 PTDBSUB00467 O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O 5 
S50 PTDBSUB00079 O=C([O-])C(=O)Cc1ccc(O)cc1 5 
S51 PTDBSUB00568 O=C([O-])CCc1ccc(O)cc1 5 
S52 PTDBSUB00666 Oc1cc2ccccc2cc1O 6 
S53 PTDBSUB00652 Oc1ccc2ccccc2c1 6 
S54 PTDBSUB00289 Oc1ccc2ccc(O)cc2c1 6 
S55 PTDBSUB00613 Oc1ccc2cc(O)ccc2c1 6 
S56 PTDBSUB00647 Nc1cccc2ccc(O)cc12 6 
S57 PTDBSUB00448 COc1cccc2ccc(O)cc12 6 
S58 PTDBSUB00451 CCOc1cccc2ccc(O)cc12 6 
S59 PTDBSUB00656 Oc1ccc(O)c2ccccc12 6 
S60 PTDBSUB00661 Oc1cccc2c(O)cccc12 6 
S61 PTDBSUB00399 Oc1ccc2c(O)cccc2c1 6 
S62 PTDBSUB00596 Oc1cccc2ccccc12 6 
S63 PTDBSUB00445 Cc1ccc2cccc(O)c2c1 6 













S68 PTDBSUB00094 Cc1cc2oc3cccc(=O)c-3c([O-])c2cc1O 6 
S69 PTDBSUB00100 Cc1c([O-])c(C)c2c(O)c3c(=O)cccc-3oc2c1C 6 
S70 PTDBSUB00091 Cc1cc2oc3cccc(=O)c-3c(O)c2c(CO)c1[O-] 6 
S71 PTDBSUB00097 Cc1cc2oc3cccc(=O)c-3c(O)c2c(C)c1[O-] 6 
S72 PTDBSUB00479 COc1ccc(-c2coc3cc(=O)cc(O)c-3c2[O-])cc1 6 
S73 PTDBSUB00472 O=c1cc2oc(-c3ccc(O)cc3)cc([O-])c-2c(O)c1 6 
S74 PTDBSUB00343 O=c1cc2oc3cc(O)cc([O-])c3c([O-])c-2c(O)c1 6 
S75 PTDBSUB00339 O=c1cc2oc3ccc(O)cc3c([O-])c-2c(O)c1 6 
S76 PTDBSUB00351 O=c1cc2oc3cc(O)ccc3c([O-])c-2c(O)c1 6 
S77 PTDBSUB00292 O=C1C=C([O-])c2c([O-])cc(O)cc2C1=O 6 
S78 PTDBSUB00606 O=C(O)c1cc2cccc([O-])c2cc1O 6 
S79 PTDBSUB00610 O=C(O)c1cc2cc(O)ccc2cc1[O-] 6 
S80 PTDBSUB00483 O=C1C[C@H](c2ccccc2)Oc2cc(O)ccc21 6 
S81 PTDBSUB00454 Cc1cc([O-])c2c(c1)O[C@H](c1ccc(O)cc1)CC2=O 6 









S84 PTDBSUB00457 Cc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)CC2O 6 
S85 PTDBSUB00475 Oc1ccc(C2=COc3cc(O)cc(O)c3C2O)cc1 6 
S86 PTDBSUB00367 Cn1c(O)c2c3c(c4c(c2c1O)=c1ccccc1=N4)N=c1ccccc1=3 6 
S87 PTDBSUB00144 COc1c(O)c(=C2C=Nc3ccccc32)c(OC)c(O)c1=C1C=Nc2ccccc21 6 
S88 PTDBSUB00396 O=C([O-])c1cccc2c1Nc1ccccc1N2 6 
S89 PTDBSUB00385 CC(=O)O[C@H]1[C@@H](C)C[NH+](C)[C@@H]2Cc3c[nH]c4cccc(c34)[C@@H]12 7 
S90 PTDBSUB00388 CC(=O)O[C@H]1[C@H](C)C[NH+](C)[C@@H]2Cc3c[nH]c4cccc(c34)[C@@H]12 7 
S91 PTDBSUB00136 CC(=O)/C=C/c1c[nH]c2ccccc12 8 
S92 PTDBSUB00300 O=C([O-])/C=C/c1c[nH]c2ccccc12 8 
S93 PTDBSUB00359 O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 8 
S94 PTDBSUB00364 O=C1N[C@@H](O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21 8 
S95 PTDBSUB00148 C=c1c(OC)c(-c2c(CC=C(C)C)[nH]c3ccccc23)c(=C)c(OC)c1-c1c[nH]c2ccccc12 8 
S96 PTDBSUB00151 C=CC(C)(C)n1cc(C2=C(OC)C(=O)C(c3c[nH]c4ccccc34)=C(OC)C2=O)c2ccccc21 8 
S97 PTDBSUB00703 [NH3+][C@H](Cc1cc(I)c([O-])c(I)c1)C(=O)[O-] 9 
S98 PTDBSUB00370 [NH3+][C@@H](Cc1cc(Br)c([O-])c(Br)c1)C(=O)[O-] 9 
S99 PTDBSUB00373 [NH3+][C@@H](Cc1cc(I)c([O-])c(I)c1)C(=O)[O-] 9 
S100 PTDBSUB00548 [NH3+][C@@H](Cc1ccc([O-])c([N+](=O)[O-])c1)C(=O)[O-] 9 
S101 PTDBSUB00706 [NH3+][C@H](Cc1ccc([O-])c([N+](=O)[O-])c1)C(=O)[O-] 9 
S102 PTDBSUB00106 [NH3+][C@@H](Cc1ccc(O)cc1)C(=O)[O-] 9 
S103 PTDBSUB00542 [NH3+][C@H](Cc1ccc(O)cc1)C(=O)[O-] 9 
S104 PTDBSUB00321 Nc1ccc(C[C@H]([NH3+])C(=O)[O-])cc1 9 
S105 PTDBSUB00545 Nc1ccc(C[C@@H]([NH3+])C(=O)[O-])cc1 9 
S106 PTDBSUB00587 [NH3+][C@H](Cc1ccc(O)c(I)c1)C(=O)[O-] 9 
S107 PTDBSUB00584 [NH3+][C@@H](Cc1ccc(O)c(F)c1)C(=O)[O-] 9 
S108 PTDBSUB00382 [NH3+][C@@H](Cc1ccc(O)c(I)c1)C(=O)[O-] 9 
S109 PTDBSUB00581 [NH3+][C@H](Cc1ccc(O)c(F)c1)C(=O)[O-] 9 
S110 PTDBSUB00112 [NH3+][C@@H](Cc1cccc(O)c1)C(=O)[O-] 9 
S111 PTDBSUB00565 [NH3+][C@H](Cc1cccc(O)c1)C(=O)[O-] 9 
S112 PTDBSUB00562 Nc1cc(C[C@@H]([NH3+])C(=O)[O-])ccc1O 9 
S113 PTDBSUB00379 [NH3+][C@@H](Cc1ccc(O)c(O)c1)C(=O)[O-] 9 
S114 PTDBSUB00590 [NH3+][C@H](Cc1ccc(O)c(O)c1)C(=O)[O-] 9 
S115 PTDBSUB00161 Cc1ccc2c(C[C@H]([NH3+])C(=O)[O-])c[nH]c2c1 10 
S116 PTDBSUB00164 Cc1ccc2c(C[C@@H]([NH3+])C(=O)[O-])c[nH]c2c1 10 
S117 PTDBSUB00310 [NH3+][C@H](Cc1c[nH]c2cc(F)ccc12)C(=O)[O-] 10 
S118 PTDBSUB00441 [NH3+][C@@H](Cc1c[nH]c2cc(F)ccc12)C(=O)[O-] 10 
S119 PTDBSUB00516 [NH3+][C@H](Cc1c[nH]c2ccc(F)cc12)C(=O)[O-] 10 
S120 PTDBSUB00438 [NH3+][C@@H](Cc1c[nH]c2ccc(F)cc12)C(=O)[O-] 10 
S121 PTDBSUB00432 [NH3+][C@@H](Cc1c[nH]c2ccc(Br)cc12)C(=O)[O-] 10 
S122 PTDBSUB00435 [NH3+][C@H](Cc1c[nH]c2ccc(Br)cc12)C(=O)[O-] 10 
S123 PTDBSUB00167 COc1ccc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c2c1 10 





S125 PTDBSUB00155 Cc1ccc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c2c1 10 
S126 PTDBSUB00158 Cc1ccc2[nH]cc(C[C@@H]([NH3+])C(=O)[O-])c2c1 10 
S127 PTDBSUB00429 [NH3+][C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)[O-] 10 
S128 PTDBSUB00511 [NH3+][C@H](Cc1c[nH]c2ccc(O)cc12)C(=O)[O-] 10 
S129 PTDBSUB00303 Cn1cc(C[C@@H]([NH3+])C(=O)[O-])c2ccccc21 11 
S130 PTDBSUB00109 [NH3+][C@@H](Cc1ccccc1O)C(=O)[O-] 11 
S131 PTDBSUB00558 [NH3+][C@H](Cc1ccccc1O)C(=O)[O-] 11 
S132 PTDBSUB00313 Cc1cccc2c(C[C@@H]([NH3+])C(=O)[O-])c[nH]c12 11 
S133 PTDBSUB00407 Cc1cccc2c(C[C@H]([NH3+])C(=O)[O-])c[nH]c12 11 
S134 PTDBSUB00120 Cc1cccc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c12 11 
S135 PTDBSUB00306 Cc1cccc2[nH]cc(C[C@@H]([NH3+])C(=O)[O-])c12 11 
S136 PTDBSUB00123 COc1cccc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c12 11 
S137 PTDBSUB00126 Nc1cccc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c12 11 
S138 PTDBSUB00274 CC(C)=CCc1cc(C)cc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c12 12 
S139 PTDBSUB00276 CC(C)=CCc1cc(C)cc2[nH]cc(C[C@@H]([NH3+])C(=O)[O-])c12 12 
S140 PTDBSUB00270 CC(C)=CCc1c(C)ccc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c12 12 
S141 PTDBSUB00272 CC(C)=CCc1c(C)ccc2[nH]cc(C[C@@H]([NH3+])C(=O)[O-])c12 12 
S142 PTDBSUB00278 COc1ccc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c2c1CC=C(C)C 12 
S143 PTDBSUB00281 COc1ccc2[nH]cc(C[C@@H]([NH3+])C(=O)[O-])c2c1CC=C(C)C 12 
S144 PTDBSUB00239 CC(C)=CCc1c(C)ccc2c(C[C@H]([NH3+])C(=O)[O-])c[nH]c12 12 
S145 PTDBSUB00242 CC(C)=CCc1c(C)ccc2c(C[C@@H]([NH3+])C(=O)[O-])c[nH]c12 12 
S146 PTDBSUB00233 CC(C)=CCc1cc(C)cc2c(C[C@H]([NH3+])C(=O)[O-])c[nH]c12 12 
S147 PTDBSUB00236 CC(C)=CCc1cc(C)cc2c(C[C@@H]([NH3+])C(=O)[O-])c[nH]c12 12 
S148 PTDBSUB00245 COc1cc(CC=C(C)C)c2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c2c1 12 
S149 PTDBSUB00248 COc1cc(CC=C(C)C)c2[nH]cc(C[C@@H]([NH3+])C(=O)[O-])c2c1 12 
S150 PTDBSUB00251 CC(C)=CCc1cccc2[nH]cc(C[C@H]([NH3+])C(=O)[O-])c12 13 
S151 PTDBSUB00253 CC(C)=CCc1cccc2[nH]cc(C[C@@H]([NH3+])C(=O)[O-])c12 13 
S152 PTDBSUB00266 CC(C)=CCc1cccc2[nH]cc(C[C@H](O)C(=O)[O-])c12 13 
S153 PTDBSUB00268 CC(C)=CCc1cccc2[nH]cc(C[C@@H](O)C(=O)[O-])c12 13 
S154 PTDBSUB00255 CC(C)=CCc1cccc2[nH]cc(C[C@H]([NH3+])CC(=O)[O-])c12 13 
S155 PTDBSUB00260 C[NH2+][C@@H](Cc1c[nH]c2cccc(CC=C(C)C)c12)C(=O)[O-] 13 
S156 PTDBSUB00257 CC(C)=CCc1cccc2[nH]cc(CC[NH3+])c12 13 
S157 PTDBSUB00262 CC(C)=CCc1cccc2[nH]cc(C[C@@](C)([NH3+])C(=O)[O-])c12 13 
S158 PTDBSUB00264 CC(C)=CCc1cccc2[nH]cc(C[C@](C)([NH3+])C(=O)[O-])c12 13 
S159 PTDBSUB00205 CC(C)=CCc1cccc2c(C[C@H]([NH3+])C(=O)[O-])c[nH]c12 14 
S160 PTDBSUB00208 CC(C)=CCc1cccc2c(C[C@@H]([NH3+])C(=O)[O-])c[nH]c12 14 
S161 PTDBSUB00226 CC(C)=CCc1cccc2c(C[C@H](O)C(=O)[O-])c[nH]c12 14 
S162 PTDBSUB00229 CC(C)=CCc1cccc2c(C[C@@H](O)C(=O)[O-])c[nH]c12 14 
S163 PTDBSUB00211 CC(C)=CCc1cccc2c(C[C@H]([NH3+])CC(=O)[O-])c[nH]c12 14 
S164 PTDBSUB00217 C[NH2+][C@@H](Cc1c[nH]c2c(CC=C(C)C)cccc12)C(=O)[O-] 14 
S165 PTDBSUB00214 CC(C)=CCc1cccc2c(CC[NH3+])c[nH]c12 14 
S166 PTDBSUB00220 CC(C)=CCc1cccc2c(C[C@@](C)([NH3+])C(=O)[O-])c[nH]c12 14 













Table S2: Structures, IDs, enzyme-related yields and number of matched PrenDB reactions. 
Substrate ID Product yield [%] Matched reactions 
  
FtmPT1 FgaPT2 CdpNPT 
 
 
1 94.1 18.2 41.3 299 
 
2 81.3 80.1 29.5 299 
 
3 - 3.2 22.1 299 
 
4 - - - 6 
 
5 - - 0.9 33 
 






7 7.0 - 10.1 57 
 
8 - - - 6 
 
9 - 5.3 - 17 
 
10 40.8 28.9 99.7 233 
 
11 48.1 17.1 88.1 238 
 
12 8.5 - 14.4 299 
 






14 2.0 - 2.6 50 
 
15 - - - 58 
 
16 68.8 34.8 29.7 20 
 
17 - - - 14 
 
18 89.1 84.9 62.0 299 
 






20 76.0 37.4 97.4 233 
 
21 98.6 99.2 99.3 233 
 
22 - - - 231 
 
23 64.8 75.0 65.2 233 
 
24a - - - 50 
 
25 - - - 50 
 






27 8.7 82.9 11.8 137 
 
28 - - - 23 
 
29b - - - 6 
 
30 60.1 59.4 96.1 229 
 
31 - - - 50 
 
32 47.5 44.7 - 299 
 






34 44.4 19.9 94.8 299 
 
35 35.5 16.3 94.1 299 
 
36b - - - 77 
 
37 - - - 137 
 
38 - - - 235 
 
39b 3.8 - 2.8 33 
 






41 9.9 22.5 13.5 325 
 
42 - 14.9 38.1 299 
a Compound 24 is the imidic acid tautomer of 25 and was thus excluded from further consideration in 
this work. Total and relative numbers throughout the manuscript reflect the number of unique 
compounds, i.e. 38. 
b These compounds could not be obtained as ordered and were excluded from further consideration in 
this work 
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ABSTRACT: Two prenyltransferases from Aspergillus ruber control the
echinulin biosynthesis via exceptional sequential prenylations. EchPT1
catalyzes the first prenylation step, leading to preechinulin. The unique
EchPT2 attaches, in a consecutive prenylation cascade, up to three
dimethylallyl moieties to preechinulin and its dehydro forms neo-
echinulins A and B, resulting in the formation of at least 23 2- to 4-fold
prenylated derivatives. Confirming these products in fungal extracts
unravels the unprecedented catalytic relevance of EchPT2 for structural
diversity.
I ndole diketopiperazine (DKP) alkaloids have been establishedas a steadily growing and reliable source for compounds of
significant biological activity.1,2 Their indole nucleus backbone,
as a privileged structure, has become a focus of fragment-based
drug discovery.1,3 This core ring system is commonly assembled
via one L-tryptophan and a second amino acid, usually catalyzed
by a nonribosomal peptide synthetase (NRPS),4 providing an
initial biosynthetic starting point in the form of an indole DKP
skeleton.5 Subsequent modification reactions including prenyla-
tions increase not only structural complexity but also biological
and pharmacological activities.4−8
Echinulins and neoechinulins derived from L-tryptophan and
L-alanine exemplify such DKPs and are highly decorated with
dimethylallyl (DMA) moieties.1,2,5 Their eponymous group
member echinulin (Figure 1) was first isolated from Aspergillus
amstelodami5 and later, together with congeners, from different
terrestrial andmarine-derived fungi,5 e.g.Aspergillus cristatus9 and
Aspergillus glaucus.10 These prenylated cyclo-L-Trp-L-Ala deriva-
tives can be classified into the echinulin, neoechinulin A, and
neoechinulin B series (Figures 1 and S1 in Supporting
Information (SI)).11 They share a reverse C2-prenyl moiety
and differ from each other in exo double bounds at the DKP ring.
In turn, the members of each series differ from each other in the
number and position of additional DMA moieties. C-5 of the
indole ring seems to be the second preferred prenylation position
in echinulins and neoechinulins. A third DMA moiety is mainly
found at C-7 or at C-4.11,12 Various intriguing pharmacological
activities have been identified for echinulin and congeners,5 such
as protection against neuronal cell death13 and antiviral14 and
antitumor activities.15 In spite of over 40 years of studies on
structures, as well as biological and pharmacological activities of
this intriguing substance group, the enzymes involved in the
biosynthesis, especially those for the transfer of the different
prenyl moieties, have not been reported prior to this study.2,5
In nature, prenyl transfer reactions are catalyzed by
prenyltransferases (PTs). These enzymes employ isoprenic
precursors of various number of C5-units such as DMAPP
(C5).
8Known indole PTs from fungi belong to the dimethylallyl-
tryptophan synthase (DMATS) superfamily and usually catalyze
regio- and stereoselective regular or reverse prenylations. In most
cases, one PT only catalyzes one specific transfer reaction.8 For
example, fumitremorgin A from Neosartorya f ischeri contains
three prenyl moieties, which are transferred from DMAPP by
three different PTs.16 Contrary examples of one PT involved in
more than one prenylation step are rare. Two membrane-bound
PTs, fromHumulus lupulus, have been reported to be responsible
for three sequential prenylation steps in the biosynthesis of β-
bitter acid,17 and in the biosynthesis of the fungal metabolite
shearinine D, JanD from the DMATS superfamily catalyzes a
tandem diprenylation.18
A large number of echinulin congeners with different numbers
of prenyl moieties have been identified in and isolated from
Received: September 19, 2017
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Figure 1. Representatives of echinulin and neoechinulins.
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Aspergillus ruber.12,14 In analogy tomost biosynthetic pathways, it
could be speculated that three or even four PTs are necessary for
the attachment of the prenyl moieties in echinulin and its
congeners. Unexpectedly, mining the A. ruber CBS 135680
genome19 reveals just three DMATS PT genes. Two of them,
coding for EYE98742 (termed EchPT1 in this study) and
EYE98746 (EchPT2), build a cluster with an NRPS (EYE98744)
gene. The third one (EYE95342) is located in a separate cluster
with a polyketide synthase gene. Homologues of the putative
NRPS-containing cluster harboring only two PT genes are also
identified in the genomes of Aspergillus cristatus YKY807 and
Aspergillus glaucusCBS 516.65 (Figure 2, Table S1). This unusual
genetic organization prompted us to investigate the functions of
the three PTs from A. ruber.
Sequence analysis revealed the incorrect annotation of the
putative NRPS EYE98744 in the database by lacking 789 amino
acids at the N-terminus, which was corrected in this study (SI).
The revised sequence of EYE98744 comprises 2113 amino acid
residues (Table S1) and shares a sequence identity of 23.5% with
the known cyclo-L-Trp-L-Pro synthetase FtmPS.20 It can be
speculated that this enzyme, tentatively named EchPS, might be
responsible for the assembly of cyclo-L-Trp-L-Ala. The two
putative echinulin prenyltransferases EchPT1 and EchPT2 are
polypeptides of 417 and 408 amino acids, respectively. They
share a clear sequence similarity with the members of the
DMATS superfamily (Figure S2).8 It seems unbelievable that
these two PTs should catalyze three or four prenylations deduced
from the number and positions of DMA moieties in echinulins
and congeners.
To investigate the possible involvement of the three PTs in the
biosynthesis of echinulin, the coding sequences of EchPT1,
EchPT2, and EYE95342 were PCR amplified from cDNA of the
endophytic fungus A. ruber QEN-0407-G212 and cloned into
pQE9 and pQE70 for heterologous expression in E. coli (SI,
Figures S3−S5). All three purified proteins were incubated
separately with the putative product of EchPS, cyclo-L-Trp-L-Ala
(1), in the presence ofDMAPP. LC-MS analysis revealed product
formation in the reaction mixture with EchPT1, but with neither
EchPT2 nor EYE95342 (Figure 3i−iii). The [M + H]+ ion of the
single EchPT1 product 1M1 indicates a monoprenylation of 1.
For a better understanding, we use M, D, T, and Q after the
substrate number for mono-, di-, tri-, and tetraprenylation,
respectively. The number after these letters refers to the order of
the identified products. Formation of 1M1 is strictly dependent
on the presence of 1, DMAPP, and active EchPT1. NMR andMS
analyses of the isolated product confirmed 1M1 to be
preechinulin. This proved unequivocally that EchPT1 catalyzes
the first prenylation in the biosynthesis of echinulin in A. ruber
(for structure elucidation and kinetic parameters see SI, Tables S2
and S3, Figures S9−11, S16, and S18).
To verify the roles of the two other PTs in the biosynthesis of
echinulins, we carried out incubations containing either two or all
three PTs (Figure 3iv−vii). Assaying 1with EchPT1 and EchPT2
resulted in the formation of 1M1 and at least four additional
products (iv). The same peaks were also detected in the assay
with all three enzymes (vii). In contrast, the combination of
EchPT1 and EYE95342 (v) yields just the EchPT1 product 1M1,
while EchPT2 and EYE95342 catalyze no conversion of 1 at all
(vi). These results prove that EYE95342 is likely not involved in
the biosynthesis of echinulins and EchPT2 catalyzes the further
metabolism of 1M1.
To gain detailed insights into the reactionmechanism of 1with
EchPT1 and EchPT2 (Figure 3iv), we assayed 1M1with EchPT2
in the presence of DMAPP. LC-MS analysis reveals six product
peaks on three consecutive prenylation levels (Figures 4a and
S6a), i.e. two di-, tri-, and tetraprenylated products each, which
was confirmed by detection of their exact [M + H]+ ions (Table
S3). The [M + H]+ ions of the first two products in ascending
order of retention times (Figure S6a) are 68Da larger than that of
1M1, proving the presence of an additional prenyl moiety in their
structures. These putative diprenylated products are termed 1D1
and 1D2. The [M + H]+ ions of the following two triprenylated
products, 1T1 and 1T2, indicate the attachment of two prenyl
residues to 1M1, and the [M + H]+ ions of the last two products
1Q1 and 1Q2 indicate even three additional prenyl units attached
to the already monoprenylated substrate 1M1. Notably, while a
large number of echinulin-related structures were described in
the literature,5,12 no derivative with four prenyl moieties has been
reported to date. From Figure 4a, it is obvious that 1T2 is the
main product of the EchPT2 reaction. To the best of our
knowledge, six products across three consecutive prenylation
levels from an incubation mixture with only one enzyme have not
been reported prior to this study. These fascinating results
prompted us to investigate the relationships between these
products and their dependence on reaction time, DMAPP and
protein concentrations (Table S2, Figures S12−15 and S17).
HPLC analysis of the reaction mixtures revealed 1T2 as the
Figure 2. Putative echinulin gene clusters in Aspergillus strains. Genes with high sequence identities at the amino acid level are indicated by dotted lines.
Details of alignment and the putative gene functions can be found in Table S1.
Figure 3. LC-MS analysis of the incubation mixtures of 1 with EchPT1,
EchPT2, and EYE95342 alone or in combinations.
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predominant product in all enzyme assays. Most interestingly,
there are two divergent fate patterns for the enzyme products. In
all three dependency assays, the formation of 1D1 and 1T1
showed an initially rapid, yet short increase, followed by a
continuous decrease. In contrast, the yields of 1D2, 1T2, 1Q1,
and 1Q2 increased steadily in all assays (Figure S13). This
indicates that 1D1 and 1T1 could serve as intermediates in a
consecutive prenylation cascade, whereas 1D2 and 1T2 as well as
1Q2 and 1Q2 may represent end products of the (branch)
pathways.
To confirm our hypothesis, we isolated EchPT2 products for
structure elucidation. Interpretation of the spectra and literature
search confirmed 1D1 and 1D2 to be tardioxopiperazines A and
B with an additional regular prenyl moiety at C-5 and C-7,
respectively, compared to that of 1M1. The two triprenylated
products 1T1 and 1T2 bear prenyl moieties at C-2 and C-5 and
differ from each other in the position of the third prenyl residue,
which is located at C-4 in 1T1 and C-7 in the case of 1T2. 1T1
and 1T2 can therefore be unequivocally identified as variecolorin
L and echinulin. Due to the low amount, the structure of 1Q1
cannot be determined in this study. 1Q2was isolated from fungal
extracts (Figure S8) and identified as a reversely C2-, regularly
C4-, C5-, and C7-tetraprenylated derivative. Judging by
incubation results described below, 1Q1 must be a reversely
C2-, regularly C4-, C5-, and C6-tetraprenylated derivative
(Scheme 1; Tables S3−S7; Figures S19−29).
The single EchPT2 products were then incubated independ-
ently with EchPT2 (Figures 4a and S6a). LC-MS analysis showed
further conversion of 1D1 by EchPT2 to 1T1, 1T2, 1Q1, and
1Q2 (ii). The last two products were also detected in the assay of
1T1 with EchPT2 (iv). Conversely, 1D2, 1T2, 1Q1, and 1Q2
underwent no further conversion by EchPT2 (iii, v, and vi).
These confirmed the hypothesis that 1D2 and 1T2 are end
products of different branches of the EchPT2 reaction and C7-
prenylation serves as a termination step in a consecutive
prenylation cascade as shown in Scheme 1. To reach the
tetraprenylated products, the putative NRPS product 1 will be
reversely prenylated at C-2 by EchPT1. The resulting product
1M1 undergoes regular prenylation at C-5, then at C-4, and
finally at C-6 or C-7. No pentaprenylated derivative was detected
in the reaction mixtures of 1M1, 1D1, 1T1, 1Q1, or 1Q2 with
EchPT2 (Figure S6a), indicating that the tetraprenylated
derivatives 1Q1 and 1Q2 are the final products of the cascade.
1M1, 1D1, 1D2, 1T1, 1T2, and a mixture of 1Q1 and 1Q2 were
also incubated with EYE95342. LC-MS analysis revealed no
conversion of these substrates (Figure S7).
Having explored the outstanding catalytic skill of EchPT2, we
wondered if the products of such a prenylation cascade, especially
the previously undescribed tetraprenylated derivatives 1Q1 and
1Q2, coexist in the fungal cultures. Based on previous results
Figure 4. LC-MS analysis of EchPT2 assays with 1M1, 1D1, 1D2, 1T1,
1T2, and 1Q1/1Q2 (a), neoechinulins A (2M1) and B (3M1) (b).
Scheme 1. Proposed Biosynthetic Pathway of Echinulin and Neoechinulin Series via Consecutive Multiprenylations by EchPT1
and EchPT2 in A. ruber
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reporting a strong influence of salt concentration on metabo-
lism,19 we cultivated A. ruber QEN-0407-G2 under different
conditions (SI). The fungal cultures were extracted and analyzed
by LC-MS (Figure S1). The enzyme products described above,
i.e. 1M1 of the EchPT1 reaction, as well as 1D1, 1D2, 1T1, 1T2,
and 1Q2 of the EchPT2 reaction, were detected by LC-MS
analysis, corresponding to the enzyme reactions with EchPT1
and EchPT2 (Figures S1, S6a, and S8).
As previously mentioned, neoechinulins with one (A series) or
two exo double bonds (B series) at the DKP ring are also
frequently identified in echinulin producers.14 LC-MS analysis of
the obtained fungal extract indeed revealed the presence of
members of both series with up to three prenylation levels
(Figure S1). In total, one mono- (neoechinulin A, 2M1), two di-,
and two triprenylated derivatives from the A series were detected.
In the case of the B series, onemono- (neoechinulin B, 3M1), two
di-, and four triprenylated derivatives were observed. In contrast
to the triprenylated 1T2 as the main metabolite of the echinulin
series (Figure S1), the monoprenylated derivatives 2M1 and
3M1 are found to be the major products of the neoechinulin
series A and B. Furthermore, cyclo-L-Trp-L-Ala (1), but not its di-
or tetradehydrogenated derivatives, i.e. the unprenylated
precursors of 2M1 and 3M1, was detected in the fungal cultures.
This could indicate that the first prenylation catalyzed by EchPT1
takes place before dehydrogenation, probably catalyzed by the
cytochrome P450 enzyme EchP450 (Scheme 1). We speculated
that both series of neoechinulins are also EchPT2 products of
sequential prenylations and, thus, isolated the monoprenylated
2M1 and 3M1 from the extracts (SI for structure elucidation,
Tables S3 and S8, Figures S30 and S31). LC-MS analysis of the
reaction mixture of 2M1 and 3M1 with EchPT2 indeed
demonstrated the clear acceptance of both substrates (Figures
4b, S6b) and the formation of eight and nine products with two to
four prenyl residues, respectively. In comparison to the fungal
extract, tetraprenylated products 2Q1 and 3Q1 were also clearly
detected in the EchPT2 assays with 2M1 and 3M1. This proves
that EchPT2 also catalyzes a prenylation cascade with 1M1
analogs bearing exo double bonds and that the biosynthetic
pathway illustrated in Scheme 1 can be expanded by neo-
echinulins. That is, conversion of 1M1 to neoechinulins A (2M1)
and B (3M1) by a putative cytochrome P450 enzyme
(EchP450)21 marks the starting point of the neoechinulin
formation. In analogy to 1M1, 2M1 and 3M1 undergo a
prenylation cascade catalyzed by EchPT2, resulting in the
formation of products with different prenylation grades.
In conclusion, this study provides the first example of a
prenyltransferase catalyzing an exceptional consecutive prenyla-
tion cascade. The unique feature of EchPT2 is its ability to accept
its ownmono-, di-, and triprenylated derivatives as substrates and
to catalyze prenylations at different positions, leading to the
formation of echinulin and congeners. It is of the utmost interest
to solve such intriguing enzymatic structures and to comprehend
the ability of EchPT2 to bind different substrates and catalyze
diverse prenylations. This knowledge would also provide a basis
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1.1.1  Sequence Analysis of Prenyltransferases  
Sequence identities for the prenyltransferases were obtained by alignments of amino acid sequences using BLAST 
(www.ncbi.nlm.nih.gov) and antiSMASH.1 The programs 2ndfind (biosyn.nih.go.jp/2.find) and FGENESH-M 
(Softberry, Mount Kisco, NY; www.softberry.com) were used for further sequence analysis and intron prediction. 
 
1.1.2  Gene Cluster Prediction 
Based on the NRPS protein sequence (GenBank: EYE98744) from the putative echinulin gene cluster of 
Aspergillus ruber CBS 135680,2 a BLAST (NCBI BLAST), analysis was performed to identify further 
homologous proteins. Two homologous NRPSs from A. glaucus (GenBank: OJJ80815)3 and A. cristatus 
(GenBank: ODM14527)4 with 2141 aa and 2131 aa, respectively, clearly differ from the annotated NRPS in A. 
ruber, which has a length of 1285 aa. For further analysis, a multiple protein alignment with the three mentioned 
NRPSs was performed with “T-Coffee” (http://tcoffee.crg.cat/apps/tcoffee/do:regular). The alignments revealed a 
high identity between the two NRPS from A. glaucus and A. cristatus. Additionally, the annotated protein sequence 
from A. ruber also shows a high identity with the beginning at the amino acid position 790. These results indicate 
that the NRPS of A. ruber is perhaps not correctly annotated and lacks 789 aa at the N-terminus. Therefore, the 
DNA sequence of the putative echinulin gene cluster was used to predict the protein sequence of the NRPS by 
employing the web tool “2ndFind”( http://biosyn.nih.go.jp/2ndfind/), which uses the AUGUSTUS protein 
prediction algorithm for predicting eukaryotic proteins (http://bioinf.uni-greifswald.de/augustus/). Based on this 
prediction, the re-annotated putative NRPS has a polypeptide length of 2113 aa, encoded by 5 exons (bp 1209589-
1210198, 1206494-1209533, 1206164-1206374, 1206019-1206108 and 1203548-1205935 of KK088413.1). The 





DMAPP was synthesized according to the previously described method for geranyl diphosphate (GPP)5.  
 
1.3 Bacterial Strains, Plasmids, and Culture Conditions 
The vectors pGEM-T Easy, pQE-9 and pQE-70 were purchased from Promega (Mannheim, Germany) and 
QIAGEN (Hilden, Germany), and used for cloning and expression experiments, respectively. Escherichia coli 
XL1 Blue MRF’ (Agilent Technologies, Amsterdam, the Netherlands) and M15 (pREP4) cells (QIAGEN, Hilden, 
Germany) were used as cloning and expression hosts. For cultivation, they were grown in liquid Lysogeny broth 
(LB) or Terrific broth (TB) medium and on solid LB medium with 1.5 % (w/v) agar at 30 or 37 oC.  For selection 
of recombinant E. coli strains, 50 μg mL−1 of carbenicillin or 25 μg mL−1 of kanamycin were used. 
 
1.4 Cultivation of A. ruber  
1.4.1  Cultivation of A. ruber for DNA and RNA Isolation.  
 
100 mL liquid potato dextrose medium (23.93g L-1) in a 300 mL cylindrical flask were inoculated with 100 µL 
spore suspension of A. ruber QEN-0407-G2,6 and incubated at 25 °C on a rotary shaker (150 rpm) in darkness. 
For messenger RNA and genomic DNA isolation, fungal mycelia were harvested after 8 and 14 days. 
 
1.4.2 Cultivation of A. ruber for Secondary Metabolite Production 
Metabolite production by A. ruber is strongly dependent on the culture conditions, particularly on salt conditions.2,7 
We therefore tested cultivation with three different media PD, PD-ASW and ASW, and at four different cultivation 
times (1, 2, 3 and 4 weeks). 500 mL media in Fernbach flasks were inoculated with spore suspension of A. ruber 
and statically incubated in darkness at 25 °C. 
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PD potato dextrose liquid media consisting of 23.93 g L-1 potato dextrose broth  
PD-ASW  potato dextrose liquid media/artificial seawater (1:1)   
ASW artificial sea water, consisting of (g L-1 solution) sodium chloride (23.93), sodium 
sulfate (4.01), potassium chloride (0.70), sodium bicarbonate (0.20), potassium 
bromide (0.10), boric acid (0.03), sodium fluoride (0.003), magnesium chloride 
(0.05), calcium chloride (0.01) 
 
LC-MS analysis of the extracts for the presence of echinulin and congeners confirmed that cultivation in PD for 
four weeks was the best one and was therefore used for all following cultivations. 
 
1.4.3  Upscaled Cultivation of A. ruber and Extraction for Structure Elucidation  
 
For isolation and structure elucidation of echinulin analogs, the fungal strain was statically cultivated in liquid PD 
media for four weeks. The cultural broth was extracted three times with one volume of ethyl acetate each and the 
combined organic phases were concentrated on a rotating vacuum evaporator at 35 °C and dissolved in methanol. 
The mycelium was frozen in liquid nitrogen, homogenised exhaustively by pestling, and extracted with 
methanol/acetone (1:1) for 2 h. The extract was concentrated on a rotating vacuum evaporator at 35 °C and 
dissolved in methanol. The combined extracts of culture broth and mycelium were subjected to a silica gel column 
chromatography and eluted with mixtures of dichloromethan and acetone in different ratios of increasing polarity 
to yield 20 fractions on the basis of TLC analysis. Echinulin (1T2), neoechinulin A (2M1), neoechinulin B (3M1), 
and the tetraprenylated derivative 1Q2 were then purified from the respective fractions on HPLC.  
 
1.5 DNA and RNA Isolation, cDNA Synthesis, PCR Amplification and Gene Cloning  
Standard procedures for DNA manipulation and propagation in E. coli were performed as described previously.8 
Genomic DNA was isolated from A. ruber mycelia harvested after 14 days using phenol/chloroform extraction. 
RNA was isolated from 8 day-old fungal mycelia by using E.Z.N.A. Fungal RNA Kit (Omega Bio-Tek) according 
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to the manufacturer’s protocol, and complementary DNA (cDNA) was synthesized by utilizing the ProtoScript M-
MuLV First Strand cDNA Synthesis Kit (NEB) with oligo(dT) primers.  
To get the genomic sequences of the homologous genes of EYE98742 (EchPT1), EYE98746 (EchPT2) and 
EYE95342 in A. ruber QEN-0407-G2, PCR amplification was carried out using genomic DNA as template. The 
primer pairs vwRbPT1-f (5’-CCGCA TGCCC TCTGA AGTAT TGAC-3’) and vwRbPT1-rL (5'-GTGCT 
CACCC AGCTC CAGC-3’) were used for echPT1, vwRbPT2-f (5’-CGCAT GCAGC CTTAC CACAC A-3’) 
and vwRbPT2-rL (5’-GATGAA ACCAA GGTCA GAAGA CCTTC-3’) for echPT2, and vwRBPT3-f (5’-
CGCAT GCCTT TACAA ACGAC CAA-3’) and vwRBTP3-rL (5’-CACAT TTCCC ATAAT CCATA TTTAT 
ACCGC-3’) for the EYE95342 homologue. The PCR amplifications were carried out at 59 °C as annealing 
temperature on an iCycler from BioRad with Expand High Fidelity PCR Kit (Roche Diagnostic, Mannheim, 
Germany). The fragments were cloned into pGEM-T Easy, resulting in the plasmids pVW75, pVW76, and 
pVW77, which were subseqeuently sequenced to verify the putative gene sequences (Seqlab Sequence 
Laboratories, Göttingen, Germany).  
The entire coding sequences of echPT1, echPT2 and the gene for EYE95342 homologue were obtained by using 
cDNA as template with an annealing temperature at 60 °C. The primer pairs used were vwRbPT1-f2 (5’-CGTCG 
ACCCC TCTGA AGTAT TGAC-3’) and vwRbPT1-r2 (5’- CCAAG CTTTT ATTTG ACCTG ATCAC TTCC-
3’) for echPT1, vwRbPT2-f2 (5’- CTGCA GCAGC CTTAC CACAC-3’) and vwRbPT2-r2 (5’- CCAAG CTTCT 
AAAAC AATGA CATGT AGATG -3’) for echPT2, and vwRBPT3-f (5’-CGCAT GCCTT TACAA ACGAC 
CAA-3’) and vwRBTP3-r (5’- CGGAT CCTAC CGCAG TTTTC TGC -3’) for EYE95342 homologue. 
Underlined letters represent the introduced restriction sites of SalI/HindIII, PstI/HindIII and SphI/BamHI. The 
resulting PCR products for echPT1 (1266bp), echPT2 (1238bp) and EYE95342 homologue (1306bp) were cloned 
into pGEM-T Easy giving the plasmids pVW88, pVW82, and pVW81, which were subsequently sequenced to 
confirm sequence integrity. Cloning of the coding seqeuences at the SalI/HindIII (echPT1) and PstI/HindIII 
(echPT2) sites in pQE-9 or alternatively at SphI/BamHI (EYE95342 homologue) in pQE-70 gave the expression 







1.6.1  Protein Overproduction and Purification  
To improve gene expression, the initial pH of the media, induction temperature and time were optimized in shaking 
cultures seperately for each construct. 
For echPT1 expression, E. coli M15 cells harboring pVW90 were cultivated in 500 mL TB media supplemented 
with carbenicillin (50 µg mL-1) in a 2 L flask. After growing at 37 °C and 230 rpm, to A600=0.60, isopropyl 
thiogalactosid was added to a final concentration of 0.5 mM for induction of gene expression. The cells were 
cultivated for another 16 h at 37 °C. The cell pellets were resuspended in lysis buffer (50 mM NaH2PO4, 300 mM 
NaCl, 10 mM imidazole, pH 8.0) at 2–5 mL per gram wet weight. After addition of lysozyme (1 mg mL-1), the 
cell suspension was incubated on ice for 30 min, and then sonicated eight times for 10 s each at 200 W. Cellular 
debris were separated from the soluble proteins by centrifugation (20 000 xg, 30 min) at 4 °C. The recombinant 
His6-tagged fusion protein was purified by affinity chromatography with Ni-NTA agarose resin (Quiagen) 
according to the manufacturer’s protocol. The obtained protein fraction was passed through a Sephadex G25 
column (PD-10 , GE Healthcare), that had been equilibrated with 50 mM Tris-HCl, 15 % glycerol (v/v), pH 7.5, 
previously, in order to change the buffer. Purified His6-EchPT1 was eluted with the same buffer and stored at -80 
°C. A protein yield was calculated to be 25 mg of purified protein per liter of culture. 
For overproduction of His6-EchPT2, E. coli M15 cells harboring pVW83 were cultivated in 2 L flasks, containing 
250 mL liquid TB medium, supplemented with carbenicillin (50 µg mL-1) whithout any induction, to minimize 
insoluble protein amount. The cultures were grown at 30 °C for 24 h and harvested by centrifugation. Protein 
purification was carried out by affinity chromatography with Ni-NTA agarose resin (Quiagen) as aforementioned. 
Protein yield was calculated to be 1.8 mg of purified protein per liter of culture. 
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For overproduction of the EYE95342 homologue, E. coli M15 cells harboring pVW84 were cultivated in 2 L 
flasks, containing 500 mL liquid TB medium, supplemented with carbenicillin (50 µg mL-1). After growing at 37 
°C and 230 rpm to A600=0.60, the gene expression was induced by addition of isopropyl thiogalactoside to a final 
concentration of 0.6 mM. The cultures were grown at 30 °C and 230 rpm for another 16 h and then centrifuged to 
harvest the cells. Protein purification was carried out by affinity chromatography with Ni-NTA agarose resin 
(Quiagen) as aforementioned. Protein yield was calculated to be 4 mg of purified protein per liters of culture. 
 
1.6.2.  Protein Analysis 
Purity of the obtained recombinant proteins was analysed on SDS-PAGE (15 %) according to the method described 
by Laemmli,9 and stained with Coomassie Brilliant Blue G-250, while protein quantification was determined on a 
NanoDrop 2000c Spectrophotometer (Thermo Fisher Scientific, Waltham, USA). Major protein bands with 
migrations near the 45 kDa size marker were observed for the three purified proteins, as shown in Figures S3-5, 
and correspond well to the calculated masses of 49.4 kDa, 47.7 kDa, and 50.9 kDa for EchPT1-His6, EchPT2-His6, 
and His6-EYE95342, respectively. The molecular mass of the native recombinant proteins for EchPT1 and EchPT2 
were determined by size-exclusion chromatography on an ÄKTA Purifier FPLC system (GE Healthcare, Freiburg, 
Germany) by using a HiLoad 16/60 Superdex 200 column (GE Healthcare) and Tris-HCl buffer (50 mM, pH 7.5) 
containing 150 mM NaCl as elution buffer. The column was calibrated with blue dextran 2000 (2000 kDa), ferritin 
(440 kDa), aldolase (158 kDa), conalbumin (75 kDa), carbonic anhydrase (29 kDa) and ribonuclease A (13.7 kDa 
(GE Healthcare). Separation was performed with a flow rate of 1 mL min-1. The multimeric state of the native 
recombinant EchPT1-His6 was determined as 276.5 kDa, and that of EchPT2-His6 as 149.0 kDa, indicating 
presumably pentameric (EchPT1) and trimeric (EchPT2) species. Previous results on DMATS enzymes proved 





1.7.1  Assays for EchPT1, EchPT2 and EYE95342 Activity Toward 1  
To determine the enzyme activity toward 1, standard assays (100 µL) contained Tris-HCl (50 mM, pH 7.50), 1 
(0.5 mM), CaCl2 (5 mM), DMAPP (3 mM), glycerol (0.5 - 5 %, v/v), DMSO (2.5 %, v/v) and the purified 
recombinant EchPT1 (1 µg, 0.20 µM), EchPT2 (10 µg, 2.13 µM), EYE95342 (20 µg, 4 µM), or their combinations. 
After incubation at 37 °C for 2 h, the reaction mixtures were extracted three times with 200 µL ethyl acetate each 
and the combined organic phases were evaporated to dryness. After desolving the residues in 100 µL methanol, 
90 µL thereof were analysed on an LC-MS system described below. Additional assays containing EYE95342 were 
incubated for 4, 8 and 16 h. 
 
1.7.2  Ion Dependency Assays 
For determination of ion dependency of EchPT1 and EchPT2 reactions, enzyme assays contained Tris-HCl (50 
mM, pH 7.50), DMAPP (1 mM for EchPT1 or 3 mM for EchPT2), 5 mM of metal ions or EDTA, and 1 mM 1 
(for EchPT1 reaction) or 1 mM 1M1 (for EchPT2 reaction). The assays were incubated at 37 °C for 20 min with 
EchPT1 (1 µg, 0.20 µM), or 15 and 20 min with EchPT2 (5 µg 1.07 µM). The respective enzyme activity without 
additive was defined as 100 %.  
 
1.7.3  Enzyme Assays for determination of Kinetic Parameters 
The assays for determination of the kinetic parameters of EchPT1 toward 1 contained 1 mM DMAPP, 2 µg EchPT1 
(Table S2) and the aromatic substrates at final concentrations from 0.002 to 5.0 mM, and were carried out at 37 
°C for 1 min (Table S2). For kinetic parameters toward DMAPP, reaction mixtures with 2 µg EchPT1, 1 (1 mM), 
CaCl2 (5 mM) and DMAPP at final concentrations of 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1.0, 2.0 and 5.0 mM were 
carried out for 1 min at 37 °C. The assays were performed as duplicates and subsequently terminated by addition 
of 100 µL methanol. The precipitated protein was removed by centrifugation at 20000 xg for 20 min, and 100 µL 
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were analyzed on HPLC as described below. The conversion yields were calculated from the peak areas of 
substrates and products in HPLC chromatogram, and their signal intensities in the 1H NMR spectra of the 
incubation mixtures. 
The assays for determination of the kinetic parameters of EchPT2 toward 1M1 were carried out with 3 mM 
DMAPP, 2 µg EchPT2 (Table S2) and the aromatic substrates at final concentrations of 0.002 to 5.0 mM, at 37 
°C for 3 min. For kinetic parameters of EchPT2 toward DMAPP, reaction mixtures with 2 µg EchPT2, 1M1 (1 
mM), CaCl2 (5 mM) and DMAPP at final concentrations of 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1.0, 2.0 and 5.0 mM 
were carried out for 3 min at 37 °C. 
 
1.7.4  Preparation and Isolation of Enzyme Products for Structure Elucidation. 
Enzyme assays for product isolation were scaled up to a volume of 12 mL reaction mixture, containing Tris-HCl 
(50 mM, pH 7.5), DMAPP (2 - 3 mM), the respective aromatic substrate (1 mM), and 1 - 10 mg purified 
recombinant proteins. The enzyme assays were incubated at 37 °C for 16 h and extracted three times with two 
volumes of ethyl acetate each. The resulting organic phases were combined and concentrated on a rotating vacuum 





The enzyme assays and fungal extracts were analyzed on an Agilent HPLC series 1200 (Agilent Technologies) by 
using an Agilent Eclipse XDB-C18 column (5 µm, 4.6 x 150 mm). H2O (solvent A) and MeCN (B), both 
containing 0.1 % (v/v) formic acid, were adjusted to a flow rate of 0.5 mL/min. The separation began with a linear 
gradient from 20 - 80 % MeCN over 10 min, followed by an isocratic elution at 80 % MeCN for 25 min, and then 
with a linear gradient from 80 - 100 % MeCN in 5 min. After each run, the column was washed with 100 % B for 
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5 min and equilibrated with 20 % MeCN for 5 min. Detection was carried out with a photodiode array detector, 
and absorptions at 277 nm were illustrated in this study. 
To isolate the enzyme products and fungal metabolites, the upscaled reaction mixtures and the fractions from a 
silica gel column were separated with the same HPLC equipment and a semipreparative Multospher 120 RP-18 
column (5 µm, 10 x 250 mm). H2O (solvent A) and MeCN (B) were used as solvents with a flow rate of 2.5 
mL/min. A linear gradient of 30 – 80 % MeCN in 15 min was followed by an isocratic elution at 80 % MeCN for 
18 min, and an additional linear gradient from 80 - 100 % MeCN in 7 min. The column was washed with 100 % 
B for 10 min and subsequently equilibrated with 20 % MeCN for another 10 min. The obtained fractions were 
further purified on an Agilent Eclipse XDB-C18 column (5 µm, 4.6 x 150 mm). The same method was used as for 
the analysis of the enzyme assays, modified by using H2O and MeCN without formic acid as solvents. 
 
1.8.2  LC‐MS Condition for Analysis of the Enzyme Products 
The enzyme products were analyzed on an Agilent HPLC 1260 series system equipped with a photo diode array 
detector and a Bruker microTOF QIII mass spectrometer by using the Agilent Eclipse XDB C18 column (5 µm, 
4.6 x 150 mm) according to the standard condition for this column described above. 
 
1.9 NMR and Mass Spectrometric Analysis  
The MS data were extracted from the LC-MS analysis and are listed in Table S3. 
For structural elucidation, the isolated enzyme products were dissolved in DMSO-d6 or CD3OD and subjected to 
NMR analysis including 1H-1H-DFC COSY, HSQC and HMBC spectra. The spectra were recorded at room 
temperature on a JEOL ECA-500 (JEOL, Akishima, Tokyo, Japan), or a Bruker Avance III 500 MHz spectrometer 
installed with a cyro probe 5 mm Prodigy for Broad Band Observation. All spectra were processed with 
MestReNova 6.0.2 (Metrelab Research, Santiago de Compostella, Spain) and the chemical shifts were referenced 






1.5 mg of 1M1 were isolated as white powder and subjected to NMR analysis.  In the 1H NMR spectrum (Figure 
S18), signals of a tert-DMA moiety have clearly been detected as three double doublets of olefinic protons 
around 5.15, 5.10 and 6.20 ppm and two methyl singlets at 1.55 ppm. In the downfield region for aromatic 
protons, signals of four coupling protons were clearly detected in the spectrum (Figure S18). In comparison with 
the respective substrate, the signals of H-2 of the indole ring disappear. The data listed in Table S4 are congruent 
with those reported previously.11 This proves unequivocallly the reverse C2-prenylation in the structures of 1M1.  
 
1.10.2 1D1 and 1D2 as well as 1T1 and 1T2 of the EchPT2 Reactions  
0.2 mg of 1D1 and 0.8 mg of 1D2 were isolated as pale yellow powders. In the 1H NMR spectra of 1D1 and 1D2 
(Figures S19 - 20), signals of a regular prenyl moiety each were observed with a typical triplet at about 5.30 ppm 
and two methyl singlets around 1.7 ppm. The three coupling aromatic protons in the spectrum of 1D2 prove the 
prenylation at the benzene ring. In the case of 1D1, two doublets and one singlet for aromatic protons also 
indicate the prenylation at the benzene ring. Comparison of the NMR data listed in Tables S4 and S5 with known 
compounds in literature proves 1D1 to be tardioxopiperazine A 12,13  and 1D2 to be tardioxopiperazine B.13  
1T1 (0.7 mg, white powder) and 1T2 (1.5 mg, white powder) were isolated from reaction mixtures of EchPT2 
with 1M1. 1.9 mg of 1T2 were also isolated as white powder from fungal extracts. In comparison to that of 1D1, 
the 1H NMR spectra of 1T1 and 1T2 (Figures S21 and 22) show signals for an additional regular prenyl moiety. 
Their identity as triprenylated cyclo-L-Trp-L-Ala were confirmed by HRMS analysis. The two doublets with 
coupling constant of 8.2 Hz in the spectrum of 1T1 indicate the C2, C4, C5-triprenylation. Comparing the NMR 
data listed in Table S5 with known compounds in literature proves 1T1 to be variecolorin L.6,14  
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The two singlets for one aromatic proton each were detected in the 1H NMR spectrum of 1T2 at 7.03 and 7.62 
ppm. These could represent H-4 and H-7 and indicate a C2, C5, C6-triprenylation. However, this would be 
somewhat surprising, because 1T2 was detected as the main product of cyclo-L-Trp-L-Ala with EchPT1 and 
EchPT2 as well as preechinulin (1M1) with EchPT2. We expected echinulin with a C2, C5, C7-triprenylation as 
the main product, due to the fact that this compound was identified as the major metabolite in the producers 
including A. ruber.6,15 Literature search reveals that the H-4 and H-6 of echinulin indeed appear as two singlets.6,15 
To confirm the structure, we isolated echinulin from the fungal culture and subjected it to NMR and MS analyses. 
The 1H NMR spectra of the isolated echinulin and the enzyme product 1T2 are perfectly in consistence with each 
other. Extensive spectroscopic analysis in different solvents including 1H-1H-DQF COSY, HSQC, and HMBC 
(Table S6, Figures S23 - 28) unequivocally confirmed the structure of echinulin to be reversely C2-, regularly C5- 
and C7-triprenylated cyclo-L-Trp-L-Ala. 
 
1.10.3 The tetraprenylated 1Q2 isolated from fungal extract 
1Q2 (approximate 0.05 mg) was isolated as white powder. Characteristic tripletts for olefinic protons of three 
regular prenyl moieties were observed at 5.37, 5.13, and 4.86 ppm, respectively (Figures S29, Table S7). A close 
comparison of these signals with those of 1T1 and 1T2 (Figures S21, S22, and S29) revealed that the three regular 
residues of 1Q2 are located at C-4, C-5 and C-7 of the indole ring. This was further verified by the observation of 




2M1 (1.8 mg, white powder) and 3M1 (1.2 mg, yellow powder) were purified from fungal extract and subjected 
to NMR analysis. In comparison to those of preechinulin (1M1), the signals for the three coupling protons (H10 
and H11) disappear in the 1H NMR spectra of 2M1 and 3M1 (Figures S30 and S31). Instead, a singlet of one 
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olefinic proton was observed at 6.88 and 6.96 ppm, respectively. In the spectrum of 3M1, the doublet of the methyl 
group at C-14 in 1M1 was changed to two singlets of olefinic protons at 5.23 and 4.92 ppm. Comparing the NMR 
data listed in Table S8 with known compounds in literature proves 2M1 and 3M1 to be neoechnulin A16,17 and 
B,18,19 respectively (Table S8). 
 
1.11 Accession Numbers.  
The nucleotide sequences of the genes from A.ruber QEN-0407-G2 reported in this study have been deposited in 




















































































































































































































































































































































































































































































































EchPT1  cyclo‐L‐Trp‐L‐Ala   (1)    2 µg      1 min 0.09 ± 0.0340 6.63 ± 0.0378  73666.7
       
EchPT2  cyclo‐L‐2‐tert‐DMA‐Trp‐L‐Ala  (1M1)  2 µg          3 min 0.03 ± 0.0021  0.36 ± 0.0015  12000.0
           
Kinetic parameters for the donor 
       
EchPT1  DMAPP with 1  2 µg,           1 min 0.18 ± 0.0056 2.96 ± 0.0360  16444.4
EchPT2  DMAPP with 1M1  2 µg,           3 min 0.10 ± 0.004 0.47 ± 0.0061  4700.0








compound  chemical formula  calculated   measured    Deviation 
(ppm) 
preechinulin (1M1)  C19H23N3O2  326.1863  326.1860  ‐0.9 
tardioxopiperazine A (1D1)  C24H31N3O2  394.2489  394.2466  ‐5.8 
tardioxopiperazine B (1D2)  C24H31N3O2  394.2489  394.2485  ‐1.0 
variecolorin L (1T1)  C29H39N3O2  462.3115  462.3133  3.8 
echinulin (1T2)  C29H39N3O2  462.3115  462.3120  3.9 
1Q1/2  C34H47N3O2  530.3741  530.3749  1.5 
neoechinulin A  (2M1)  C19H22N3O2  324.1707  324.1702  ‐1.5 
2D1  C24H30N3O2  392.2330  392.2313  ‐4.3 
2D2  C24H30N3O2  392.2330  392.2311  ‐4.8 
2D3  C24H30N3O2  392.2330  392.2332  0.5 
2T1  C29H38N3O2  460.2959  460.2949  ‐2.1 
2T2  C29H38N3O2  460.2959  460.2968  1.9 
2T3  C29H38N3O2  460.2959  460.2952  ‐1.5 
2T4  C29H38N3O2  460.2959  460.2959  0 
2Q1  C34H46N3O2  528.3585  528.3593  1.5 
neoechinulin  B (3M1)  C19H20N3O2  322.1550  322.1552  0.6 
3D1  C24H28N3O2  390.2176  390.2175  ‐0.3 
3D2  C24H28N3O2  390.2176  390.2168  ‐2.0 
3D3  C24H28N3O2  390.2176  390.2177  ‐0,2 
3T1  C29H36N3O2  458.2802  458.2783  ‐4.1 
3T2  C29H36N3O2  458.2802  458.2789  ‐2.8 
3T3  C29H36N3O2  458.2802  458.2781  ‐4.5 
3T4  C29H36N3O2  458.2802  458.2791  ‐2.4 
3T5  C29H36N3O2  458.2802  458.2798  ‐0.8 
3Q1  C34H44N3O2  526.3248  526.3258  1.9 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Pos.  δH, multi     J in Hz    COSY Corr     δC derived from HMBC data .  ,                 HMBC Corr.                                  
         
  NH‐1  1H  9.71,  s  ‐ ‐  2,  3,  4,  8,  9, 3’
  2      141.77   
  3      105.26   
  4  1H  7.03,  s  H‐6 114.88  3, 6,  8,  9,  1’’ 
  5    ‐  ‐ 131.78  ‐ 
  6  1H  6.62,  s  H 4 121.25  4, 8, 1’’, 1’’’ 
  7    ‐  ‐ 123.83  ‐ 
  8      132.45   
  9      129.50   
  10a  1H  3,02,  dd,  14.4, 9.6  H‐11,  H‐10b 31.34  2, 3, 9, 11, 16 
  10b  1H  3,33#  H‐11,  H‐10a 2, 3, 9, 11, 16 
  11  1H  3.91,  m  NH‐12, H‐10a, H‐10b 55.74  3, 10,  13 
  NH‐12  1H  7.45,  d,  2.95  H‐11 ‐  11, 14, 16 
  13      168.27   
  14  1H  3.80,  dq,  7.1, 2.5  H‐17, NH‐15 50.42  17, 13, 
  NH‐15  1H  8.18,  d,  2.5  H‐14 ‐  11, 13, 14 
  16      167.72   
  17  3H  1.32,  d,  7.1  H‐14 20.96  13, 14 
         
  1’  1H  5.07,  dd,  17.5, 1.1  H‐2’,  H‐1b’ 112.13   2, 2’, 3’, 4’, 5’  
    1H  5.03,  dd,  10.6, 1.1  H‐2’,  H‐1a’ 2, 2’, 3’ 4’ 5’ 
  2’  1H  6.21,  dd,  17.5, 10.6 H‐1’ 147.09  2, 3’ 4’ 5’ 
  3’      39.10   
  4’  3H  1.51,  s  ‐ 28.01  2, 2’, 3’, 5 
  5’  3H  1.49,  s  ‐ 28.01  2, 2’, 3’, 4 
         
  1’’  2H  3,27#  H‐2’’, H‐4’’/ H‐5’’ 34.23  4, 5, 6, 2’’, 3’’, 4’’, 5’’
  2’’  1H  5.29,  t,  7.3  H‐1’’,  H‐4’’/ H‐5’’ 125.14  5, 4’’, 5’’, 1’’ 
  3’’      130.64  
  4’’  3H  1,683,  m  H‐1’’,  H‐2’’ 17.69  1’’’, 2’’’, 3’’’, 5’’’ 
  5’’  3H  1,677,  m  H‐1’’,  H‐2’’ 25.55  1’’’, 2’’’, 3’’’ 4’’’ 
         
  1’’’  2H  3.56,  d,  7.2  H‐2’’’, H‐4’’’/ H‐5’’’ 29.02  6, 2’’, 3’’, 4’’, 5’’ 
  2’’’  1H  5.37,  t,  7.2  H‐1’’’, H‐4’’’/ H‐5’’’ 123.00  7, 1’’, 4’’, 5’’  
  3’’’      132.02   
  4’’’  3H  1,732,  s  H‐1’’’ 17.84  1’’, 2’’, 3’’, 5’’ 
  5’’’  3H  1,727,  s  H‐1’’’ 25.66  1’’, 2’’, 3’’, 4’’ 












































































    Pos.    δH, multi     J in Hz   
   
  NH‐1  1H 9.56,  s  
  4  ‐ ‐  
  5  ‐ ‐  
  6  1H 6.62,  s  
  7  ‐ ‐  
  10a  1H 3.43#  
  10b  1H 3.18#  
  11  1H 3.95,  br. d,  10.3  
  NH‐12  1H 6.83,  d,  1.7  
  14  1H 3.86,  q,  6.7  
  NH‐15  1H 8.19,  d,  2.5  
  17  3H 1.31,  d,  7.0  
     
  1’  1H 5.09,  dd,  17.5, 1.0  
    1H 5.04,  dd,  10.6, 1.0  
  2’  1H 6.21,  dd,  17.5, 10.6  
  3’   
  4’  3H 1.51,  s  
  5’  3H 1.54,  s  
     
  1’’  2H 3.33#  
  2’’  1H 5.13, t,  6.7  
  4’’  3H 1,67,  s  
  5’’  3H 1,66,  s  
     
  1’’’  2H 3.33#  
  2’’’  1H 4.86, t,  5.2  
  4’’’  3H 1,70,  s  
  5’’’  3H 1,61,  s  
     
  1’’’’  1H 3.54,  d,  7.4  
  2’’’’  1H 5.37, t,  7.3    
  4’’’’  3H 1.74,  s  
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Abstract
The prenyltransferases EchPT1 and EchPT2 from Aspergillus ruber are responsible for the consecutive prenylations of cyclo-L-
Trp-L-Ala, leading to the formation of the triprenylated echinulin as the predominant product. In this study, we demonstrate that
EchPT1 also accepts all stereoisomers of cyclo-Trp-Ala and cyclo-Trp-Pro and catalyses regiospecific reverse C2-prenylation at
the indole nucleus. EchPT1 products were well accepted by EchPT2 for multiple consecutive prenylations, with conversion
yields of 84 to 98% for six of the eight substrates. C2-, C5- and C7-triprenylated derivatives are identified as major enzyme
products, with product yields of 40 to 86% in seven cases. High product yields of 25–36%, i.e. approximate 30% of the total
enzyme products, were observed for tetraprenylated derivatives in the four reaction mixtures with one D- and one L-configured
amino acid residues. To the best of our knowledge, enzymatic preparation of tetraprenylated cyclodipeptides with such high
efficacy has not been reported prior to this study.
Keywords Aspergillus ruber . Chemoenzymatic synthesis . Cyclodipeptides . Multiprenylated derivatives . Prenyltransferases
Introduction
Indole diketopiperazine (DKP) alkaloids exemplify the struc-
tural richness of natural products and are predominantly pro-
duced by filamentous fungi belonging to the genera
Aspergillus and Penicillium of Ascomycota (Ma et al. 2016).
Most DKP alkaloids are derived biogenetically from
cyclodipeptides of two tryptophan molecules or a tryptophan
and an additional amino acid. In fungi, the formation of such
dipeptides is catalysed by non-ribosomal peptide synthetases
(Xu et al. 2014). Structural diversification of the DKP back-
bone is subsequently achieved by different tailoring enzymes
inc luding ox idoreduc tases , methy l t r ans fe rases ,
prenyltransferases and cyclases (Giessen and Marahiel 2015;
Ma et al. 2016; Winkelblech et al. 2015; Xu et al. 2014). This
leads not only to more structural complexity of natural prod-
ucts but also improvement of their biological and pharmaceu-
tical activities (de Sá Alves et al. 2009; Ma et al. 2016; Netz
and Opatz 2015). Attachment of nxC5-units to the DKP skel-
eton by prenyltransferases increases the lipophilicity and im-
proves the bioavailability by better interactions with their tar-
gets such as biological membranes or proteins (Botta et al.
2005). The majority of the known fungal prenyltransferases
belong to the dimethylallyltryptophan synthase (DMATS) su-
perfamily and catalyse mostly the transfer of a dimethylallyl
moiety from dimethylallyl diphosphate (DMAPP) to the in-
dole ring in a regular or reverse manner (Winkelblech et al.
2015). For example, the biologically active indole alkaloids
echinulin and congeners are multiprenylated cyclo-L-Trp-L-
Ala derivatives. In a previous study, we demonstrated that
two prenyltransferases from the DMATS superfamily,
EchPT1 and EchPT2, are involved in the biosynthesis of
echinulin and neoechinulins in Aspergillus ruber
(Wohlgemuth et al. 2017).
Knowledge gained in the last years showed that the
prenyltransferases of the DMATS superfamily are in general
relatively strict in their acceptance of the prenyl donor, but
often use a wide variety of aromatic substrates as prenyl
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acceptors (Fan et al. 2015; Winkelblech et al. 2015; Yu and Li
2012). Together with the high regio- and stereoselectivity of
the reactions, this substrate promiscuity makes these enzymes
interesting tools for creation of new drug candidates and for
protein engineering (Chen et al. 2017; Fan et al. 2015; Yu and
Li 2012). We demonstrated in previous studies that the stereo-
chemistry of the amino acid residues in DKPs can influence
the acceptance and stereoselectivity of the enzymes (Mundt
and Li 2013; Yu et al. 2013). The unique feature of the afore-
mentioned EchPT2 is its ability to catalyse a prenylation cas-
cade of the reversely C2-prenylated cyclo-L-Trp-L-Ala,
preechinulin (1M1), leading to the formation of di-, tri- and
tetraprenylated products including tardioxopiperazine A
(1D1), tardioxopiperazine B (1D2), variecolorin L (1T1),
echinulin (1T2) and two tetraprenylated compounds (1Q1
and 1Q2) (Fig. 1) (Wohlgemuth et al. 2017). For better under-
standing, we adopted the nomenclature from the previous
publication (Wohlgemuth et al. 2017), where BM^ after the
substrate number refers for monoprenylated, BD^ for
diprenyla ted, BT^ for t r iprenyla ted and BQ^ for
tetraprenylated. The number after these letters indicates the
order of the identified products. Both in in vitro assays and
in the producer, 1T2 was identified as the major product. The
yields of the tetraprenylated 1Q1/1Q2 were very low, contrib-
uting only to 4% of total conversion in enzyme assay, while in
the producer just 1Q2 appears as a single tetraprenylated prod-
uct. The outstanding ability of EchPT2 to catalyse a consecu-
tive prenylation cascade prompted us to test its behaviour
towards other stereoisomers, especially the degree of the
prenylation cascade and the ratio of different products. For
this purpose, we prepared reversely C2-prenylated derivatives
of cyclo-Trp-Ala and cyclo-Trp-Pro isomers by EchPT1 and
used them as substrates for EchPT2 reactions.
Materials and methods
Chemicals
DMAPP was synthesised according to the previously de-
scribed method for geranyl diphosphate (Woodside et al.
1988). Cyclo-Trp-Ala and cyclo-Trp-Pro stereoisomers were
synthesised as reported elsewhere (Yin et al. 2013).
Bacterial strains and culture conditions
Escherichia coli strain M15 (pREP4) (QIAGEN, Hilden,
Germany) was used as expression host and cultivated in
Terrific broth (TB) medium at 30 or 37 °C. For cultivation
on solid LB medium, 1.5% (w/v) agar was added. Selection of
recombinant E. coli strains was achieved with 50 μg mL−1
carbenicillin and 25 μg mL−1 of kanamycin in the precultures
and 50 μg mL−1 carbenicillin in the main cultures.
Protein overproduction and purification
Induction of echPT1 and echPT2 expression was carried out
in E. coli M15 cells with the plasmids pVW90 and pVW83,
respectively (Wohlgemuth et al. 2017). Subsequent protein
purification was achieved by affinity chromatography with
Ni-NTA agarose resin (Qiagen) according to the manufac-
turer’s protocol. Twenty-five milligrams of EchPT1 and
1.8 mg of EchPT2 were purified from 1 L of culture.
Enzyme assays of EchPT1 and EchPT2 reactions
EchPT1 reactions were carried out with cyclo-L-Trp-L-Ala (1)
and its stereoisomers cyclo-L-Trp-D-Ala (2), cyclo-D-Trp-D-
Ala (3) and cyclo-D-Trp-L-Ala (4) as well as the four stereo-
isomers cyclo-L-Trp-L-Pro (5), cyclo-L-Trp-D-Pro (6), cyclo-D-
Trp-D-Pro (7) and cyclo-D-Trp-L-Pro (8). Standard assays
(100 μL) contained Tris-HCl (50 mM, pH 7.5), one of the
eight cyclodipeptides (0.5 mM), CaCl2 (5 mM), DMAPP
(1 mM), glycerol (0.5–5%, v/v), DMSO (2.5%, v/v) and the
purified recombinant EchPT1 (1 μg, 0.20 μM).
Standard assays (100 μL) of the EchPT2 reactions
contained Tris-HCl (50 mM, pH 7.5), one of the eight reverse-
ly C2-prenylated cyclodipeptides (1M1–8M1) (0.5 mM),
CaCl2 (5 mM), DMAPP (3 mM), glycerol (0.5–5%, v/v),
DMSO (2.5%, v/v) and the purified recombinant EchPT2
(10 μg, 2.13 μM). Unless stated otherwise, the reaction mix-
tures were incubated at 37 °C for 2 h and subsequently ex-
tracted with 200 μL ethyl acetate each for three times. The
organic phases were brought to dryness and the residues were
dissolved in 100μLmethanol. Ninetymicrolitres thereof were
analysed on a LC-MS system as described below.
Enzyme assays for determination of kinetic
parameters
The assays for determination of the kinetic parameters of
EchPT1 towards 2–8 contained 1 mM DMAPP, 0.05–2 μg
EchPT1 and the aromatic substrates at final concentrations
from 0.002 to 5.0 mM and were carried out at 37 °C for 1–
30 min (Figs. S1–S7, Table 1).
The assays for determination of the kinetic parameters of
EchPT2 towards 2M1–8M1 were carried out with 3 mM
DMAPP, 2 μg EchPT2 and the aromatic substrates at final
concentrations of 0.002 to 5.0 mM at 37 °C for 3–30 min
(Figs. S8–S14, Table 1). The assays were performed as dupli-
cates and terminated by addition of 100 μL methanol. The
precipitated proteins were removed by centrifugation at
20000×g for 20 min, and 100 μL were analysed on HPLC
as described below. The conversion yields were calculated
from the peak areas of the respective substrate and products
in HPLC chromatograms and verified by signal intensities in
the 1H NMR spectra of the incubation mixtures.
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Assays for isolation of enzyme products
and subsequent structure elucidation
The volumes of the enzyme assays were scaled up to 12 mL
containing Tris-HCl (50 mM, pH 7.5), DMAPP (3 mM),
CaCl2 (10 mM), the respective aromatic substrate (1 mM)
and 1–10 mg purified recombinant protein. These enzyme
assays were incubated at 37 °C for 16 h and extracted three
times with two volumes of ethyl acetate each. The organic
phases were combined and brought to dryness on a rotating
vacuum evaporator at 35 °C. The residues were dissolved
afterwards in 200 μL methanol for isolation on an HPLC
system with the conditions given below.
HPLC conditions for analysis and isolation
Analysis of the enzyme assays was carried out on an
Agilent HPLC series 1200 (Agilent Technologies)
equipped with an Agilent Eclipse XDB-C18 column
(5 μm, 4.6 × 150 mm). Separation was achieved with
H2O and MeCN, both containing 0.1% (v/v) formic acid
and a flow rate of 0.5 mL/min. A linear gradient from 20
to 80% MeCN over 10 min was followed by 25 min
isocratic elution at 80% MeCN and a further linear gradi-
ent from 80 to 100% MeCN in 5 min. The column was
afterwards washed with 100% MeCN for 5 min and equil-
ibrated with 20% MeCN for 5 min. Detection was carried
out with a photodiode array detector and absorptions at
277 nm were illustrated in this study.
The same HPLC system equipped with a semipreparative
Multospher 120 RP-18 column (5 μm, 10 × 250 mm) was
used for isolation of the enzyme products from the upscaled
reaction mixtures. H2O and MeCN without acid were used as
solvents at a flow rate of 2.5 mL/min. Separation was done
with a linear gradient of 30–80% MeCN in 15 min, followed
by an isocratic elution at 80% MeCN for 18 min and an
additional linear gradient from 80 to 100% MeCN in 7 min.
The column was then washed with 100% B for 10 min and
subsequently equilibrated with 20% MeCN for another
10 min. The obtained fractions were further purified on an
Agilent Eclipse XDB-C18 column (5 μm, 4.6 × 150 mm).
The same elution profile was applied for the analysis of the
enzyme assays by using H2O and MeCN without acid as
solvents.
LC-MS analysis
Enzyme products were analysed on an Agilent HPLC
1260 series system equipped with a photo diode array
detector and a Bruker microTOF QIII mass spectrometer
by using the Agilent Eclipse XDB C18 column (5 μm,
4.6 × 150 mm) according to the standard condition for this
column described above. The parameters of the spectrom-
eter were set as the following: electrospray positive ion
mode for ionisation, capillary voltage with 4.5 kV, colli-
sion energy with 8.0 eV. HR-ESI-MS data of the enzyme
products are given in Table S1.
NMR analysis
NMR spectra of the isolated enzyme products were
recorded at room temperature on a JEOL ECA-500
(JEOL, Akishima, Tokyo, Japan). The samples were dis-
solved in CD3OD or CDCl3. All spectra were processed
with MestReNova 6.0.2 (Metrelab Research, Santiago
de Compostella, Spain) and the chemical shifts were
referenced to those of the solvents. The NMR spectra of
the monoprenylated products are supplied as Figs. S15–
S24, triprenylated as Figs. S25–S39 and tetraprenylated
















preechinulin (1M1) tardioxopiperazine A (1D1) 
tardioxopiperazine B  (1D2) 



























































Fig. 1 Prenylation cascade catalysed by EchPT1 and EchPT2 in the biosynthesis of echinulin and derivatives
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Results
EchPT1 accepts very well cyclo-Trp-Ala
and cyclo-Trp-Pro isomers and catalyses regiospecific
reverse C2-prenylations
In a previous study, we demonstrated the regiospecific reverse
C2-prenylation of cyclo-L-Trp-L-Ala (1) by EchPT1. In this
study, 1 and its stereoisomers 2–4 as well as the four stereo-
isomers cyclo-Trp-Pro 5–8 were selected as prenyl acceptors.
After incubation of 1–8 with 0.5 μg EchPT1 and 1 mM
DMAPP at 37 °C for 10 min, the reaction mixtures were
analysed on HPLC. As shown in Fig. 2, 1, 2, 4, 5, 6 and 8
were very well accepted by EchPT1, with conversion yields of
52.6 ± 2.4 to 87.3 ± 1.8%. Among the eight tested substrates,
the two cyclodipeptides comprising exclusively D-configured
amino acids, i.e. 3 and 7, were poorly accepted, with conver-
sion yields of 16.3 ± 3.9 and 42.5 ± 1.9%, respectively.
Interestingly, better acceptance was observed for a given
cyclo-Trp-Pro isomer than the respective counter partner of
cyclo-Trp-Ala, i.e. 1 versus 5, 2 versus 6, 3 versus 7 as well
as 4 versus 8.
To get insights into the catalytic efficiency, kinetic param-
eters were determined for EchPT1 towards 2–8 under the re-
spective best tested conditions and compared with those for 1
determined previously (Wohlgemuth et al. 2017). As shown in
Figs. S1–S7, the reactions of EchPT1 with all the tested sub-
strates followedMichaelis-Menten kinetics. LowKM values of
less than 0.1 mM and high turnover numbers of more than
2.8 s−1 were determined for the two substrates 1 and 5
comprising exclusively L-configured amino acids. In contrast,
high KM values and low turnover numbers were determined
for the two substrates 3 and 7 consisting of only D-configured
amino acids. The other four substrates display moderate KM
values between 0.17 ± 0.0097 and 0.24 ± 0.0010 mM and
turnover numbers between 0.29 ± 0.0212 and 0.69 ±
0.0068 s−1 (Table 1). These data correspond well to the ob-
served conversion yields (Fig. 2). It is obvious that the stereo-
chemistry of the amino acids plays an essential importance for
their acceptance by EchPT1.
Detailed inspection of the HPLC chromatograms revealed
that, as in the reaction mixture of its natural substrate 1, only
one product peak each was detected for substrates 2–8, indi-
cating also regiospecific prenylations for these substances. To
elucidate their structures, the products 2M1–8M1were isolat-
ed on HPLC from reaction mixtures of the respective sub-
strates 2–8 with EchPT1 and subjected to NMR and MS anal-
yses. HR-ESI-MS data (Table S1) confirmed the
monoprenylation in 2M1–8M1 by detection of [M +H]+ ions,
which are 68 Da larger than those of the respective substrates.
Inspection of the 1H NMR spectra of 2M1–8M1 (Figs. S15–
S22) revealed clear presence of signals for a reverse prenyl
moiety each (Table S2) at 6.20–6.22 (dd, J = 17.5, 10.6 Hz),
5.13–5.15 (dd, J = 17.5, 1.0–1.2 Hz) and 5.10–5.12 ppm (dd,
J = 10.6, 1.0–1.2 Hz). Signals of four coupling aromatic pro-
tons are present in all spectra. Comparison of these spectra
with that of 1M1 reported in a previous study (Figs. S22–
S24) revealed nearly the same chemical shifts and coupling
constants for the aforementioned aromatic and olefinic pro-
tons in 1M1–4M1. The same conclusion can also be drawn
Table 1 Kinetic parameters of EchPT1 towards 1–8 and EchPT2 towards 1M1–8M1 in the presence of DMAPP
Enzyme Substrates Protein amount and incubation time KM [mM] kcat [s
−1] kcat/KM [s
−1 M−1]
EchPT1a cyclo-L-Trp-L-Ala (1) 2 μg 1 min 0.09 ± 0.0340 6.63 ± 0.0378 73,666.7
EchPT1 cyclo-L-Trp-D-Ala (2) 2 μg 5 min 0.18 ± 0.0096 0.34 ± 0.0036 1888.9
EchPT1 cyclo-D-Trp-D-Ala (3) 0.25 μg 30 min 1.82 ± 0.1983 0.08 ± 0.0421 95.3
EchPT1 cyclo-D-Trp-L-Ala (4) 2 μg 5 min 0.24 ± 0.0010 0.69 ± 0.0068 2875.0
EchPT1 cyclo-L-Trp-L-Pro (5) 2 μg 1 min 0.06 ± 0.0031 2.81 ± 0.0852 46,833.3
EchPT1 cyclo-L-Trp-D-Pro (6) 2 μg 5 min 0.17 ± 0.0097 0.34 ± 0.0055 2000.0
EchPT1 cyclo-D-Trp-D-Pro (7) 0.25 μg 30 min 0.39 ± 0.0015 0.06 ± 0.0102 153.8
EchPT1 cyclo-D-Trp-L-Pro (8) 0.05 μg 30 min 0.18 ± 0.0302 0.29 ± 0.0212 1945.0
EchPT2a cyclo-L-2-tert-DMA-Trp-L-Ala (1M1) 2 μg 3 min 0.03 ± 0.0021 0.36 ± 0.0015 12,000.0
EchPT2 cyclo-L-2-tert-DMA-Trp-D-Ala (2M1) 2 μg 8 min 0.04 ± 0.0031 0.29 ± 0.0060 7250.0
EchPT2 cyclo-D-2-tert-DMA-Trp-D-Ala (3M1) 2 μg 10 min 0.14 ± 0.0223 0.15 ± 0.0089 1071.4
EchPT2 cyclo-D-2-tert-DMA-Trp-L-Ala (4M1) 2 μg 8 min 0.05 ± 0.0010 0.36 ± 0.0080 6468.2
EchPT2 cyclo-L-2-tert-DMA-Trp-L-Pro (5M1) 2 μg 5 min 0.07 ± 0.0014 0.42 ± 0.0047 7200.5
EchPT2 cyclo-L-2-tert-DMA-Trp-D-Pro (6M1) 2 μg 10 min 0.07 ± 0.0006 0.36 ± 0.0099 5142.9
EchPT2 cyclo-D-2-tert-DMA-Trp-D-Pro (7M1) 2 μg 30 min 0.19 ± 0.0026 0.11 ± 0.0015 578.9
EchPT2 cyclo-D-2-tert-DMATrp-L-Pro (8M1) 2 μg 10 min 0.09 ± 0.0029 0.65 ± 0.0031 7222.2
aData of the kinetic parameters are from a previous study and are included for comparison (Wohlgemuth et al. 2017)
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for 5M1–8M1. As expected, the spectra of the enantiomeric
pairs, i.e. 1M1 and 3M1, 2M1 and 4M1, 5M1 and 7M1 as
well as 6M1 and 8M1 are nearly identical. All these data
proved unequivocally the reverse C2-prenylation of 2–8 by
EchPT1.
EchPT2 accepts very well reverse C2-prenylated
cyclodipeptides and catalyses similar di-
and triprenylations with C2-, C5- and C7-prenylated
derivatives as main products
Preliminary tests indicated that EchPT2 also shows broad sub-
strate specificity for DKPs with a C2-prenyl moiety. 1M1–
8M1 were subsequently incubated with 2.13 μM of EchPT2
in the presence of 3 mM DMAPP at 37 °C for 2 h. LC-MS
analysis of the reaction mixtures showed good acceptance by
EchPT2, with total product yields in the range of 21.2 ± 2.4 to
98.3 ± 1.2% (Figs. 3, 4 and 5). Again, the isomers with a (R,
R)-configuration, i.e. 3M1 and 7M1, were poorly consumed
by EchPT2, which was also confirmed by determination of the
kinetic parameters (Figs. S8–S14, Table 1) (see below for
details). The characteristic multiprenylation profiles with di-
and triprenylated products are similar to that of 1M1, proving
the consecutive prenylations of 2M1–8M1 by EchPT2 (Figs.
3 and 4).
Detailed inspection of the LC-MS chromatograms of the
EchPT2 reactions with 2M1–8M1 (Figs. 3 and 4) revealed, as
in the case of 1M1, the presence of two diprenylated deriva-
tives 2D1–8D1 and 2D2–8D2 asminor peaks each with 68Da
larger [M + H]+ ions than those of 2M1–8M1. A triprenylated
derivative each (2T2–8T2) with 136 Da larger [M + H]+ ions
than those of 2M1–8M1 was detected as the predominant
product. These peaks are found in the relative position like
echinulin (1T2) in the reaction of EchPT2 with 1M1 (Figs. 3
and 4). To elucidate their structures, 2T2–8T2 were isolated
from incubation mixtures of 2M1–8M1 with EchPT2 and
subjected to NMR analysis including 1H-1H COSY. For better
comparison, the previously isolated and identified echinulin
(1T2) (Wohlgemuth et al. 2017) was redissolved in CD3OD
and also subjected to 1H NMR analysis (Figs. S25 and S26).
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Fig. 2 HPLC analysis of EchPT1 reactions with 1–8. The enzyme assays
contained 0.5 mM aromatic substrate, 5 mM of CaCl2, 1 mM of DMAPP
and 0.5 μg of purified recombinant EchPT1 and were incubated at 37 °C
and pH 7.5 for 10 min. Conversion rates are given in parentheses
136
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As shown in Figs. S25–S39, in addition to the above-
described reverse prenyl moiety at position C-2 of the indole
ring, the characteristic signals for two additional regularly
attached prenyl moieties were detected (Tables S3 and S4).
These include signals of two triplets of septets around
5.35 ppm, two doublets at about 3.35 and 3.55 ppm and four
methyl singlets between 1.74 and 1.80 ppm. Inspection of the
downfield range between 6.6–7.2 ppm for aromatic protons
revealed the presence of two singlets each, with nearly the
same chemical shifts in 1T2–4T2. The two signals of the
enantiomers 5T2 and 7T2 are slightly closer than those of
another pair 6T2 and 8T2. Comparing these results with those
from previous studies (Li et al. 2008; Meng et al. 2015;
Wohlgemuth et al. 2017) and the high-resolution mass data
(Table S1) proves 2T2–8T2 to be reverselyC2-, regularly C5-
and C7-triprenylated cyclodipeptides (Fig. 6). This indicates
that EchPT2 also prefers two sequential prenylations at C-5
and C-7 for all stereoisomers of cyclo-Trp-Ala and cyclo-Trp-
Pro. 2T2 was identified as a racemisation product of 1T2 by
treatment with triethylamine for 2 to 3 days (Westley et al.
1968). 4T2 was obtained as epiechinulin by chemical synthe-
sis (Inoue et al. 1977; Takamatsu et al. 1971). To the best of
our knowledge, the triprenylated substances 3T2 and 5T2–
8T2 have not been described prior to this study. Differing
from that of 1M1, all the assays of 2M1, 4M1, 6M1 and
8M1 showed an additional small triprenylated product, name-
ly 2T3, 4T3, 6T3 and 8T3, with a slightly larger retention
time than that of 2T2, 4T2, 6T2 and 8T2, respectively
(Figs. 3 and 4).
Product yields of C2-, C4-, C5- and C7-tetraprenylated
derivatives are strongly dependent
on the stereochemistry of the substrates
Most interestingly, just one tetraprenylated product each, 2Q1,
4Q1, 6Q1 or 8Q1, was found in the assays of cyclodipeptide
derivatives with one L- and one D-configured amino acid
(Figs. 3 and 4). These products represent approximately
30% of the total conversion yields in the respective reactions
(Fig. 5). In comparison, the 1M1 reaction has two
tetraprenylated derivatives, 1Q1 and 1Q2, as minor products
with a total conversion yield of 4% (Figs. 3 and 5). Twominor
products, 3Q1 and 3Q2, with a total conversion yield of 4%
were also observed in the assay with 3M1. No tetraprenylated
product was detected in the assays with 5M1 and 7M1
(Fig. 4).
The enzyme products 2Q1, 4Q1, 6Q1 and 8Q1 were iso-
la ted from the enzyme assays of the respect ive
monoprenylated substrate with EchPT2 and subjected to
NMR analysis. As shown in Figs. S40–S51, signals of one
reverse and three regular prenyl moieties are clearly observed
in their spectra. Comparison of the spectra of the
tetraprenylated derivatives with those of the respective
triprenylated counterpart (Fig. S52) revealed the presence of
signals for an additional regular prenyl moiety and the disap-
pearance of the singlet for H-4. The singlet for H-6 is still
present in the range of 6.7–6.8 ppm. Together with the high-
resolution mass data (Table S1), these results prove unequiv-
ocally 2Q1, 4Q1, 6Q1 and 8Q1 to be reversely C2-, regularly
C4-, C5- and C7-tetraprenylated cyclodipeptides (Fig. 6,
Tables S5 and S6). To the best of our knowledge, these com-
pounds have not been described prior to this study.
To get further insights into the reaction efficacy of the
EchPT2 reactions, kinetic parameters were determined for
2M1–8M1 in the presence of 3 mM DMAPP under their
respective best conditions. As shown in Figs. S8–S14, the
EchPT2 reactions also followed the Michaelis-Menten kinet-
ics. High affinities with KM values between 0.03 ± 0.0021 and
0.19 ± 0.0026 mMwere determined for 2M1–8M1. Turnover
numbers were found from the highest value at 0.36 ±
0.0015 s−1 for 1M1 to the lowest value for 7M1 at 0.11 ±
0.0015 s−1. Again, the two substrates, 3M1 and 7M1 derived
from two D-configured amino acids, are poorly accepted by
EchPT2.
Discussion
Cyclodipeptides with a DKP backbone are widely distributed
in nature and mainly produced by bacteria and fungi. The
DKP scaffolds are chemically condensation products of two
amino acids. In fungi, DKPs are usually assembled by
bimodular non-ribosomal peptide synthetases (Maiya et al.
2006;Walsh 2016; Xu et al. 2014), whereas in bacteria mainly
by tRNA-dependent cyclodipeptide synthases (Giessen and
Marahiel 2014; Gondry et al. 2009; James et al. 2015;
Moutiez et al. 2017). Investigation in the last decades proved
DKPs to be interesting candidates for drug discovery and de-
velopment, due to their structural richness and their diverse
biological activities (Borthwick 2012; Ma et al. 2016; Mishra
et al. 2017). Their structural complexity as well as biological
and pharmacological activities can be further increased by
different tailoring enzymes like methyltransferase, hydroxy-
lases, cyclases and prenyltransferases (Borthwick 2012;
Giessen et al. 2013; Giessen and Marahiel 2015; Li 2010;
Xu et al. 2014). Among the DKPs, tryptophan-containing
members have received a remarkable increasing interest in
recent years, due to the presence of the indole moiety for
Fig. 3 LC-MS analysis of the prenylation cascade catalysed by EchPT2
with C2-prenylated cyclo-Trp-Ala isomers. The stereochemistry is
visualised with orange for S and green for R. Extracted ion
chromatogram (EIC) traces in the respective colours indicate the
prenylation level
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diversification by a large number of prenyltransferases
(Winkelblech et al. 2015).
Prenylated derivatives including prenylated DKPs are
products of prenyltransferases alone or together with other
modification enzymes. They are important secondary metab-
olites in plants and microorganisms (Li 2010; Xu et al. 2014;
Yazaki et al. 2009). By prenylation, the small molecules be-
come more lipophilic and can better interact with biological
membranes or proteins (Botta et al. 2005, 2009; Kim et al.
2012). Among the prenylated natural products, there are also
examples of polyprenylated derivatives such as polycyclic
polyprenylated xanthones and acylphloroglucinols from
plants (Cottet et al. 2015; Guttroff et al. 2017) and
polyprenylated indole alkaloids from fungi (Liu et al. 2014;
Mundt et al. 2012). Usually, one prenyltransferase catalyses
one specif ic prenyl t ransfer react ion and several
prenyltransferases are involved in the formation of a given
polyprenylated derivative (Mundt et al. 2012; Zou et al. 2015).
In a previous study (Wohlgemuth et al. 2017), we demon-
strated the involvement of the two prenyltransferases EchPT1
and EchPT2 in the biosynthesis of echinulin (1T2). EchPT1
catalyses the reverse C2-prenylation of cyclo-L-Trp-L-Ala and
EchPT2 afterwards a reaction cascade of up to three
prenylation steps (Fig. 1). By incubation of EchPT2 with the
isolated mono-, di- and triprenylated intermediates, we have
shown that prenylations can take place at C-4, C-5, C-6 and C-
7 of the indole ring and C7-prenylation leads to termination of
the reaction cascade (Fig. 1). The first prenylation catalysed
by EchPT2 is either at C-5 or C-7.C2,C5-diprenylated 1D1 is
then converted to C2, C4, C5-triprenylated 1T1 and C2, C5,
C7-triprenylated 1T2 (echinulin). 1T1 finally undergoes
prenylation at C-6 or C-7, leading to the formation of the
tetraprenylated 1Q1 and 1Q2 (Fig. 1). With the exception
for 1Q1, other products were also detected in the cultures of
the producer (Wohlgemuth et al. 2017). However, the yields
of most products are too low to be used biotechnologically. In
this study, we successfully used EchPT1 and EchPT2 as
biocatalysts for enzymatic preparation of eight triprenylated
cyclodipeptides with high efficiency. As for its natural sub-
strate 1M1, C2, C5, C7-triprenylated derivatives were also
detected as main products of EchPT2 with seven other unnat-
ural substrates 2M1–8M1 (Figs. 3, 4 and 5). 17 and 42% of
7M1 and 3M1 were converted to 7T2 and 3T2, respectively.
Fig. 5 Product yields of EchPT2
reactions
Fig. 4 LC-MS analysis of the prenylation cascade catalysed by EchPT2
with C2-prenylated cyclo-Trp-Pro isomers. The stereochemistry is
visualised with orange for S and green for R. Extracted ion
chromatogram (EIC) traces in the respective colours indicate the
prenylation level
Appl Microbiol Biotechnol (2018) 102:2671–2681 2679
140
Higher conversion yields of 56 to 90% were found for other
substrates to their respective triprenylated derivatives. In four
cases, high product yields, approximate 30% of the total con-
version, were also achieved for tetraprenylated derivatives
from reversely C2-prenylated cyclodipeptides comprising
one L- and one D-amino acids, i.e. 2M1, 4M1, 6M1 and
8M1. It is obvious that the stereochemistry had a strong influ-
ence on the prenylation cascade catalysed by EchPT2. The
stereoisomers with solely L,L-configuration, as in the cases
of 1M1 and 5M1, or D,D-configuration as in the cases of
3M1 and 7M1, showed only low (about 4% from 1M1 and
3M1) or no conversion (5M1 and 7M1) to tetraprenylated
derivatives (Figs. 3, 4 and 5). The spatially larger proline
compared to alanine residue seems to hinder the formation
of tetraprenylated products with an L,L- or D,D-configuration.
It can be expected that EchPT2 could also be successfully
used for production of other tri- and tetraprenylated
cyclodipeptides. Structure analysis for EchPT2, determination
of the substrate binding sites and structure-based enzyme de-
sign will increase the accessibility for biotechnological appli-
cation, which is now under investigation.
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cyclo‐L‐2‐tert‐DMA‐Trp‐D‐Ala (2M1)  C19H23N3O2  326.1863  326.1864  0.3 
2D1  C24H31N3O2  394.2489  394.2491  0.5 
2D2  C24H31N3O2  394.2489  394.2486  ‐0.7 
2T1  C29H39N3O2  462.3115  462.3125  2.1 
cyclo‐L‐2‐tert‐DMA‐5,7‐di‐DMA‐Trp‐D‐Ala (2T2)  C29H39N3O2  462.3115  462.3126  2.4 
2T3  C29H39N3O2  462.3115  462.3116  0.2 
cyclo‐L‐2‐tert‐DMA‐4,5,7‐tri‐DMA‐Trp‐D‐Ala (2Q1) C34H47N3O2  530.3741  350.3740  ‐0.2 
   
cyclo‐D‐2‐tert‐DMA‐Trp‐D‐Ala (3M1)  C19H23N3O2  326.1863  326.1874  3.4 
3D1  C24H31N3O2  394.2489  394.2468  ‐5.3 
3D2  C24H31N3O2  394.2489  394.2474  ‐3.8 
3T1  C29H39N3O2  462.3115  462.3094  ‐4.5 
cyclo‐D‐2‐tert‐DMA‐5,7‐di‐DMA‐Trp‐D‐Ala (3T2)  C29H39N3O2  462.3115  462.3122  1.5 
3Q1/2  C34H47N3O2  530.3741  530.3732  ‐1.6 
     
cyclo‐D‐2‐DMA‐Trp‐L‐Ala (4M1) C19H23N3O2  326.1863  326.1859  ‐1.2 
4D1  C24H31N3O2  394.2489  394.2473  ‐4.1 
4D2  C24H31N3O2  394.2489  394.2483  ‐1.5 
4T1  C29H39N3O2  462.3115  462.3109  ‐1.3 
cyclo‐D‐2‐DMA‐5,7‐di‐DMA‐Trp‐L‐Ala (4T2)  C29H39N3O2  462.3115  462.3123  1.7 
4T3  C29H39N3O2  462.3115  462.3113  ‐0.4 
cyclo‐D‐2‐DMA‐Trp‐L‐Ala (4Q1) C34H47N3O2  530.3741  530.3732  ‐1.7 












cyclo‐L‐2‐DMA‐Trp‐L‐Pro (5M1) C21H25N3O2   352.2020  352.2031  3.1 
5D1  C26H33N3O2  420.2646  420.2628  ‐4.1 
5D2  C26H33N3O2  420.2646  420.2633  ‐3.1 
5T1  C31H41N3O2  488.3272  488.3264  ‐1.6 
cyclo‐L‐2‐DMA‐5,7‐di‐DMA‐ Trp‐L‐Pro (5T2)  C31H41N3O2  488.3272  488.3274  ‐0.4 
         
cyclo‐L‐2‐DMA‐Trp‐D‐Pro (6M1) C21H25N3O2   352.2020  352.2015  ‐1.4 
6D1  C26H33N3O2  420.2646  420.2633  ‐2.8 
6D2  C26H33N3O2  420.2646  420.2632  ‐3.1 
6T1  C31H41N3O2  488.3272  488.3265  ‐1.4 
cyclo‐L‐2‐DMA‐5,7‐di‐DMA‐Trp‐D‐Pro (6T2)  C31H41N3O2  488.3272  488.3261  ‐2.2 
6T3  C31H41N3O2  488.3272  488.3259  ‐2.6 
cyclo‐L‐2‐DMA‐4,5,7‐tri‐DMA‐Trp‐D‐Pro (6Q1)  C36H49N3O2  556.3898  556.3886  ‐2.2 
         
cyclo‐D‐2‐DMA‐Trp‐D‐Pro (7M1) C21H25N3O2   352.2020  352.2032  3.4 
7D1  C26H33N3O2  420.2646  420.2634  ‐2.8 
7D2  C26H33N3O2  420.2646  420.2638  ‐1.9 
7T1  C31H41N3O2  488.3272  488.3261  ‐2.3 
cyclo‐D‐2‐DMA‐5,7‐di‐DMA‐Trp‐D‐Pro (7T2)  C31H41N3O2  488.3272  488.3265  ‐1.4 
   
cyclo‐D‐2‐DMA‐Trp‐L‐Pro (8M1)  C21H25N3O2   352.2020  352.2025  1.4 
8D1  C26H33N3O2  420.2646  420.2643  ‐0.7 
8D2  C26H33N3O2  420.2646  420.2635  ‐2.6 
8T1  C31H41N3O2  488.3272  488.3273  0.2 
cyclo‐D‐2‐DMA‐5,7‐di‐DMA‐Trp‐L‐Pro (8T2)  C31H41N3O2  488.3272  488.3277  1.9 
8T2  C31H41N3O2  488.3272  488.3255  ‐3.5 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure S23 selected region (6.1 – 7.6 ppm) of the 1H NMR spectra of 1M1 (Wohlgemuth et al. 2017) and 2M1 –
8M1 in CD3OD 
 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.4. Genomic locus of a Penicillium crustosum pigment as an integration site for 
secondary metabolite gene expression. 
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Genomic Locus of a Penicillium crustosum Pigment as an Integration
Site for Secondary Metabolite Gene Expression
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ABSTRACT: Heterologous expression of secondary metabolite genes and gene clusters has been proven to be a successful
strategy for identification of new natural products of cryptic or silent genes hidden in the genome sequences. It is also a useful
tool to produce designed compounds by synthetic biology approaches. In this study, we demonstrate the potential usage of the
gene locus pcr4401 in the fast-growing filamentous fungus Penicillium crustosum as an integration site for heterologous gene
expression. The deduced polyketide synthase (PKS) Pcr4401 is involved in the dihydroxynaphthalene (DHN)-melanin pigment
formation, and its deletion in P. crustosum PRB-2 led to an albino phenotype. Heterologous expression of pcr4401 in Aspergillus
nidulans proved its function as the melanin precursor YWA1 synthase. To ensure gene expression after genomic integration and
to easily identify the potential transformants by visualization, the gene locus of pcr4401 was chosen as an integration site. For
heterologous expression in P. crustosum, the expression constructs were created by ligation-independent homologous
recombination in Escherichia coli or Saccharomyces cerevisiae. A pyrG deficient strain was also created, so that both the pyrG and
hph resistance gene can be used as selection markers. Successful expression in P. crustosum was demonstrated by using one
uncharacterized PKS gene from Aspergillus and two from Penicillium strains. All three genes were successfully introduced,
heterologously expressed, and their biosynthetic products elucidated. The results presented in this study demonstrated that P.
crustosum can be used as a suitable host for heterologous expression of secondary metabolite genes.
N atural products (NPs) produced by microorganisms area valuable source for finding and development of new
potential drugs. In total, 46% of the 1562 approved drugs
between the years 1981 and 2014 originated from natural
sources including NPs (4%) and their derivatives (21%) as well
as NP mimics or pharmacophores (21%).1 Bacteria, especially
the actinobacteria, are often producers of promising NPs.2
Eukaryotic fungi of the phylum Ascomycota, e.g., Penicillium
and Aspergillus belong to another important group of NP
producers.3 In recent years, bioactive fungal secondary
metabolites (SMs) have been increasingly identified. From
2001 to 2010, 61% of the total identified bioactive microbial
metabolites originated from fungi.4 The ongoing process in
sequencing technology significantly decreased the cost for
genome sequencing. Therefore, the scientific community easily
gets access to a rapidly increasing number of microbial
genomes.5 Mining the bacterial and fungal genomes revealed
the presence of a huge genetic potential for SM production,
which is far from being exhausted. Most biosynthetic gene
clusters (BGCs) for SM production remain silent under
laboratory culture conditions. Such silent BGCs are estimated
to be approximately 90%.6 Several approaches including
alterations in the cultivation conditions, use of biotic and
abiotic elicitors, or interference with the condensation state of
the genomic DNA, which regulates the accessibility of a DNA
region for transcription factors, were developed to activate the
silent BGCs.7 In addition, heterologous expression of single
genes or whole BGCs in an appropriate host is very promising
to further access microbial SM production capability or to
increase product diversity by synthetic biology approaches.8
Next to Escherichia coli and Saccharomyces cerevisiae,
filamentous fungi belonging to the genus Aspergillus are the
most used heterologous expression hosts for SM produc-
tion.8−10 In particular, the model organism Aspergillus nidulans
is an already established and frequently used host for
heterologous gene expression. Aspergillus oryzae, known from
food technology, also proved to be a reliable host.
Furthermore, Aspergillus niger can also be a suitable choice
for heterologous expression. In comparison, there are only a
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few reports on heterologous expression in Penicillium species.
For example, the penicillin producer Penicillium rubens
(formerly known as Penicillium chrysogenum) was successfully
applied as an expression host.11
Heterologous expression may be hindered by host-depend-
ent factors, e.g., insufficient or missing supply of biosynthetic
precursors, different intron splicing behavior compared to the
native host or host-dependent cross-chemistry. Song et al.12
reported the difficulties for the heterologous expression of a
polyketide synthase-nonribosomal peptide synthetase (PKS-
NRPS) hybrid gene. The reason was different splicing in the
native host Magnaporthe oryzae and in the expression host A.
oryzae. In a recent study, Geib et al.13 investigated NRPS-like
enzymes by domain swapping and heterologous expression in
A. niger and A. oryzae and observed host-dependent product
formation. The authors suggested to use different heterologous
expression hosts for characterization of yet unknown NRPS-
like enzymes.
Penicillium crustosum is a ubiquitously occurring filamentous
fungus and has been identified and isolated from a wide range
of ecological niches including goods for human consumption
like corn, bread, meat, cheese, fruits, and nuts.14 It is a fast-
growing fungus on various media within a temperature range of
5 to 35 °C with an optimal growth temperature of 25 °C.15 P.
crustosum strains are also known producers of SMs including
different mycotoxins like the neurotoxic penitrems, andrastins,
terrestric acid, roquefortines, viridicatols, peniphenones, and
penilactones.16,17 Initially interested in the biosynthetic
pathway of polyketides produced by P. crustosum PRB-2,17
we sequenced its genome and identified a nonreducing
polyketide synthase (NR-PKS), named Pcr4401, being
responsible for the biosynthesis of the DHN-melanin precursor
YWA1. In this study, we report the potential use of the pcr4401
gene locus in P. crustosum as an integration site for
heterologous gene expression.
■ RESULTS AND DISCUSSION
Genome Sequencing for P. crustosum PRB-2. Sequenc-
ing the genome of P. crustosum PRB-2 resulted in a draft
genome sequence with an estimated genome size of 32.4 Mbp
organized in 145 contigs. This sequence was used for the
identification of SM backbone genes by antiSMASH,18
combined with a BLAST search using PKS and NRPS
domains as queries. Open reading frame and protein sequence
prediction were achieved with FGENESH19 and secondFind
(http://biosyn.nih.go.jp/2ndfind/). In total, 52 backbone
genes including 23 PKSs, 19 NRPSs, 6 NRPS-like enzymes,
as well as 4 NRPS-PKSs have been identified.
Identification of Pcr4401 as a Putative Conidial
Pigment Polyketide Synthase. Six of the identified PKSs
are NR-PKSs. To identify possible biosynthetic products of the
NR-PKSs, a BLAST search and sequence comparison with
known PKSs were performed. Thereby, PKS Pcr4401 showed
sequence identities of 66.6% on the amino acid level to the
polyketide synthase for naphthopyrone YWA1 encoded by the
wA gene in A. nidulans and 65.8% to the conidial pigment
polyketide synthase Alb1 from A. fumigatus. All three PKS
share the same SAT-KS-AT-PT-ACP-ACP-TE domain archi-
tecture (see ref 20 for the PKS domain abbreviations). We
proved Pcr4401 function by gene deletion in P. crustosum. A
deletion cassette was prepared by inserting the sequence of the
hph gene under the control of the constitutive gpdA promoter
and the trpC terminator from A. nidulans between the up- and
downstream sequences of pcr4401 (Tables S1 and S2 in the
Supporting Information). Introducing this DNA fragment into
wildtype strain PRB-2 and selection on hygromycin B-
containing plates led to identification of 215 resistant colonies.
A total of 21 of them showed an albino phenotype (e.g., strain
FK02 in Figure 1). PCR amplification verified the replacement
of pcr4401 by the hph gene (Figure 2A,B and Table 1),
indicating the crucial role of Pcr4401 in the pigmentation. No
changes on other SMs or growing behavior (Table S3) could
be detected in the Δpcr4401 strain FK02, compared to the
wildtype. Moreover, cultivation of P. crustosum in Czapek dox
broth (CDB) and metabolite analysis showed a relatively clear
SM background (Figure S1), providing a solid basis for
detection and isolation of heterologously produced com-
pounds.
The gene targeting efficiency was estimated to be 9.8%
(Table 2). In total, 194 or 90.2% of the transformants showed
hygromycin B resistance without deletion of the gene pcr4401,
most likely due to ectopic integration of the gene deletion
cassette instead of homologous recombination at the targeted
gene. Gene targeting efficiency could be increased by using a
nonhomologous end joining deficient (Δku70/80) strain or
using split-marker gene deletion method.21,22 For deletion or
disruption of genes related to pigment formation, e.g., the
pcr4401 gene locus, the albino phenotype upon successful
targeted integration can be easily detected by visualization, so
Figure 1. Phenotypes of fungal strains grown on GMM for 7 days at
25 °C. Deletion and replacement of pcr4401 in P. crustosum led to the
albino phenotype as detected in strains FK02 and FK11−FK13.
Similar phenomenon was also observed in A. nidulans strain FK14
after vector integration into the wA locus of LO8030. Heterologous
expression of pcr4401 in A. nidulans LO8030 restored the green
conidial color of the wild type (FK10).
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that these strategies are not essential for heterologous
expression at such loci.
Heterologous Expression Proved Pcr4401 as an
YWA1 Synthase. To clarify whether Pcr4401 is indeed
involved in the biosynthesis of the green conidial pigment, the
whole pcr4401 sequence was amplified from PRB-2, cloned
into the expression vector pYH-wA-pyrG,23 and introduced
site-specifically into the wA locus of A. nidulans LO8030,24
resulting in the strain FK10. In parallel, the wA locus was also
replaced by the empty vector and the resulted strain FK14 was
used as a control. Cultivation of FK10 on GMM showed
secretion of yellow compounds to the medium and restored
green conidial pigmentation compared to strain FK14 (Figure
1). This proved that pcr4401 can complement the function of
wA. Liquid chromatography−mass spectrometry (LC−MS)
analysis of the extract of a 3 day old rice culture led to the
detection of two additional product peaks at 7.7 min with a [M
+ H]+ ion at m/z 275.0568 (C14H12O6) and 9.0 min with a [M
+ H]+ ion at m/z 259.0599 (C14H10O5), which are absent in
the extract of FK14 (Figure 3). The mass data and UV spectra
of the two compounds correspond very well to those of the
known heptaketide YWA1 (1) and its dehydrated derivative
YWA2, also known as nor-rubrofusarin (2) (Figure S2A,B). To
confirm their structures, both compounds were isolated by
high-performance liquid chromatography (HPLC) and sub-
jected to 1H NMR analysis, which unequivocally proved their
integrity (Figures S5 and S6, Table S5).25,26 The yields of
Figure 2. Schematic presentation of the gene deletions/replacements
at the pcr4401 and pcr6370 (pyrG) locus in P. crustosum (A, C, E, G,
and I) and PCR verification (B, D, F, H, and J). UP, upstream; DW,
downstream; hph, hygromycin B resistance; afpyrG, A. fumigatus
pyrG.
Table 1. Strains Used and Created in This Study
strains genotype source
P. crustosum PRB-2 wild type 27
P. crustosum FK02 Δpcr4401::PgpdA-hph in P. crustosum PRB-2 this study
P. crustosum FK11 Δpcr4401::PgpdA-PCAMFM013_S003g000758:hph in P. crustosum PRB-2 this study
P. crustosum FK12 Δpcr4401::PgpdA-gm1.7502_g:hph in P. crustosum PRB-2 this study
P. crustosum FK13 Δpcr4401::PgpdA-EURHEDRAFT_547227:afpyrG, Δpcr6370 in P. crustosum PRB-2 this study
P. crustosum FK15 Δpcr6370 this study
A. nidulans LO8030 pyroA4, riboB2, pyrG89, nkuA::argB, deletion of eight SM biosynthetic gene clusters 24
A. nidulans FK10 ΔwA::PgpdA-pcr4401:afpyrG in A. nidulans LO8030 this study
A. nidulans FK14 ΔwA::afpyrG in A. nidulans LO8030 this study
A. nidulans JN03 ΔwA::PgpdA-EURHEDRAFT_547227:afribo in A. nidulans LO8030 this study
P. camemberti FM013 wild type 28
P. brevicompactum NRRL864 wild type NRRL
A. ruber QEN-0407-G2 wild type 29




[μg] marker protoplasts total proven
positive
[%]
pFK06 10 hph 2.1 × 108 134 15 11.2
10 hph 2.0 × 107 38 2 5.2
10 hph 1.2 × 107 43 4 9.3
pFK21 2 hph 5.4 × 107 51 4 7.8
2 hph 2.0 × 107 62 4 6.5
2 hph 1.2 × 107 47 3 6.4
pFK22 2 hph 3.1 × 107 36 3 8.3
2 hph 2.0 × 107 68 5 7.4
2 hph 1.2 × 107 40 3 7.5
pFK24 5 pyrG 8.7 × 107 21 2 9.5
5 pyrG 1.7 × 107 19 2 9.5
5 pyrG 1.5 × 107 32 1 6.3
pFK25 10 5-FOAa 1.0 × 108 2 2 100
10 5-FOAa 1.7 × 107 2 1 50
10 5-FOAa 1.5 × 107 4 1 25
a5-Fluoroorotic acid was used for selection of pyrG deficient P.
crustosum strains.
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YWA1 and nor-rubrofusarin were calculated to be 122 mg and
60 mg per kg of 7 day-old rice culture, respectively. Elongated
cultivation of FK10 increased the green conidial color
intensity, indicating the conversion of YWA1 to the conidial
pigments.
Guzman-Chavez et al.30 demonstrated by gene deletion and
heterologous overexpression experiments that PKS17
(CAP96497.1) from P. rubens is an orthologue of A. fumigatus
naphthopyrone synthase Alb131 and also catalyzes the
formation of YWA1. Thereby they proved the crucial role of
PKS17 in the DHN-melanin biosynthetic pathway and in
conidial pigmentation in P. rubens. Pcr4401 from P. crustosum
showed a high sequence identity of 93.9% at the amino acid
level to PKS17 from P. rubens. From the genome sequence of
P. crustosum, we were able to identify genes coding for the
same orthologous enzymes in the DHN-melanin pathway in A.
fumigatus (Figure S3, Table S4), with sequence identities of
48.6−69.9%. We assume that the DHN-melanin formation in
P. crustosum is catalyzed in the same manner as in A. fumigatus
and P. rubens.
Heterologous Gene Expression in P. crustosum PRB-
2. Successful deletion of pcr4401 with the hygromycin B
resistance marker under the control of the A. nidulans gpdA
promoter proved that this system is also working in P.
crustosum. The next step was to investigate the possibility of
heterologous gene expression in P. crustosum. For proof of
principal, we selected two genes coding for the PKS
CRL19966 from Penicillium camemberti and Gm1.7502_g
from Penicillium brevicompactum for heterologous expression.
For this purpose, an expression vector pFK20 (Figure S4) with
the hygromycin B resistance marker was constructed. The gene
to be expressed will be cloned after the gpdA promoter
sequence. The up- and downstream flanking regions of
pcr4401 were inserted before the gpdA promoter responsible
for expression of the gene of interest and behind the
hygromycin B resistance gene. This ensures the site-specific
integration at the pcr4401 locus for active gene expression and
easy identification of the transformants by visual observation of
the albino phenotype.
The PKS CRL19966.1 from P. camemberti was reannotated
with secondFind leading to a revised protein sequence with
2636 amino acids and a SAT-KS-AT-PT-ACP-ACP-MT-TE
domain architecture (Figure 4B). To the best of our
knowledge, this PKS has not been investigated experimentally.
A BLAST analysis against the UniProt database32 revealed that
the top three hits of known PKSs are AndM,33 AusA,34 and
MpaC35 with 42.4, 41.3, and 40.4% sequence identities at the
amino acid level, respectively. The revised protein sequence is
supported by a multiple sequence alignment with AndM,
AusA, and MpaC (Figure S10). These PKSs are involved in the
biosynthesis of meroterpenoids anditomin, austinol, and
mycophenolic acid. Thereby AndM and AusA catalyze the
formation of 3,5-dimethylorsellinic acid (DMOA) and MpaC
that of 5-methylorsellinic acid.33−35
Cloning the genomic sequence of CRL19966 into pFK20
resulted in the expression construct pFK21. Eleven of the 160
resistant pFK21 transformants showed the albino phenotype
(e.g., strain FK11 in Figure 1, Tables 1 and 2), indicating
successful integration into the pcr4401 locus, which was
subsequently confirmed by PCR (Figure 2C,D). The strain
FK11 was cultivated in CDB for 3 days and extracted with
EtOAc for LC−MS analysis. In comparison to that of the
Δpcr4401 strain FK02, one predominant peak with a [M + H]+
ion at m/z 197.0802 was detected at 7.6 min (Figure 4A,B).
Isolation and structural elucidation by UV and NMR analyses
(Figures S2C and S7, Table S5) proved its structure as
DMOA.33 The product yield was calculated to be 11.2 mg per
liter of culture. This small aromatic polyketide is a common
intermediate in the biosynthesis of diverse meroterpenoids. In
contrast to the BGCs of the PKS AndM, AusA, and MpaC with
a farnesyltransferase gene, no homologous genes could be
identified in the proximity of CRL19966. Until now, there has
been no report on DMOA related meroterpenoids or other
DMOA based SMs in P. camemberti.
The PKS Gm1.7502_g from P. brevicompactum shows a
SAT-KS-AT-PT-ACP-ACP-TE domain architecture (Figure
4C). UniProt BLAST analysis revealed sequence identities of
43.2, 42.3, and 42.1% to CTB1 from Cercospora nicotianae,
Figure 3. Heterologous expression of pcr4401 from P. crustosum in A.
nidulans LO8030: (A) domain architecture and the expected products
and (B) LC−MS analysis of the control strain FK14 and the pcr4401
expression strain FK10 after cultivation on rice for 3 days.
Figure 4. Heterologous expression of PKS genes in P. crustosum (B−
D) and A. nidulans (E). LC−MS analysis of the extracts from different
transformants and schematic representation of the PKS domain
architectures with products.
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Fsr1 from Fusarium fujikuroi, and wA from A. nidulans in the
aforementioned DHN-melanin biosynthesis.25 CTB1 catalyzes
the formation of nor-toralactone, which is further metabolized
to cercosporin.36 Fsr1 is responsible for the formation of 6-O-
demethylfusarubinaldehyde, a precursor of fusarubins.37 In
analogy to CRL19966, the sequence of Gm1.7502_g was
amplified from the genomic DNA of P. brevicompactum and
integrated into the pcr4401 locus of P. crustosum by
transformation of the construct pFK22 resulting in the strain
FK12 (Figure 2E,F). A total of 11 of the 144 resistant
transformants showed the albino phenotype (Figure 1, Table
1) and were subsequently cultivated in CDB for 4 days. The
SMs were then extracted and analyzed via LC−MS (Figure
4C). Again, one dominant product peak at 9.2 min with a [M
− H]− ion at m/z 257.0451 was detected, which is absent in
the control strain (Figure 4A). Isolation and structural
elucidation with the help of UV and 1H NMR spectrum
(Figures S2D and S8, Table S5) led to the identification of
nor-toralactone (Figure 4C).38 The product yield was assumed
to be 6.5 mg per liter of culture. To the best of our knowledge,
there are no reports on the production of nor-toralactone or
related SMs in P. brevicompactum.
Heterologous Expression in a pyrG Deficient P.
crustosum Strain. Heterologous overexpression of the
genes coding for CRL19966 and Gm1.7502_g and the
subsequent isolation of the accumulated compounds proved
that P. crustosum PRB-2 is a suitable fast-growing host for
heterologous overexpression with reliable genetic tractability
(Tables 1 and 2). Furthermore, heterologous expression of
both PKS genes did not affect the growing behavior of P.
crustosum (Table S3). We manipulated therefore P. crustosum
for more convenience as a heterologous expression host by
identification and deletion of the pyrG gene (pcr6370)
encoding the orotidine 5′-phosphate decarboxylase. This
deletion provides the possibility to use pyrG as a second
selection marker besides the hygromycin B resistance gene.
Furthermore, using pyrG as selection marker enables multiple
gene deletion or gene insertions by selection marker recycling
based on the bidirectional selection of pyrG deficient or pyrG
intact transformants. For gene deletion, the flanking regions of
the pyrG gene were fused and cloned into the vector pGEM-T
Easy to give the plasmid pFK25. Afterward, the fused flanking
regions were amplified from pFK25 via PCR and transformed
into P. crustosum (Figure 2G). Selection of pyrG deficient
mutants was achieved by supplementing 5-fluoroorotic acid (5-
FOA), uracil, and uridine. Success of the deletion was
additionally proven by PCR (Figure 2H) and by the uracil
and uridine auxotrophic selection of the transformants.
To prove the functionality of the pyrG selection marker, we
constructed a second plasmid pFK23 (Figure S4) for
heterologous expression based on the pyrG selection marker
from A. fumigatus (afpyrG), and the hph resistance cassette in
pFK20 was replaced by the af pyrG selection marker.
Subsequently, a putative 6-methylsalicylic acid synthase
(EURHEDRAFT_547227) from Aspergillus ruber was cloned
into pFK23 and used for integration into the pcr4401 locus of
P. crustosum. Successful integration was subsequently con-
firmed via PCR (Figure 2I,J). A total of 5 of the 72
transformants showed the albino phenotype (Tables 1 and 2,
FK13 in Figure 1). Transformant FK13 was selected for
cultivation in CDB and SM screening. Growth rate of the pyrG
deficient strain FK15 was reduced compared to the wildtype or
FK02 strain. However, complementation of the pyrG
deficiency through transformation of the heterologous
expression construct restored the growth rate in strain FK13
back to the wildtype level (Table S3). LC−MS analysis of an
EtOAc extract of a 3 day old culture showed a major product
peak at 7.4 min with a [M − H]− ion at m/z 151.0408 (Figure
4D). Isolation and structural elucidation with the help of
ultraviolet (UV) spectroscopy and 1H NMR spectroscopy
(Figures S2E and S9, Table S5) confirmed its integrity as the
expected 6-methylsalicylic acid.39 The product yield was
estimated to be 2.1 mg per liter of culture. Heterologous
expression of the same 6-methylsalicylic acid synthase gene in
A. nidulans (Figure 1 and Table 1) under the identical
conditions resulted in comparable product yields (Figure 4E).
This proved the functionality of the afpyrG as selection marker
for heterologous gene expression in P. crustosum and the
convenient identification of desired transformants by insertion
into the pcr4401 locus.
In conclusion, we demonstrated that the pcr4401 gene locus
of P. crustosum is a suitable integration site for heterologous
expression of fungal genes and shows a good and reliable
genetic tractability. Successful transformation of P. crustosum
resulted, on average, in more than 18 transformants per
microgram of transformed DNA. By using the pcr4401 locus
for integration, selection of transformants with correct
integration is easily achieved by the albino phenotype. Three
independent experiments proved the gene targeting efficiency
for deletion or heterologous expression in the range of 5−11%
(Table 2). Together with both of the plasmids pFK20 and
pFK23 for site-specific expression in P. crustosum PRB-2 and
the created pyrG deficient strain, we expand herewith the
spectrum of fungal expression hosts.
■ METHODS
Strains, Media, and Culture Conditions. Escherichia coli strains
XL1 Blue MRF′ (Stratagene) and DH5α (Invitrogen) were used for
cloning and plasmid propagation. They were cultivated in lysogeny
broth (LB) at 37 °C. For cultivation on solid LB medium, 1.5% (w/v)
agar was added. For selection of the recombinant E. coli strains, 50 μg
mL−1 carbenicillin was used.
Fungal strains used and created in this study are listed in Table 1. P.
crustosum PRB-227 was cultivated under static conditions at 25 °C in
glucose minimal medium (GMM),40 potato dextrose broth (PDB,
Sigma-Aldrich), or Czapek dox broth (CDB, BD). For cultivation on
solid medium, 1.5% (w/v) agar was added to the respective medium.
For selection of P. crustosum PRB-2 ΔpyrG mutants, GMM
supplemented with 2.05 mM uridine, 4.46 mM uracil, and 7.5 mM 5-
FOA at pH 4 was used. P. crustosum PRB-2 ΔpyrG was cultivated in
GMM supplemented with uridine and uracil.
A. nidulans LO8030 was cultivated under static conditions at 37 °C
in GMM supplemented with riboflavin, pyridoxine, uridine, and uracil
as reported previously.24 Cultivation of A. nidulans strains FK10 and
FK14 was done on rice supplemented with 6.6 μM riboflavin and 3
μM pyridoxine at 25 °C. Strain JN03 was cultivated in CDB medium
supplemented with uridine, uracil, and pyridoxine.
Isolation of Genomic DNA. For genomic DNA isolation, P.
crustosum, Penicillium camemberti (kindly provided by Joelle Dupont,
the National Museum of Natural History), Penicillium brevicompactum
(provided by ARS Culture Collection), A. ruber (provided by Bingui
Wang, Institute of Oceanology, Chinese Academy of Sciences), and A.
nidulans were cultivated in PDB for 2 days at 25 °C. Genomic DNA
was isolated according to the method described previously.21
Genome Sequencing and Sequence Analysis. The draft
genome sequence was obtained from BerryGenomics by using Nova-
seq6000/X-ten (Illumina). For prediction of open reading frames and
protein sequences, secondFind (http://biosyn.nih.go.jp/2ndfind/)
and FGENESH19 were used. Nucleotide sequences and predicted
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proteins reported in this study are available at GenBank under
accession numbers MK575554 (pcr4401), MK575555 (pcr4448−
pcr4453), MK575556 (pcr8116), and MK575557 (pcr6370).
The nucleotide and protein sequences of the investigated
polyketide synthases from P. camemberti and A. ruber originate from
NCBI database. By using secondFind, the coding sequence of
CRL19966 from P. camemberti was revised to have five exons (bp
1803195−1803854, 1803909−1805009, 1805071−1806264,
1806326−1810358, and 1810441−1811363 of HG793136.1) with a
deduced product of 2636 amino acids. The data of the P.
brevicompactum PKS Gm1.7502_g were obtained from the Joint
Genome Institute (JGI) (https://genome.jgi.doe.gov/Penbr2/
Penbr2.home.html). The coding gene is located between bp
2335606−2342342 bp at scaffold 4 with the protein ID 60339 and
the transcript ID 60527.
Gene Cloning, Plasmid Construction, and Genetic Manip-
ulation. The plasmids generated and used in this study are listed in
Table S1. Oligonucleotide primers used for construction of deletion
and heterologous expression vectors and transformant verification are
listed in Table S2. Phusion high-fidelity DNA polymerase (New
England Biolabs) was used for amplifications on a T100 thermal
cycler from Bio-Rad.
Construction of the deletion and heterologous expression vectors
was done by ligation-independent homologous recombination in E.
coli or S. cerevisiae.41,42 Briefly, vector backbones were linearized via
PCR with subsequent DpnI digestion or via restriction digestion with
subsequent purification via a HiYield PCR Clean-up and Gel-
Extraction Kit (SLG Südlaborbedarf). Primers with overlapping
homologous parts (20−25 bp) were used for DNA fragment
amplification. Subsequently the fragments with homologous overlaps
were mixed and transformed into E. coli DH5α or S. cerevisiae
HOD114-2B. The recombinant plasmids were verified by restriction
analysis.
For the pcr4401 deletion construct pFK6, two 1.5 kbp fragments of
its up- and downstream regions were amplified from P. crustosum
genomic DNA by using primers given in Table S2 with overlapping to
pGEM-T Easy vector and the hph cassette. The pGEM-T Easy vector
was linearized via PCR, and the remaining template was destroyed by
DpnI digestion. The hph cassette was amplified from plasmid
pUChph via PCR, followed by DpnI treatment. A pcr4401 deletion
fragment of 5916 bp was PCR amplified from pFK6 and subsequently
transformed into P. crustosum.
Construct pFK19 for heterologous expression of pcr4401 in A.
nidulans LO8030 is a derivative of the vector pYH-wA-pyrG.23 The
vector was linearized by restriction with NheI followed by SAP
treatment. Pcr4401 was amplified from genomic DNA of P. crustosum
PRB-2 (Table S2) as a full-length fragment with an additional 549 bp
at the 3′ end to include the native terminator sequence and
homologous overlaps to pYH-wA-pyrG. Assembled plasmid pFK19
was linearized with SwaI prior to transformation.
For the P. crustosum PRB-2 pyrG (Δpcr6370) deletion construct
pFK25, two 1.5 kbp fragments of up- and downstream regions were
amplified, mixed with PCR linearized pGEM-T Easy vector, and
transformed into E. coli DH5α. Using the obtained plasmid as a
template, the pyrG deletion cassette was amplified by PCR.
The vectors pFK20 and pFK23 for heterologous gene expression in
P. crustosum with hph or afpyrG as a selection marker are based on the
plasmid pYH-wA-pyrG. For targeting the pcr4401 locus as an
integration site, the 5′ and 3′ wA flanking regions from pYH-wA-
pyrG were replaced with 1 kbp flanking regions of the pcr4401 gene.
For creation of pFK23, the up- and downstream regions of pcr4401,
the pyrG selection marker with the gpdA promoter, and the E. coli ori/
ampR together with the ScURA-CEN/ARS were amplified by PCR
with the primers given in Table S2. For creation of pFK20, the same
up- and downstream flanking regions of pcr4401 were amplified by
PCR. Additionally, the gpdA promoter without the pyrG selection
marker and the E. coli ori/ampR together with the ScURA-CEN/ARS
were amplified from the vector pYH-wA-pyrG. The hygromycin B
resistance cassette originated from pUChph.
The vectors pFK20 and pFK23 were linearized via NheI digestion,
and the respective PKS genes were amplified by PCR from genomic
DNA with an additional 0.5 kbp at the 3′ ends. Corresponding
l inear i zed vector and fu l l - l ength PCR fragments of
PCAMFM013_S003g000758 , gm1.7502_g , and EURHE-
DRAFT_547227 were transformed into E. coli DH5α to give the
plasmids pFK21, pFK22, and pFK24, which were verified by
restriction analysis. The correct plasmids were linearized via SwaI
digestion prior to transformation.
The vector pYWB2 was cut with BamHI and NheI and used for
cloning the amplified afribo fragment coding for the riboflavin
biosynthetic gene and gpdA promoter via homologous recombination
in S. cerevisiae. The resulting vector pJN017 was then cut with SfoI
and transformed together with the PCR product of EURHE-
DRAFT_547227 into S. cerevisiae to create pJN015.
Transformation of P. crustosum PRB-2 and A. nidulans LO8030 was
achieved by polyethylene glycol (PEG) mediated protoplast trans-
formation according to the protocol of Yin et al.23 with modifications
for P. crustosum PRB-2. Germination time and temperature were
adjusted to 12 h at 25 °C. For protoplastation, the mycelia were
incubated with 50 mg of lysing enzymes from Trichoderma harzianum
(Sigma-Aldrich) and 20 mg of yatalase from Corynebacterium sp. OZ-
21 (OZEKI Co., Ltd.) per 10 mL of osmotic medium at 30 °C for 2 h.
Resistant transformants were selected by using 200 μg of hygromycin
B per mL bottom GMM and 100 μg per mL top GMM.
Cultivation and Product Extraction and Isolation. For
heterologous expression of pcr4401 in A. nidulans LO8030, the strain
FK10 was cultivated on rice medium supplemented with riboflavin
and pyridoxine at 25 °C for 7 days. SMs of the cultures were extracted
with EtOAc three times. Organic phases were combined and dried by
using a rotary evaporator and dissolved in methanol for HPLC and
LC−MS analyses. Heterologous expression in P. crustosum PRB-2 was
done in CDB as static cultures for 3−7 days at 25 °C. SMs were
extracted and analyzed as mentioned above.
YWA1 (1) and nor-rubrofusarin (2) were isolated from the crude
extract of FK10 on an Agilent HPLC series 1200 (Agilent
Technologies) with a semipreparative ZORBAX Eclipse XDB-C18
column (9.4 mm × 250 mm, 5 μm) (Agilent). Water (A) and
acetonitrile (B), both with 0.05% (v/v) trifluoroacetic acid, were used
as solvents. Elution of the substances was achieved isocratically with
45% (v/v) B in A at a flow rate of 4.0 mL/min. This column was also
used for 6-methylsalicylic acid (5) isolation from the FK13 extract
with a linear gradient from 10% to 55% B in 20 min at a flow of 3.0
mL/min.
3,5-Dimethylorsellinic acid (3) was isolated from strain FK11.
Crude extract was subjected to silica gel column chromatography
(silica gel 60, 0.04−0.063 mm) with a stepwise elution with CH2Cl2/
MeOH (100:0 to 70:30, v/v). A total of 13 fractions were achieved
and analyzed on LC−MS. Two fractions were further purified on the
HPLC mentioned above by using a Multospher 120 RP18 HP column
(10 mm × 250 mm, 5 μm) (CS-Chromatographie Service GmbH)
and with 40% solvent B in solvent A at a flow of 4.0 mL/min. This
column was also used for nor-toralactone (4) isolation from strain
FK12, and 50% solvent B in solvent A with a flow rate of 5.0 mL/min
was applied.
6-Methylsalicylic acid (5) was isolated from the extract of strain
FK13 by semipreparative HPLC. Water (A) and acetonitrile (B), both
with 0.02% (v/v) trifluoroacetic acid were used as solvents at a flow of
3.0 mL/min. Separation was done with a linear gradient from 10% to
55% B in 20 min. Afterward, the column was washed with 100% B for
5 min and subsequently equilibrated with 10% B for 5 min.
LC−MS and NMR Analyses. For LC−MS analysis, 5 μL samples
were injected into an Agilent 1260 series HPLC system (Agilent)
combined with a Bruker microTOF QIII mass spectrometer under
conditions described previously.43 1H NMR spectra were taken on a
JEOL ECA-500 MHz spectrometer (JEOL) and processed with the
software MestReNova 6.1.0 (Metrelab). Signals of the solvents were
used as reference of the chemical shifts.
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Table S1: Plasmids created and used in this study 
Plasmid Description  Source 
pUChph hygromycin B resistance vector, A. nidulans gpdA promoter, hph gene, 
A. nidulans trpC terminator  
1 
pGEM-T easy ampR, f1 ori, ColE1 ori Promega 
pYH-wA-pyrG URA3, wA flanking, A. nidulans gpdA promoter, A. fumigatus pyrG 
(afpyrG), ampR 
2 
pESC-URA Saccharomyces cerevisiae and E. coli shuttle vector Agilent 
pFK6 a 1500 bps PCR fragment of the upstream region of pcr4401 from 
genomic DNA of P. crustosum PRB-2 was fused to the 2875 bps hph 
resistance cassette from pUChph, which is connected to the 1500 bps 
PCR fragment of the downstream region of pcr4401 from P. crustosum 
PRB-2. The fused fragment was inserted into pGEM-T easy 
This study 
pFK19 a PCR fragment of 6660 bps containing pcr4401 and its native 
terminator region (549 bps) was amplified from genomic DNA of P. 
crustosum PRB-2 and inserted into pYH-wA-pyrG 
This study 
pFK20 a 1014 bps PCR fragment of the upstream region of pcr4401 from 
genomic DNA of P. crustosum PRB-2 was fused to the 3481 bps PCR 
fragment including the E. coli ori, ampR, and the ScURA-CEN/ARS from 
pYH-wA-pyrG, the 720 bps gpdA promoter originated from pYH-wA-
pyrG, the 2875 bps hph resistance cassette from pUChph, and the 983 
bps downstream region of pcr4401 from genomic DNA of P. crustosum 
PRB-2. 
This study 
pFK21 a 8169 bps fragment of PCAMFM013_S003g000758 coding for the PKS 
CRL19966 with native terminator region 502 (bps) was amplified from P. 
camemberti genomic DNA and inserted into pFK20 
This study 
pFK22 a 6737 bps fragment of gm1.7502_g coding for the PKS Gm1.7502_g 
with its native terminator region (526 bps) was amplified from P. 
brevicompactum genomic DNA and inserted into pFK20 
This study 
pFK23 a 1014 bps PCR fragment of the upstream region of pcr4401 from 
genomic DNA of P. crustosum PRB-2 was fused to a 2401 bps PCR 
fragment including the gpdA promoter and the afpyrG marker from pYH-
wA-pyrG, the 983 bps PCR fragment of the downstream region of 
pcr4401 from genomic DNA of P. crustosum PRB-2, and the 3481 bps 
PCR fragment including the E. coli ori, ampR and the ScURA-CEN/ARS 
from pYH-wA-pyrG.  
This study 
pFK24 a 5596 bps fragment of EURHEDRAFT_547227 coding for the PKS 
EYE91246 with its native terminator region (499 bps) was amplified from 
genomic DNA from A. ruber and inserted into pFK23 
This study 
pFK25  a 1500 bps PCR fragment of the upstream region of pcr6370 was fused 
to the 1500 bps PCR fragment of the downstream region of pcr6370 and 
inserted into pGEM-T easy  
This study 
pYWB2 URA3, wA flanking, A. fumigatus riboB (afribo), ampR 3 
pJN017 a 1445 bps fragment of the gpdA promoter amplified from A. nidulans 
inserted into pYWB2.  
This study 
pJN015 a 6096 bps fragment containing EURHEDRAFT_547227 coding for the 
PKS EYE91246 with its native terminator region (698 bps) was amplified 





Table S2: Primers used in this study 
Primer Oligonucleotide sequence (5’-3’) Uses 
pGEM_linear1 ACTAGTGAATTCGCGGCCG Linearization of pGEM-t easy vector via 
PCR pGEM_linear2 AATCGAATTCCCGCGGCC 
HygB_pUChph_f AGCTCTCCAAAGGGCG Amplification of the hph gene under the 
control of the A. nidulans gpdA promoter 





CTCCGTGGATTTGGGATTT Amplification of the upstream region of 







TTAAACAGCTAGCTGAAATCTAAC Amplification of the downstream region of 





Screening of ∆pcr4401 transformants  
pcr4401_con_r GCTGCTGCAATCCATGTG 
∆pcr4401_con_f GTCCTTCTACACGAGATGGC 
Screening of ∆pcr4401 transformants  
∆pcr4401_con_r GAACATATCGAGCGTTGTTTG 
hph_con_f AGATACAGCTCATCTGCAATG 




TTCGATTGAATGATCGGCACGAAAG Amplification of the upstream region of 







TGCACGCTGGTGGGGTTGGCGGG Amplification of the downstream region of 





Screening of ∆pcr6370 transformants  
PyrG_k_gen_f TCCAGAAACAGTACCACAACGGC 
PyrG_k_r_gen TGGTACTGTTTCTGGACTGTGTTGC 





Amplification of the upstream region of 
pcr4401 from P. crustosum for 
construction of the heterologous 
expression vectors pFK20 and pFK23 for 







Amplification of the downstream region of 
pcr4401 from P. crustosum for 
construction of the heterologous 







Amplification of the E. coli ori/ampR and 
ScURA-CEN/ARS from pYH-wA-pyrG for 












Amplification of afpyrG gene and gpdA 







Amplification of the downstream region of 
pcr4401 from P. crustosum for construction 
of heterologous expression vector pFK20 






TAGCGATTAAAGGTTCTTGGATG Amplification of the gpdA promoter from 






AGTTCCAGGTGGAATGTTATG Amplification of hph resistance cassette 







Amplification of the full length 
PCAMFM013_S003g000758 including the 





CRL19966_con_F CGAAGAAAACAAGGTCAATGG Screening of PCAMFM013_S003g000758 




Amplification of the full length gm1.7502_g 
including its native terminator region from 









Amplification of the full length 
EURHEDRAFT_547227 including its native 
terminator region from A. ruber 6-MSA-R 
TCAGACACAGAATAACTCTCGCTAGG
GCACGTGAGAAGTTTTTTTATTG 
6-MSAS_con_f TGCTATTCTCGAAGAGTTCCC Screening of EURHEDRAFT_547227 




Amplification of the full length pcr4401 
including its native terminator region from 





GCACGTGAGAAGTTTTTTTATTG Amplification of the full length 
EURHEDRAFT_547227 including its native 
terminator region from A. ruber 6-MSA_2-R 
GCTACCCCGCTTGAGCAGACATCACCGGC
ATGTGTACCTCTACTCCTTC 
Afumigatus_Ribo_f CACATGGGATTAAAATATGG Amplification of the A. fumigatus afribo 
selection marker Afumigatus_Ribo_r GACCGGGGTCTCTAG 
ANidulans_gpdA_f 
GGACTTGACTCTCCTTCTCCTGATCGGATC








Table S3: Colony size of P. crustosum strains grown on GMM plates. Values are means of three 
replicates.  
Strain 
Colony diameter in mm 
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
WT 0.8 ± 0.2 3.8 ± 0.6 9.5 ± 0.7 13.8 ± 0.6 18.0 ± 0.4 23.0 ± 0.8 26.8 ± 0.6 
FK02 1.0 ± 0.0 4.3 ± 0.2 10.8 ± 0.2 14.7 ± 0.5 18.7 ± 0.5 23.8 ± 0.6 27.2 ± 0.2 
FK11 1.0 ± 0.0 4.8 ± 0.2 11.5 ± 0.4 15.7 ± 0.5 19.5 ± 0.4 24.8 ± 0.2 28.7 ± 0.2 
FK12 0.7 ± 0.2 4.2 ± 0.2 11.8 ± 0.2 16.7 ± 0.5 19.3 ± 0.5 24.3 ± 0.5 27.8 ± 0.2 
FK13 1.0 ± 0.0 4.7 ± 0.5 12.2 ± 0.6 16.3 ± 0.9 19.0 ± 0.8 24.2 ± 1.0 28.2 ± 0.8 





Table S4: DHN-melanin biosynthetic candidates in P. crustosum and homologues from A. fumigatus 















Pcr4401 2139 EAL94057.1 
(Alb1) 
65.8 XP_002568608.1 93.9 polyketide synthase 
Pcr4448 686 EAL94051.2 
(Abr1) 
48.6 XP_002568645.1 76.3 oxidase 
Pcr4449 354 - - XP_002568646.1 58.8 hypothetical protein 
Pcr4450 191 - - XP_002568647.1 12.5 hypothetical protein 
- 764 - - XP_002568648.1 - hypothetical protein 
Pcr4451 171 EAL94055.1 
(Arp1) 
68.4 XP_002568649.1 81.9 scytalone dehydratase 
Pcr4452 268 EAL94053.1 
(Arp2) 
69.9 XP_002568650.1 95.1 1,3,6,8-tetrahydroxynaphthalene 
reductase 
Pcr4453 409 EAL94052.1 
(Ayg1) 























































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure S1: HPLC analysis of ethyl acetate extracts of CDB medium (negative control), P. crustosum 






Figure S2: UV spectra from the isolated compounds. See reference 9 for YWA1, 9 for nor-rubrofusarin, 







Figure S3: Schematic presentation of the DHN-melanin BGCs in P. crustosum, P. rubens, and A. 








Figure S4: Schematic representation of the two plasmids pFK20 (A) and pFK23 (B) for site-specific 
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 5. Conclusion and outlook 
 
5. Conclusion and outlook  
In this thesis, different approaches have been used for expanding of the diversity of natural products. 
The biochemical characterization of enzymes with respect to their specific reaction conditions, 
substrates and cofactors involved as well as the elucidation of their crystal structures, are increasingly 
becoming standard procedures. This forms the basis for their further usage as biocatalysts in synthetic 
biology approaches to produce new compounds. The DMATS prenyltransferase family with more than 
60 well-characterized members provides numerous biochemical information on their reactions. The 
systematic analysis of these data combined with chemoinformatic methods led to the development of 
the PrenDB to predict new potential substrates for prenyltransferases. The experimental verification 
of these predictions confirmed the proof of principle and the strength of this database. The possibility 
to extend this database by implementing newly characterized prenyltransferases will further improve 
the accuracy of the predictions. 
The prenyltransferases EchPT1 and EchPT2 are such two examples of newly characterized DMATS 
members. Their characterization was the prerequisite for establishing the biosynthetic hypothesis of 
echinulin. Interaction of both prenyltransferases leads to reverse prenylation at position C2 of cyclo-L-
tryptophanyl-L-alaninyl with subsequent multiple prenyl transfers to the indole nucleus. The 
promiscuity known from prenyltransferases with respect to their accepted substrates was also 
confirmed for these two prenyltransferases. This allowed their application in the production of 
multiple prenylated tryptophan-containing cyclic dipeptides. It was observed that the configuration of 
the substrates has a strong influence on the formation of tetra-prenylated products. An even better 
usability of EchPT1 and EchPT2 for the biosynthesis of new substances can certainly be achieved by 
elucidating their crystal structure.  
In contrast to in vitro methods for the extension and investigation of natural products, heterologous 
expression in host organisms is an alternative in vivo method. Various hosts are already successfully 
used for the heterologous expression of secondary metabolites. However, obstacles such as different 
splicing patterns compared to the donor organism are encountered, making the use of these hosts 
sometimes difficult. To overcome this, alternative hosts for heterologous expression are necessary and 
welcome. Sequencing the genome of Penicillium crustosum and the generation of a pyrG deficient 
strain built the basis for using this fungus as a heterologous expression host. With the two generated 
plasmids pFK20 and pFK23, the easy detection upon successful integration into the pcr4401 locus is 
ensured by the occurrence of an albino phenotypes. The suitability as an expression host was then 
proven by the successful expression of three PKS genes and the subsequent isolation and structural 
elucidation of the formed product. Additional genetic modification can further improve the potential 
of Penicillium crustosum as an expression host. 
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 5. Conclusion and outlook 
 
The following subjects are planned for further investigations: 
➢ Ongoing maintenance and improvement of the PrenDB database by implementing newly 
characterized DMATS prenyltransferases and their reactions. 
➢ Further investigation of the newly identified prenyltransferase substrate classes by in vitro 
enzyme assays and elucidation of the formed products. 
➢ Elucidation and analysis of the crystal structures of the prenyltransferases EchPT1 and EchPT2. 
➢ Targeted protein engineering of the prenyltransferases EchPT1 and EchPT2 to expand the 
prenyl acceptor and prenyl donor space. 
➢ Improving the applicability of Penicillium crustosum as heterologous expression host through 
deletion of the backbone genes claF and traA involved in the biosynthesis of peniphenones 
and penilactones. 
➢ Generation of a Penicillium crustosum KU70 deletion strain for the improvement of the gene 
targeting rate. 
➢ Further use of Penicillium crustosum for the heterologous expression of whole gene clusters 
with associated structural elucidation of the possible products formed.
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